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ABSTRACT 
Dopamine (DA) is a key neuromodulator in the brain that can exert a profound impact on 
brain physiology and cognitive functions. There is consensus that DA plays critical roles in 
reward prediction error, reinforcement learning, and motor control, and that dysregulation of 
DA signaling is common in many neuropsychiatric diseases, such as Parkinson’s disease, 
drug addiction, and depression. Although the tools to study the functional roles of DA have 
considerably expanded with novel genetic tools and optical imaging methods, we are still 
limited in our ability to record or visualize DA release in vivo with long-term stability and 
high spatiotemporal resolution. This is an unmet need in DA research, as DA release at the 
post-synaptic sites can be decoupled from DA cell body firing due to local circuit interaction 
and influence from other afferent activities. In parallel, there is growing evidence that DA is 
functionally heterogeneous beyond its classically described roles for reward and movement, 
based on its anatomical location, projection target, electrophysiological properties, and 
response patterns to stimuli with motivational valence. Pharmacological and genetic studies 
have provided indirect evidence that DA can promote strong behavioral arousal and signal 
salience, but the precise neural substrates for these functions remain largely unknown. 
Towards this end, my thesis work has been focused on 1) developing and characterizing 
optical tools to visualize DA release in vivo and 2) utilizing such optical and genetic tools to 
study the overlooked, sparse DA populations in the dorsal midbrain, demonstrating that they 
are functionally unique DA cells for broadcasting arousal and salience signals to the forebrain 
targets. 
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As neuromodulatory systems exert profound influences on brain function, 
understanding how these systems modify the operating mode of target circuits requires 
spatiotemporally precise measurement of neuromodulator release. Towards this goal, in 
Chapter II, my colleagues and I developed dLight1, an intensity-based genetically encoded 
DA indicator, to enable optical recording of DA dynamics with high spatiotemporal 
resolution in behaving mice. We demonstrated the utility of dLight1 by imaging DA 
dynamics simultaneously with pharmacological manipulation, electrophysiological or 
optogenetic stimulation, and calcium imaging of local neuronal activity. dLight1 enabled 
chronic tracking of learning-induced changes in millisecond DA transients in mouse 
striatum. Further, we used dLight1 to image spatially distinct, functionally heterogeneous 
DA transients relevant to learning and motor control in mouse cortex. We also validated 
our sensor design platform for developing norepinephrine, serotonin, melatonin, and opioid 
neuropeptide indicators. Together, this tool provides a unique opportunity to optically 
monitor DA release dynamics in vivo with long-term stability and unprecedented 
spatiotemporal resolution. 
 
In Chapter III, I have characterized the functional roles of sparse DA populations in the 
dorsal raphe nucleus (DRN) and discovered that these neurons play key roles in promoting 
behavioral arousal. I first demonstrated that DRNDA neurons are activated by diverse forms 
of motivationally salient stimuli, irrespective of valence. Simultaneous fiber photometry 
and polysomnographic recordings showed that DRNDA neuronal activity is correlated with 
distinct sleep-wake states, showing highest activities during wakefulness over sleep states. 
Optogenetic activation of DRNDA neurons was sufficient to cause immediate sleep-to-wake 
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transitions and promote longer wakefulness upon sustained stimulation. On contrary, 
DRNDA inhibition via chemogenetics reduced wakefulness and promoted non-rapid eye 
movement sleep, even in the presence of ethologically relevant salient stimuli. Taken 
together, this pinpoints DRNDA neurons as the critical contributor of arousal-promoting 
DA system in the brain. 
 
In Chapter IV, I further characterized the encoding dynamics of DRNDA neurons during 
classical conditioning tasks where mice learned the association between neutral cues and 
outcomes with positive or negative outcomes. DRNDA neurons developed phasic, positive 
responses to cues predicting both positive and negative unconditioned stimuli across 
learning, suggesting that these populations track motivational salience rather than valence. 
In addition, DRNDA neurons encoded unsigned prediction error, demonstrating higher 
neuronal activity to unexpected reward or punishment over fully expected outcomes. 
Collectively with Chapter III, these results expand on the existing literature on functionally 
heterogeneous roles of DA in the brain and propose that DRNDA neurons play critical roles 
in signaling arousal and motivational salience to the forebrain regions to coordinate 
appropriate behavior, depending on the nature of environmental stimuli.   
 x 
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C h a p t e r  1  
INTRODUCTION 
1.1 Dopamine as a neuromodulator 
Neurons communicate with each other in electrochemical language, where electrical 
signals such as action potentials are translated into chemical transmission by releasing 
neurotransmitters or neuromodulators from synaptic terminals to the post-synaptic targets, 
which in turn convert into electrical potentials via ion channels or triggers biochemical 
signaling cascade through G-protein coupled receptors (GPCR). One such media for the 
neuronal transmission is dopamine (DA), which exerts a profound influence on neural 
circuit dynamics and behavior.  
 
DA is an organic chemical neurotransmitter within the catecholamine family. It is 
synthesized in a particular group of neurons in the brain (see Chapter 1.3 for details) and 
cells in the medulla of the adrenal glands to be used as circulatory hormone. Several 
metabolic pathways exist for DA synthesis but they all start from L-Phenylalanin, which 
is converted to L-Tyrosine with biopterin-dependent aromatic amino acid hydroxylase. In 
the primary pathway, L-Tyrosine is converted to L-DOPA, a precursor of DA, by the rate-
limiting enzyme tyrosine hydroxylase. Finally, DA is synthesized from L-DOPA by the 
enzyme DOPA decarboxylase. DA can be used as an independent neurotransmitter, but at 
the same time in a subset of catecholamine neurons, it is used as a precursor for 
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synthesizing another aminergic neurotransmitters norepinephrine with the enzyme 
dopamine b-hydroxylase.  
 
DA mediates its effects in downstream regions by binding to and activating DA receptors. 
All DA receptor types are GPCRs, which suggest that they exert their post-synaptic effects 
through biochemical signal cascade and second messenger system and indirectly influence 
neuronal excitability. DA receptors are often divided into two subtypes, D1-like and D2-
like. The D1-like family consists of D1 and D5 receptors, both of which are Gs-coupled 
ones to increase the intracellular level of cyclic adenosine monophosphate (cAMP) by 
activating adenylyl cyclase. In most cases, the ultimate effect of activating D1-like 
receptors is to increase the excitability of the post-synaptic neurons by diverse mechanisms, 
including opening of sodium channels. The D2-like family is composed of D2, D3, and D4 
receptors, all of which are Gi-coupled to decrease the intracellular level of cAMP by 
inhibiting adenylyl cyclase. Upon activating D2-like receptors, post-synaptic cells are 
mostly inhibited, in part through the opening of potassium channels. Therefore, it is not 
straightforward to describe the post-synaptic action of DA either as excitatory or inhibitory, 
as it depends on the type of DA receptors expressed in the post-synaptic neurons and the 
type of GPCR they are coupled to.  
 
DA is synthesized in the cell bodies or axons of dopaminergic neurons, and they are 
transported to the synaptic vesicles from the cytosol via vesicular monoamine transporter. 
Synaptic vesicles containing DA molecules can be released into the synaptic cleft either 
via action potential firing or via activation of intracellular trace amine-associated receptors. 
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Once DA is released from synaptic terminals, it can bind to post-synaptic DA receptors 
or pre-synaptic auto-receptors (mostly D2 receptors). After activation, DA can be rapidly 
unbound from them and absorbed back into the presynaptic cells by the dopamine 
transporter (DAT). The relative concentration of DAT on axon terminals can dictate the 
spatiotemporal window of DA action in the post-synaptic circuits: for example, DA axons 
in the prefrontal cortex show sparse immunoreactivity to DAT (Sesack et al. 1998), unlike 
the DAT-enriched striatum, therefore showing reduced DA reuptake and longer distance 
of volume transmission (Cass and Gerhardt, 1995). 
 
There are two modes of DA neuronal firing and subsequent DA release: 1) tonic mode, 
where DA cells continuously fire in 2-5 Hz like pacemakers, and 2) phasic mode, where 
DA neurons fire high-frequency bursts, usually not longer than 500 ms (Grace et al., 2007). 
Tonic firing ensures the consistent release of DA into the post-synaptic targets. Phasic 
firing of DA neurons rapidly and transiently elevates extracellular DA levels, reaching up 
to ~100 uM in the striatum, and preferentially activates D1-like receptors with lower 
affinity (Grace et al., 2007; Dreyer et al., 2010). The interaction between tonic and phasic 
transmission modes is important in modulating downstream circuit functions, as the post-
synaptic effect of phasic firing is dependent on the basal level of dopamine (from tonic 
firing) within the synaptic environment (Wanat et al., 2009).  
 
Through decades of research, DA has been implicated in a wide range of cognitive function 
and behavior, such as motor control, reward, motivation, reinforcement, executive 
function, and arousal. Tools to detect DA release in vivo have also been developed to study 
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the functional role of DA, and they will be discussed in the following Chapter 1.2. Specific 
functions of DA signaling mediated by separate sub-groups will be discoursed in the 
Chapter 1.3. One critical function of DA most relevant to this thesis is its role in promoting 
behavioral arousal. Systemic change of DA tone in the brain is demonstrated to modulate 
the level of behavioral arousal. For example, some recreational and addictive drugs such 
as cocaine or amphetamine cause strong behavioral arousal, in part by increasing 
extracellular DA concentration through blocking the reuptake action of DAT (Arias-
Carrion et al., 2011). Another pharmacological evidence comes from Modafinil, one of the 
most clinically effective drugs to treat patients with narcolepsy and other sleep disorders, 
and DAT blocking action contributes to its wake-promoting mechanism (Zolkowska, et al., 
2009). In mice, selective knockout of DAT gene reduced non-rapid eye movement sleep 
and increased wakefulness, arguing for DA’s stimulant role in promoting wakefulness 
(Wisor et al., 2001). Overall, it is well accepted that systemic increase of DA tone in the 
brain does promote behavioral arousal, but the neural substrate or specific group of DA 
neurons responsible for its action and its specific encoding properties are not well known. 
 
  
5 
1.2 Tools for measuring dopamine release in vivo 
In order to investigate the functional roles of DA on post-synaptic circuits and behavior, it is 
critical to detect DA release in vivo. With the recent success of genetically encoded calcium 
indicator GCaMP family (Chen et al., 2013), Ca2+ imaging of dopamine neurons or axons 
contributed to revealing novel insights on DA dynamics during behavior. For example, fiber 
photometry and two-photon imaging of GCaMP-expressing DA axons revealed rapid and 
phasic signaling associated with locomotion in the dorsal striatum, which could be 
differentiated from separate axons that signal reward (Howe and Dombeck, 2016). In 
addition, multi-site fiber photometry recording of DA axons revealed heterogeneous 
responses to reward and punishment depending on projection targets (Kim et al., 2016). 
 
While these type of studies may reveal novel insights on DA firing or neuronal activity 
associated with specific behavior, these findings cannot be directly generalizable to DA 
release dynamics since the relationship between Ca2+ dynamics of DA axons (as an indirect 
measure of DA action potential firing) and actual DA release to post-synaptic targets is 
nonlinear. Other factors, such as local acetylcholine signaling, autoreceptors, and various 
neuropeptides, can contribute to DA release in vivo, in addition to DA neuronal firing (Sulzer 
et al., 2016). Indeed, it was recently shown from simultaneous electrochemical and single-
unit recordings that striatal DA release can be decoupled from DA cell firing (Mohebi et al., 
2018). Therefore, it is important to have complementary recording techniques to directly 
measure DA release within a defined target circuit, preferably with high spatiotemporal 
resolution. There have been a number of existing methods to detect DA release in vivo, such 
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as microdialysis, fast scan cyclic voltammetry (FSCV), and optical sensors. While they have 
been widely used to study DA function, each of method suffers from some critical 
weaknesses. 
 
Microdialysis is a chemical sampling technique that requires the insertion or implantation of 
a small probe into the tissue of interest. This probe mimics a blood capillary with semi-
permeable membrane and has inlet/outlet tubing for allowing the perfusion of aqueous 
solution, such as artificial cerebrospinal fluid if used in the brain. When the probe is inserted 
in a tissue, small solutes or molecules can pass through the semi-permeable membrane by 
passive diffusion, and the concentration of these solutes can be measured and analyzed. Key 
advantages of microdialysis include easy construction of probes and its versatility. 
Practically, it can detect any neurotransmitter or neuromodulator of interest, including DA, 
and is well tolerable in in vivo experiments. The most critical disadvantage, however, is its 
poor temporal resolution: as it takes minutes to collect enough samples for analysis, 
concentration of molecules can only be resolved in minute-scale, usually resulting in 10-15 
minutes as a single temporal step. This limits the number of compatible behavioral assays 
that can be paired with microdialysis, since it cannot measure faster component of DA release 
dynamics. Another disadvantage is that it samples DA (or other molecules of interest) in the 
extracellular space where the probe is located, and therefore it does not necessarily correlate 
with its concentration near the post-synaptic targets.  
 
Another prevalent method in measuring DA release is the FSCV, which utilizes the inserted 
carbon-fiber microelectrodes and oxidization-reduction capabilities of DA depending on 
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voltage levels. Once the carbon-fiber microelectrode is inserted into the brain region of 
interest, the potential at the microelectrode is ramped up and down at a high scan rate. When 
dopamine is oxidized to dopamine-o-quinone, it donates two electrons that can be measured 
as electrical current. As the potential scan rate is fast enough (~400 V/s), the key strength of 
this method is its capability to measure DA concentration at millisecond time scale. This is 
a vital reason that FSCV has been the gold standard to investigate fast DA transients in 
response to short-lived stimuli or behavioral tasks. However, it also suffers from several 
limitations. First, similar to microdialysis, the measurement takes place in the extracellular 
space, and therefore it does not necessarily match with actual DA concentration acting on 
post-synaptic receptors. Second and more importantly, FSCV cannot differentiate DA from 
norepinephrine (NE), another catecholamine neurotransmitter, due to its similarity in 
chemical structures. As NE shows same oxidization-reduction properties as dopamine, the 
current measured from the microelectrode cannot differentiate the relative contributions from 
two distinct catecholamine molecules. This has limited the application of FSCV for DA 
studies only in the striatum, where dense DA projections are existent without NE innervation. 
Therefore, this method is not feasible to measure DA release dynamics in other areas, such 
as the cortex where both of DA and NE signaling are present.  
 
Recently, there have been attempts to using optical methods for detecting DA release in vivo. 
One such tool is CNiFER (cell-based neurotransmitter fluorescent engineered reporters), 
which utilize the G-protein-coupled receptor (GPCR) and its biochemical pathway to detect 
DA (Muller et al., 2014). CNiFER is derived from HEK293 cells and expresses chimeric D2 
dopamine receptor and TN-XXL, a genetically encoded FRET-based Ca2+ sensor. Once DA 
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binds and activates the GPCR, it triggers signal cascade through the phospholipase C-
inositol triphosphate pathway and increases cytosolic Ca2+ concentration. This increased 
Ca2+ inside the cell leads to a fluorescent increase in FRET from the TN-XXL. While this 
method is compatible in vivo and can differentiate DA release from NE action, it is relatively 
slow (second to minute scale) due to endogenously slow temporal kinetics of GPCR 
signaling pathway, and the signal-to-noise ratio of FRET sensor is suboptimal. Another 
recently developed technique to detect DA release in vivo is iTango, a light- and ligand-gated 
gene expression system (Lee et al., 2017). As iTango expresses reporter gene (such as 
fluorescent protein) or Cre recombinase depending on the presence of both ligand and blue 
light, it can visualize or even manipulate cells affected by DA during specific, user-defined 
temporal window. For example, Lee et al. (2017) labeled striatal cells affected by DA during 
locomotion (by delivering blue light only during locomotion) and showed that optogenetic 
activation of these cells in turn triggers locomotion, but not from neurons labeled during 
reward consumption. Although iTango system allows for visualization or manipulation of 
cells influenced by DA in a genetically and functionally defined manner, it again suffers from 
poor temporal resolution, as it cannot report the dynamic DA concentration in real-time.  
 
Current limitations of these existing methods hint at some of desired properties for novel 
dopamine sensor. First, it is desirable for such system to be based on endogenous dopamine 
receptors for high specificity over other chemically similar neurotransmitters. Second, it has 
to have fast kinetics to capture sub-second changes in DA signaling. Third, optical readout 
methods are preferable to others to quantify DA levels through visualization, potentially at 
cellular or even sub-cellular level. Finally, this sensor should be expressed in the membrane 
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in a genetically specific manner in order to measure DA in close proximity to defined post-
synaptic cells. In Chapter II, I present dLight1, an intensity-based optical sensor for 
dopamine based on D1 receptor, to meet such needs for measuring DA release in vivo. My 
colleagues and I further demonstrate the utility of dLight1 in various settings, from ex vivo 
slice setups to measuring DA release in freely moving animals, and to monitoring cortical 
DA dynamics in vivo at the cellular resolution. 
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1.3 Anatomical and functional heterogeneity of dopamine system 
DA has been best known as the neurotransmitter responsible for reinforcement learning, 
reward-seeking behavior, and motor control, because seminal studies have shown its unique 
role in encoding reward prediction error (RPE; Schultz et al., 1997). Moreover, dysregulation 
of the DA pathways is implicated in relevant pathological conditions, such as drug addiction 
and Parkinson’s disease (Volkow et al., 2017; Charvin et al, 2018). However, it is 
increasingly recognized that DA has more diverse functions beyond reward and movement, 
and can encode aversion, alertness, arousal, and salience (Bromberg-Martin et al., 2010; 
Lammel et al., 2014).  
 
Although most of DA studies have focused on the ventral midbrain populations, there is a  
great degree of anatomical and functional heterogeneity within DA systems in the brain. 
Dopaminergic populations were first systemically described by Dahlstroem and Fuxe, who 
labeled monoaminergic neurons starting with the letter A for “aminergic” (Dahlstroem and 
Fuxe, 1964). In their description, A1-A7 populations denote the groups containing 
norepinephrine, while A8-A14 groups consist of anatomically segregated DA populations. 
Substantia nigra pars compacta (SNc or A9) and ventral tegmental area (VTA or A10) are 
located in the ventral midbrain and the most well-studied DA groups. SNcDA neurons mostly 
project to the dorsal striatum, terms as “nigrostriatal” pathway, and are known to regulate 
motor function, action learning, and movement vigor (Groenewegen, 2003; Howe and 
Dombeck, 2016; da Silva et al., 2018). SNcDA populations are specifically vulnerable to 
neurodegeneration, and severe loss of these DA neurons can result in motor symptoms of 
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Parkinson’s disease (Charvin et al., 2018). There is evidence for molecular and functional 
diversity even within the A9 group: for example, SNcDA neurons defined by distinct genetic 
or molecular markers showed differential vulnerability to Parkinsonian attack (Poulin et al., 
2014). In addition, SNcDA neurons in the most lateral side, which uniquely co-express 
glutamatergic marker (vglut2) and project to the tail of the striatum, were shown to contain 
little information about movement but to encode the presence of salient or aversive stimuli 
in order to reinforce avoidance behavior (Poulin et al., 2018; Menegas et al., 2017 and 2018). 
 
VTADA (A10) populations are another relatively well-studied group in the ventral midbrain, 
sending projections mainly to the ventral striatum (including the nucleus accumbens) and 
prefrontal cortex, but also to the amygdala, hippocampus, and olfactory bulb. VTADA 
neurons, especially the mesolimbic pathway projecting to the nucleus accumbens (NAc), 
have been widely recognized for its function in reward-seeking behavior and reinforcement 
learning, as VTADA neurons encode reward prediction error (Schultz, 1997; Bromberg-
Martin et al., 2010), gate associative learning (Steinberg et al. 2013), and support intracranial 
self-stimulation through operant conditioning (Witten et al., 2011). Mesolimbic DA pathway 
is heavily implicated in neural mechanisms of drug addiction, as many drugs for substance 
use can “hijack” this DA-dependent reward circuitry through maladaptive learning 
mechanisms (Chen et al., 2010). While the activity profiles of most VTADA neurons are 
compatible with its proposed role in positive reinforcement learning and RPE encoding 
(Schultz et al., 1997; Cohen et al., 2012; Witten et al., 2011), there are some VTADA neurons 
described to signal aversion, showing phasic responses to non-rewarding, aversive stimuli 
(Brischoux et al. 2009; Matsumoto and Hikosaka, 2009). Consistent with this idea, it has 
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recently been demonstrated by optical recordings that VTADA terminals in the ventral NAc 
medial shell are excited by aversive outcomes and their cues (de Jong et al., 2019). Similarly, 
VTADA terminals in the mPFC and basolateral amygdala were also excited by aversive 
events (Kim et al., 2016), suggesting that positive and negative valences may be separately 
encoded by distinct VTADA neurons defined by projection targets. This functional diversity 
within VTADA subgroups may arise in part from distinct input patterns (Lammel et al., 2012), 
indicating that complex anatomical connectivity can give rise to divergent functions in a 
seemingly homogenous population. These studies expand from the reward-centric view of 
VTADA neurons and provide novel mechanisms on how they carry distinct diverse 
information, such as aversion, alertness, or salience, to the forebrain regions (Bromberg-
Martin et al., 2010).  
 
Other DA neuronal groups are found in distinct sub-regions within the hypothalamus, but 
their functional roles are not well known. A11 group in the posterior hypothalamus projects 
to the spinal cord and may contribute to coordinating limb movements, as its dysfunction 
is implicated in restless leg syndrome (Paulus and Schomburg, 2006). Small portions of 
these neurons also project to the inferior colliculus and the auditory brainstem, suggesting 
its potential role in auditory processing (Nevue et al., 2016). DA neurons in the arcuate and 
periventricular nucleus of the hypothalamus, or A12 group, consist of the 
tuberoinfundibular pathway projecting to the pituitary gland and inhibits the release of the 
hormone prolactin. A subpopulation of this A12 group was recently shown to govern 
maternal behavior by controlling the level of oxytocin secretion through its projection to 
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the paraventricular hypothalamus (Scott et al., 2015). The functional property of A13 
DA neurons in the zona incerta is not known, as there have not been much of studies on 
this group, but some anatomical studies demonstrated their projections to diverse regions 
including basal forebrain, central amygdala and dorsolateral periaqueductal gray (Eaton et 
al., 1994; Messanvi et al., 2013). 
 
Another poorly characterized DA neuronal population is found within the dorsal raphe 
nucleus (DRN), a heterogeneous brainstem region that contains diverse neuronal cell types 
including serotonin, glutamate, GABA, dopamine, and various neuropeptides. Historically, 
this group was labeled “A10dc”, the dorsocaudal extension of A10 VTA group. As it is 
correct that DRNDA neurons are continuously extended from VTADA neurons through 
dorsal and caudal directions, these neurons were often overlooked, and hence their 
functions were simply assumed to be equivalent as A10 group. However, some of recent 
studies propose against this notion. For example, A10dc group may be directly involved in 
regulating sleep-wake states. Whereas the role of ventral midbrain DA neurons in sleep-
wake regulation has been ambiguous as these neurons do not change their mean firing rate 
across different behavioral states (Miller et al., 1983), DA neurons in the DRN and ventral 
periaqueductal gray were more activated during wake or forced wake period over sleep 
states, as shown by increased c-fos expression (Lu et al., 2006). Further, selective 
neurotoxic lesion of DRNDA cells, while sparing other neighboring types of cells, resulted 
in hypersomnia phenotype where rats spent ~20 % more time in sleep during both dark and 
light cycles, suggesting that their endogenous role may be to promote wakefulness (Lu et 
al., 2006). Another study characterized DRNDA neurons in the regulation of pain 
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perception, demonstrating that chemogenetic activation of these neurons mediated 
supra-spinal anti-nociceptive effect (Li et al., 2016).  
 
A recently study on DRNDA neurons by Matthews and colleagues unraveled novel ideas 
about physiology, anatomical connectivity and function of these neurons (Matthews et al, 
2016). They first showed that DRNDA neurons preferentially project to the extended 
amygdala structures, both central amygdala and bed nucleus of stria terminalis, unlike 
VTADA neurons mostly projecting to the ventral striatum and prefrontal cortex. They also 
confirmed that these neurons release DA to those downstream regions via FSCV detection 
methods, and some of them express molecular marker for glutamate (vglut2) to co-release 
glutamate. Importantly, optogenetic activation of DRNDA neurons promoted social 
interaction but did not support operant conditioning. Rather, phasic photostimulation of 
DRNDA neurons resulted in mild aversion to the light-paired chamber. Additionally, with 
ex vivo and in vivo recording data that DRNDA neurons are activated by social targets and 
sensitive to the experience of acute social isolation, they suggested that increased social 
interaction results from negative reinforcement mechanisms and DRNDA neuronal activity 
represents the “loneliness-like” emotional state. 
 
These seemingly disparate roles suggested for DRNDA neurons imply that they may play 
more general roles than representing specific aspects of behavior. All of these studies on 
sleep-wake regulation, anti-nociception, and social isolation suggest one fundamental link 
in common: these neurons may signal arousal or alertness towards external, motivationally 
salient stimuli. During my doctoral training, I have devoted a significant amount of my 
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time to understanding the unique functional roles of DRNDA neurons using novel optical 
and genetic tools. In Chapter III, I demonstrate that these neurons are indeed critical 
modulators of sleep-wake regulation, showing that DRNDA neuronal activity was highest 
at wake over sleep states and that bi-directional manipulation of these neurons can affect 
the level of arousal. In Chapter IV, I further show that these neurons encode motivational 
salience and unsigned prediction error. Collectively, these data propose that DRNDA 
neurons are fundamentally distinct from VTADA neurons in both anatomical connectivity 
and functional property, and that their endogenous role is to signal arousal and salience to 
the selected forebrain targets to guide appropriate behavior. 
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C h a p t e r  2  
ULTRAFAST NEURONAL IMAGING OF DOPAMINE DYNAMICS 
WITH DESIGNED GENETICALLY ENCODED SENSORS  
[1] Patriarchi, T. and Cho, J. R. et al. (2018). “Ultrafast neuronal imaging of dopamine dynamics 
with designed genetically encoded sensors.” In: Science 360.6396, pii: eaat4422. doi: 
10.1126/science.aat4422. 
 
 
2.1 Summary 
INTRODUCTION: Neuromodulators, such as dopamine, norepinephrine, or serotonin, 
exert powerful control over neural circuit dynamics that give rise to diverse neural function 
and behavior. Altered neuromodulator signaling is a key feature of virtually all human 
neurological and psychiatric disorders, including Parkinson’s disease, schizophrenia, 
depression, and addiction. Hence, drugs that mimic or block neuromodulators have become 
important components in the treatment of these disorders. Much work is devoted to 
determining exactly what information neuromodulatory neurons represent, but very little 
is known about how these signals alter the function of their target circuits.  
 
RATIONALE: To address this problem, scientists need to be able to monitor the 
spatiotemporal dynamics of neuromodulatory signals in target circuits while also 
measuring and manipulating the elements of the circuit during natural behavior. However, 
existing technologies for detecting neuromodulators, such as analytic chemical or cell-
based approaches, have limited spatial or temporal resolution, thus preventing high-
resolution measurement of neuromodulator release in behaving animals. We recognized 
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the potential of combining genetically encoded indicators based on fluorescent proteins 
with modern microscopy to support direct and specific measurement of diverse types of 
neuromodulators with needed spatial and temporal resolution.  
 
RESULTS: We report the development and validation of dLight1, a novel suite of 
intensity-based genetically encoded dopamine indicators that enables ultrafast optical 
recording of neuronal dopamine dynamics in behaving mice. dLight1 works by directly 
coupling the conformational changes of an inert human dopamine receptor to changes in 
the fluorescence intensity of a circularly permuted green fluorescent protein. The high 
sensitivity and temporal resolution of dLight1 permit robust detection of physiologically 
or behaviorally relevant dopamine transients. In acute striatum slices, dLight1 faithfully 
and directly reports the time course and concentration of local dopamine release evoked by 
electrical stimuli, as well as drug-dependent modulatory effects on dopamine release. In 
freely moving mice, dLight1 permits deep-brain recording of dopamine dynamics 
simultaneously with optogenetic stimulation or calcium imaging of local neuronal activity. 
We were also able to use dLight1 to chronically measure learning-induced dynamic 
changes within dopamine transients in the nucleus accumbens at subsecond resolution. 
Finally, we show that two-photon imaging with dLight1 revealed a high-resolution 
(cellular level) dopamine transient map of the cortex showing spatially distributed, 
functionally heterogeneous dopamine signals during a visuomotor learning task.  
 
CONCLUSION: To overcome the major barriers of current methods and permit high- 
resolution imaging of dopamine dynamics in the mammalian brain, we developed and 
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applied a new class of genetically encoded indicators. This work validates our sensor 
design platform, which could also be applied to developing sensors for other 
neuromodulators, including norepinephrine, serotonin, melatonin, and opioid 
neuropeptides. In combination with calcium imaging and optogenetics, our sensors are well 
poised to permit direct functional analysis of how the spatiotemporal coding of 
neuromodulatory signaling mediates the plasticity and function of target circuits.  
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2.2 Introduction 
Animal behavior is influenced by the release of neuromodulators such as dopamine (DA), 
which signal behavioral variables that are relevant to the functioning of circuits brainwide. 
Projections from dopaminergic nuclei to the striatum and cortex, for example, play 
important roles in reinforcement learning, decision-making, and motor control. Loss of DA 
or dysfunction of its target circuits has been linked to disorders such as Parkinson’s disease, 
schizophrenia, and addiction (Tritsch and Sabatini, 2012; Wise, 2004; Dudman and 
Krakauer, 2016).  
 
Much work has been devoted to determining how neural representations of behavioral 
states are encoded in the firing patterns of neuromodulatory neurons (Schultz et al., 1997; 
Lee and Dan, 2012; Marder, 2012; Schultz, 2016; Pan et al., 2005; Cohen et al., 2012), but 
very little is known about how the precise release of neuromodulators alters the function 
of their target circuits (Howe and Dombeck, 2016; Cui et al., 2013). To address this 
problem, an essential step is to monitor the spatiotemporal dynamics of neuromodulatory 
signals in target circuits while also measuring and manipulating the elements of the circuit 
during behavior.  
 
Analytical techniques such as microdialysis and electrochemical microsensors have 
provided useful insights about neuromodulator presence (Jaquins-Gerstl et al., 2015; 
Genesana et al., 2017) but suffer from poor spatial and/or temporal resolution and cannot 
be targeted to cells of interest. Optical approaches such as injected cell-based systems 
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(CNiFERs) (Muller et al., 2014) and reporter gene–based iTango (Lee et al., 2017) can 
reveal DA release with high molecular specificity. However, these systems are limited by 
poor temporal resolution (seconds to hours), preventing direct detection of DA release 
events that occur on a subsecond time scale (Ford et al., 2009 and 2010).  
 
High-quality single fluorescence protein (FP)– based sensors that report calcium or 
glutamate transients with subsecond temporal resolution have recently been developed and 
are widely used (Chen et al., 2013; Marvin et al., 2013). Here, we report the development 
of a set of single FP–based DA sensors, named dLight1, that enables imaging of DA 
transients with high spatiotemporal resolution in behaving animals.  
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2.3 Sensor engineering 
Sensitive optical readout of changes in DA concentration was achieved by directly 
coupling the DA binding–induced conformational changes in human DA receptors to 
changes in the fluorescence intensity of circularly permuted green fluorescent protein 
(cpGFP). We did this by replacing the third intracellular loop (IL3) of the human dopamine 
D1 receptor (DRD1), D2 receptor (DRD2), and D4 receptor (DRD4) with a cpGFP module 
from the genetically encoded calcium indicator GCaMP6 (Fig. 1A).  
 
To determine the insertion site of cpGFP in IL3 that produces maximal coupling of ligand- 
induced conformational changes to cpGFP fluorescence, we aligned the sequences of 
DRD1 and DRD4 with that of the b2 adrenergic receptor (B2AR) (Fig. 1B), for which both 
active and inactive structure are available (Manglik et al., 2015). The initial variant, 
obtained by inserting a cpGFP module with original linker sequences (LSSLE-cpGFP- 
LPDQL) between Lys232 and Lys269 of DRD1, was well expressed at the plasma membrane 
of human embryonic kidney (HEK293) cells and showed a fluorescence decrease (DF/Fmax 
= –19.4 ± 0.02%) in response to puffed DA (Fig. S1A). To obtain a positive-response 
sensor, we screened a library of 585 variants in HEK cells (Fig. 1C and Fig. S1B). The 
variant with the largest positive fluorescence response (max DF/Fmax = 230 ± 9%) and 
excellent membrane localization was named dLight1.1 (Fig. 1D). In situ DA titration on 
HEK cells revealed submicromolar apparent affinity of dLight1.1 (affinity constant Kd = 
330 ± 30 nM; Fig. 1E).  
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We next sought to further tune the dynamic range and affinity of the sensor. Mutation of 
Phe129, a highly conserved residue among many G protein–coupled receptors (GPCRs) 
(Rasmussen et al., 2011), into Ala (dLight1.2) slightly increased dynamic range 
(maxDF/Fmax =340±20%, Kd =770±10nM; Fig. 1, D and E). Optimizing the cpGFP 
insertion site in dLight1.1 and dLight1.2 (Fig. S1, C to G) greatly increased the dynamic 
range but also reduced the affinity to micromolar range (dLight1.3a: DF/Fmax=660±30%, 
Kd=2300±20nM,Fig.S2, A and B; dLight1.3b: DF/Fmax = 930 ± 30%, Kd = 1680 ± 10 nM; 
Fig. 1, D and E). Insertion of the cpGFP module into DRD4 and DRD2 produced dLight1.4 
and dLight1.5, respectively, which exhibited nanomolar affinity with a relatively small 
dynamic range [dLight1.4: DF/Fmax = 170 ± 10%, Kd = 4.1 ± 0.2 nM, Fig. 1, B, D, and E; 
dLight1.5: DA,DF/Fmax=180±10%,Kd=110±10nM; quinpirole (synthetic agonist of D2 
dopamine receptors), DF/Fmax = 124 ± 19%, Fig. S2, A to C]. In addition, we engineered 
a control sensor by incorporating a D103A mutation in dLight1.1 to abolish DA binding 
(control sensor: DF/F = 0.4 ± 4%, Fig. 1E) (Strader et al., 1988). Because dLight1.1 and 
dLight1.2 produced large responses at low DA concentration (e.g., 100 nM) without 
approaching response saturation (Fig. 1E, inset) and had submicro-molar affinity, we 
further characterized these two sensors.  
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2.4 Sensor characterization 
These two sensors showed peak emissions at 516 nm and 920 nm for one- and two-photon 
illumination in HEK cells, respectively (Fig. S3). In situ titration on dissociated 
hippocampal neurons and on HEK293 cells showed similar apparent affinities to DA (Fig. 
1E and Fig. S4, A to C). Single 5-ms pulses of uncaged DA were robustly detected on the 
dendrites of cultured neurons, and the fluorescence response tracked uncaging pulse 
duration (Fig. S4, D to F). In cultured hippocampal slices, dLight1 could reliably detect 
submicromolar DA concentration changes at dendrites and single dendritic spines (Fig. S4, 
G to I).  
 
We then investigated the endogenous and pharmacological molecular specificity of the 
sensor. dLight1 was less sensitive to norepinephrine and epinephrine than to DA by factors 
of ~70 and ~40, respectively; negligible responses were observed to all other 
neuromodulators tested (Fig. S5). The amplitude of the response to each pharmacological 
compound reflected the efficacy of drugs on the wild-type receptors, with the largest 
response to the full agonist dihydrexidine (DF/F = 300 ± 10%), followed by partial agonists 
(Fig. 1F). The response to DA was abolished in the presence of the DRD1 antagonists SKF-
83566 and SCH-23390 but was unaffected by the DRD2 antagonists haloperidol and 
sulpiride (Fig. 1F).  
 
To investigate the possible interference of sensor expression with G protein signaling, we 
first measured the effect of sensor expression on the ligand-induced cyclic adenosine 
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monophosphate (cAMP) response (Fig. S6) (Irannejad et al., 2013). Transiently 
transfected dLight1.1 and dLight1.2 triggered no significant cAMP response in HEK cells, 
similar to the negative control (EGFP), whereas wild-type DRD1 receptor significantly did 
(Fig. S6A). The conversion of DRD1 to a fluorescent sensor thus apparently blocked the 
scaffold’s ability to bind G protein and trigger the signaling cascade. When introduced into 
a cell line that endogenously expressed DRD1 (U2OS), dLight1 did not significantly alter 
the dose-response curve for DA (P = 0.96, Fig. S6B). dLight1 also showed a significant 
reduction in agonist-induced internalization, a readout of DRD1 engagement of b-arrestin 
(Vickery and von Zastrow, 1999), when compared to wild-type DRD1 (Fig. S6C). Total 
internal reflectance fluorescence (TIRF) imaging verified that dLight1 remained diffusely 
distributed in the plasma membrane, without any detectable internalization, during a 
complete cycle of ligand-dependent fluorescence change (Fig. S6, D to F). Taken together, 
these results indicate that the dLight sensors are suitable for use on the cell membrane 
without affecting endogenous signaling through G proteins or engagement of b-arrestins.  
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2.5 Versatile application to other neuromodulators 
We next applied the design strategy of dLight1 to modularly develop a class of intensity-
based sensors for various neuromodulators and neuropeptides. We selected a subset of 
GPCRs, including Gs-coupled b1 and b2 adrenergic receptors (B1AR and B2AR); Gi-
coupled k- and m-type opioid receptors (KOR, MOR) and a2 adrenergic receptor (A2AR); 
and Gq-coupled 5-hydroxytryptamine (serotonin) receptor-2A (5HT2A) and melatonin 
type-2 receptor (MT2). As with dLight1, we replaced IL3 with cpGFP, with insertion sites 
chosen to preserve the conserved positive charges (Fig. S7A). All sensors localized to the 
membrane and showed positive fluorescence responses to their respective agonists (Fig. 
S7B).  
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2.6 Two-photon imaging of DA release in dorsal striatum ex vivo and in 
vivo 
We next used dLight1 to measure the time course and concentration of endogenous DA 
release triggered by electrical stimulation and drug modification in acute striatal slices with 
two-photon imaging (Fig. 2A). Two to four weeks after injection of an adeno-associated 
virus encoding dLight1 (AAV9.hSynapsin1.dLight1.2) into the dorsal striatum, we 
observed both broadly distributed and localized fluorescence transients across the field of 
view (Fig. 2, B and C, and Fig. S8, A to C) in response to a single electrical stimulus. Fast 
line scan at these hotspots (Fig. 2C) revealed a rapid onset of fluorescence increase (rise 
t1/2 = 9.5 ± 1.1 ms) followed by a plateaued peak (averaged DF/F = 220 ± 50%) for about 
150 ms, which decayed to baseline in about 400 ms (decay t1/2 = 90 ± 11 ms, Fig. 2D). 
We observed robust and reproducible fluorescent transients to low-frequency stimuli over 
a prolonged imaging period, whereas subsequent higher-frequency stimuli elicited 
significantly smaller responses (Fig. 2, E and F), indicating strong depression from an 
initially high probability of release. Blockade of DA reuptake with cocaine significantly 
prolonged the decay of fluorescence from peak to baseline (Fig. 2, G and H), but with 
equivocal effect on response amplitude (Fig. 2, G and H). Application of the competitive 
antagonist SKF83566 eliminated the responses (Fig. S8F), confirming that fluorescent 
signals are indeed attributable to DA binding.  
 
We next used dLight1 to estimate released DA concentration induced by a brief electrical 
stimulus. By comparison with a concentration-response curve (Fig. S8, D, E, and G), the 
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fluorescence response suggested a DA release of 10 to 30 mM (Fig. 2I), which is one to 
two orders of magnitude higher than previously reported in ventral striatum using fast-scan 
cyclic voltammetry (FSCV) (Yorgason et al., 2017) and is similar to that reported by 
measuring DRD2 activation (Coutney and Ford, 2014). Addition of saturating 
amphetamine (10 mM in the presence of 400 mM sulpiride) increased tonic DA to 3.3 mM 
(Fig. S8, F and G).  
 
We then examined the action of known modulators of DA release using dLight1 (Fig. 2, J 
to L). Activation of D2 autoreceptors with quinpirole decreased the electrically evoked 
fluorescence transients; this effect was significantly reversed by the application of sulpiride 
(Fig. 2J). Perfusion with a k-opioid receptor agonist (U69,593) caused a small decrease in 
the amplitude, which was completely blocked by naloxone (Fig. 2J). We then imaged the 
effects of nicotinic receptor activation in mediating the probability of DA release.  
 
Blockade of nicotinic receptors with hexamethonium profoundly reduced the fluorescence 
transient, which depended on the number of stimuli (Fig. 2, K and L). In the absence of 
hexamethonium, the amplitude of the fluorescence remained consistent regardless of the 
stimulation protocol (Fig. 2, K and L) (Mamaligas et al., 2016).  
 
Next, we asked whether dLight1 could reliably report DA signals associated with mouse 
locomotion in dorsal striatum, which was labeled with AAV1.hSynapsin1.dLight1.1/1.2 
and AAV1.hSynapsin1.flex.tdTomato. We measured DA transients with two-photon 
imaging during rest and self-initiated locomotion (Fig. S9). Consistent with in vivo two-
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photon calcium imaging of substantia nigra pars compacta (SNc) axon terminals in 
dorsal striatum (Howe and Dombeck, 2016), dLight1 reliably showed widespread and 
synchronous subsecond transients associated with spontaneous locomotion, which was 
clearly distinguishable from motion artifacts (Fig. S9, A to E). The DA transients were 
rapidly and bidirectionally modulated with respect to locomotion. Accelerations were 
associated with an increase and decelerations with a decrease in fluorescence (peak mean 
cross-correlation 240 ms Fig. S9, F to L).  
 
In summary, dLight1 faithfully and directly reports the time course and concentration of 
local DA release and drug-dependent modulatory effects on DA release in an acute striatum 
slice. In addition, dLight1 enables direct visualization of locomotion-triggered DA release 
in behaving mice.  
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2.7 Deep brain recording of DA dynamics simultaneously with 
optogenetics or calcium imaging 
The nucleus accumbens (NAc) receives projections from dopaminergic neurons in the 
ventral tegmental area (VTA). To directly probe DA release in freely moving mice, we 
delivered AAV9. CAG.dLight1.1 or AAV9.CAG.control_sensor in NAc, followed by fiber 
photometry imaging (Fig. 3 and Fig. S10, A and B). dLight1 revealed visible spontaneous 
DA transients, which were absent in the imaging sessions using the control sensor (Fig. 
S10C).  
 
To optically activate VTA dopaminergic neurons, we infected VTA of TH::IRES-Cre mice 
with AAV5.hSynapsin1.flex.ChrimsonR.tdTomato (Gunaydin et al., 2014) (Fig.3,AtoC, 
Fig.S11, A and B, and Fig.S12, A and D). The high temporal resolution of dLight1 enabled 
detection of individual peaks of DA transients in response to 5-, 10-, and 20-Hz 
photostimulation (Fig. 3D and Fig. S13, A to C). The amplitude of fluorescence increase 
was correlated with the frequency of photostimulation (Fig. 3, D and F). In contrast, no 
fluorescence changes were observed with the control sensor using 20-Hz stimuli (Fig. 3, D 
and E). Relative to saline-injected controls, systemic administration of SCH-23390 
significantly reduced optogenetically induced dLight1 responses, whereas the re-uptake 
inhibitor GBR-12909 enhanced them (Fig. 3, G and H).  
 
Next, we examined whether dLight1 can report inhibition of DA transients. To induce 
transient inhibition of VTA dopaminergic neurons, we optogenetically stimulated VTA g-
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aminobutyric acid–releasing (GABAergic) neurons in VGAT:: IRES-Cre mice (Tan et 
al., 2012) (Fig. 3I). Histology confirmed ChrimsonR expression in VTA GABAergic 
neurons (Fig. S12, B, C, and E). We observed rapid and reversible reductions in dLight1 
fluorescence in response to VTA GABAergic neuron photoactivation at 40 Hz (Fig. 3, J 
and K, and Fig. S13D), indicating that dLight1 can report bidirectional changes in local 
DA release.  
 
Motivationally salient stimuli modify DA neuron firing and downstream NAc activity 
(Cohen et al., 2012; Tan et al., 2012; Brischoux et al., 2009). To link the DA release to 
local neuronal activity, we performed dual-color measurements with dLight1 and the red-
shifted calcium indicator jRGECO1a (Dana et al., 2016) in lateral core/shell regions (Fig. 
3L and Figs. S10B, S11A, and S12F). When mice voluntarily consumed a reward (50 ml 
of 5% sucrose), we observed a concordant increase of DA concentration and local 
population activity (Fig. 3, M and N, and Fig. S13E), similar to a class of NAc single units 
showing excitation upon reward (Taha and Fields, 2005). In contrast, footshocks 
suppressed DA release while enhancing local neuronal activity, indicating dissociation 
between DA dynamics and local circuit activity (Fig. 3, O and P, and Fig. S13F).  
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2.8 Chronic imaging of DA dynamics throughout cue-reward learning 
We next examined the utility of dLight1 in reporting modulation of DA signaling in 
response to conditioned stimuli (CS) and unconditioned stimuli (US) throughout Pavlovian 
conditioning (Fig. 4A) (Pan et al., 2005; Day et al., 2007; Clark et al., 2010). Mice 
successfully learned to associate the predictive cues to the reward, as shown by increasing 
number of licks during CS over the course of training and by decreasing numbers of licks 
during extinction learning (Fig. 4B).  
 
Repeated fiber photometry recordings in NAc revealed two types of DA transients 
modulated during associative learning: increased DA response to the predictive cues and 
decreased response to reward consumption across sessions. In the first session, a small and 
time-locked phasic DA signal was present at the CS onset, whereas after US the DA signal 
was larger and also more temporally spread (Fig. 4, C and D), consistent with US 
consumption onsets being highly variable at early stages (Fig. S14, A and B). Aligning to 
consumption onset revealed large DA signal to the US at the first session (Fig. 4C and Fig. 
S14A). Upon repeated cue-reward pairings, the amplitude of CS response significantly 
increased (Fig. 4, C, D, F, and H, and Fig. S14C). On the other hand, US response, when 
aligned to the consumption onset, showed a monotonic decrease across learning sessions 
(Fig. 4, G and H, and Fig. S14D) (Cohen et al., 2012; Day et al., 2007). During extinction, 
we observed an attenuated phasic CS response (Fig. 4, E, F, and H). The amplitude of the 
phasic CS response was correlated with CS-triggered licking behavior during both learning 
and extinction sessions (Fig. S14E).  
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We further investigated whether dLight1 can report signals correlated with “reward 
prediction error” (Schultz and Dayan, 1997). After the animals had fully learned CS-US 
association, mice underwent “unexpected reward availability” sessions (in which the US 
was occasionally made available without the CS) between normal paired trials (Fig. 4I). 
Unexpected availability of reward elicited significantly higher fluorescence than did 
expected consumption (Fig. 4, J and K). In the “unexpected reward omission” session, 
where the US was occasionally omitted after the predictive CS, fluorescence decreased 
below the pre-CS baseline after the time at which the US would have normally become 
available after CS presentation (Fig. 4, L and M).  
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2.9 Cellular-level imaging of functionally heterogeneous DA transients 
in mouse cortex 
Finally, we tested whether two-photon imaging with dLight1 could reveal the 
spatiotemporal release of DA associated with reward in the cortex. The cortex receives 
projection axons from both SNc and VTA. Inputs from these nuclei carry distinct 
dopaminergic signals influencing motor control and reward learning, respectively (Howe 
and Dombeck, 2016; da Silva et al., 2018). To demonstrate the utility of dLight1 in 
detecting behavior-related DA signals, we broadly labeled frontal/motor cortex with 
AAV9.hSynapsin1. dLight1.2, followed by two-photon imaging of dLight1-expressing 
layer 2/3 neurons in head-fixed mice. The animals had fully learned a visuomotor 
association task that required them to run in response to a visual “Go” cue in order to 
receive a water reward (Fig. 5, A and B). We observed task-related DA transients, 
distinguishable from motion artifacts (Fig. S15), across cell-sized regions of interest (ROIs) 
across the field of view (Fig. 5C and Fig. S16).  
 
Aligning the DA transients to trial/stand-still phase onset, we found two types of task-
relevant DA responses during the reward expectation and reward delivery intervals. An 
average of 63% of responsive ROIs showed significantly increased DA transients that 
correlated with reward, which were abolished by unexpected reward omission (20% of 
randomly selected trials) (Fig. 5D, right). A subset of ROIs (~37%) showed significantly 
increased DA transients that lasted during the short phase of “Go” stimulus presentation 
for both rewarded and non-rewarded trials (Fig. 5D, left). These transient increases during 
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the stimulus presentation phase were not caused by the stimulus appearance itself, 
because no significant increase in DA levels was observed during miss trials during which 
the animal saw the stimulus but did not respond (Fig. 5D, yellow traces).  
 
To investigate whether these early responses shown in 37% of ROIs reflect increased DA 
levels during reward expectation or correlate with locomotion, we aligned the trials at 
running onset (Fig. 5E, group averages; Fig. S16G, single ROIs) and compared the DA 
transients of runs triggered by the “Go” stimulus (when the animals expected a reward) 
with spontaneous runs that erroneously occurred during the standstill phase (with no 
reward expectation). A small subset of responsive ROIs (5%) showed significant increases 
in DA transients during reward expectation but not spontaneous running (Fig. 5E, center), 
whereas the other 32% of ROIs correlated with locomotion (Fig. 5E, left). The 63% of 
ROIs responsive to reward only (Fig. 5D, right) also showed increased DA transients 
during the early stimulus presentation phase consisting of both locomotion- and reward 
expectation–related responses (Fig. 5E, right). All three types of responses were 
consistently seen across animals. Comparing the heterogeneity of response transients 
between layer 1 and layers 2/3 of cortical area M1 (Fig. S16, E and F), we found that layer 
2/3 showed more ROIs active during reward. A similar number of ROIs responded to 
locomotion and reward expectation in both layers (Fig. S16H). Mesocortical dopaminergic 
projections are thus spatially intermingled, and activation of these inputs leads to 
spatiotemporally heterogeneous DA signals in the cortex whose dynamics depends on 
motor behavior, reward expectation, and consumption.  
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2.10 Conclusion 
We developed and applied a new class of genetically encoded indicators that overcome 
major barriers of current methods to permit high-resolution imaging of DA dynamics in 
acute brain slices and in behaving mice. The sub-micromolar affinity and fast kinetics of 
dLight1 offer fast temporal resolution (10 ms on, 100 ms off) to detect the physiologically 
or behaviorally relevant DA transients with higher molecular specificity relative to existing 
electrochemical or cell-based probes (Muller et al., 2014). For example, in NAc of freely 
behaving mice, longitudinal measurements revealed different changes in time-resolved DA 
signals encoding either predictive cue or reward consumption across learning.  
 
The disparate contributions of synaptic, extra-synaptic, and spillover DA events to circuit 
function are not addressable without fast, robust, and genetically encoded sensors. In a 
dorsal striatal slice, dLight1 reliably detected the concentration and time course of DA 
transients and their modifications by pharmacological compounds. The rapid rise of 
fluorescence (10 ms) and the peak concentration (10 to 30 mM) of DA after electrical 
stimulation indicates that the initial measures of DA are closely associated with the site of 
release (Coutney and Ford, 2014). The decline of fluorescence, particularly in the presence 
of cocaine, results primarily from re-uptake and diffusion of DA away from release sites.  
 
dLight1 also permits measurement of functionally heterogeneous DA transients at the 
cellular level with high spatial resolution. In the cortex, two-photon imaging with dLight1 
revealed a DA transient map with spatially distributed, functionally heterogeneous DA 
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signals during a visuomotor learning task. Simultaneous calcium imaging can further 
determine how spatiotemporal differences in DA levels relate to ongoing neural activity 
and influence associative learning or goal-directed behavior.  
 
dLight1.1 and dLight1.2 are optimized sensor variants that can be immediately applied to 
ex vivo or in vivo studies, as they offer a good balance between dynamic range and affinity. 
Other dLight variants may be suitable for measuring synaptic release (dLight1.3) or tonic 
DA transients (dLight1.4). Given the broadly tunable affinity and dynamic range of 
dLight1, protein engineering and high-throughput screening efforts can further optimize 
the signal-to-noise ratio and molecular specificity (Piatkevich et al., 2018) as well as the 
performance of other neuromodulator indicators.  
 
In combination with calcium imaging and optogenetics, our sensors are well poised to 
permit direct functional analysis of how the spatiotemporal coding of neuromodulatory 
signaling mediates the plasticity and function of target circuits.  
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2.11 Main figures 
 
Fig. 1. Development and characterization of dLight1. (A) Simulated structure of 
dLight1 consisting of DRD1 and cpGFP module. (B) Sequence alignment of 
transmembrane (TM) domain 5 and 6 in b2AR, DRD1, and DRD4. Library design is 
shown. Amino acid abbreviations: A, Ala; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; 
K, Lys; L, Leu; M, Met; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; Y, Tyr. (C) 
Screening result of 585 linker variants. Red and blue vertical bars indicate fluorescence 
changes (DF/F) in response to 10 mM DA; significance values of DF/F are shown by 
colored bars and scale (n = 3 trials, two-tailed t test). (D) Expression of dLight variants in 
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HEK cells. Fluorescence intensity and signal-to-noise ratio of apo and sat state are 
shown. Scale bars, 10 mm. (E) In situ titration of DA on HEK cells. Data were fitted with 
the Hill equation (n = 5). (F) Pharmacological specificity of dLight1.1. DRD1 full agonist 
(dihydrexidine, 295 ± 8%, n = 5); DRD1 partial agonists (SKF-81297, 230 ± 7.7%, n = 5; 
A77636, 153 ± 7.8%, n = 7; apomorphine, 22 ± 0.8%, n = 6); DRD1 antagonists (SCH-
23390, –0.04 ± 0.01%, n = 7; SKF-83566, 0.04 ± 0.03%, n = 7); DRD2 antagonists 
(sulpiride, 213 ± 5.1%, n = 5; haloperidol, 219 ± 11%, n = 6). Data are means ± SEM. 
****P < 0.0001 [one-way analysis of variance (ANOVA), Dunnett posttest]; n.s., not 
significant.  
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Fig. 2. Imaging electrically evoked and pharmacologically modulated dopamine 
release in acute dorsal striatum slices. (A) Schematics of experimental setup. (B) Single-
trial fluorescence response (average in black) in response to a single stimulus (0.5 ms). 
Images were acquired at 15 Hz using two-photon light at 920 nm. Averaged DF/F = 182 ± 
21% across seven trials, mean ± SEM. (C) Representative hotspot (DF/F) for line scan. 
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Scale bar, 20 mm. (D) Individual fluorescence traces during line scan (500 Hz) in 
response to a single stimulus (average in black across 13 trials). Inset shows zoomed-in 
view of the fluorescence plateau. (E) Fluorescence responses to low- and high-frequency 
stimuli (left, 0.2 Hz; right, 1 Hz). (F) Quantification of data in (E) [relative (fold) change 
in DF/F = 0.506 ± 0.061 at 1 Hz across five trials]. (G) Single-trial fluorescence response 
in the presence of cocaine (10 mM) triggered by a single stimulus, overlaid with trace 
without cocaine. (H) Quantification of fold change in peak fluorescence amplitude (1.056 
± 0.095, n = 7, P = 0.056) and duration (3.15 ± 0.213, n = 4). (I) Estimation of released DA 
concentration (single-trial trace shown). (J) Quantification of fold change in peak 
fluorescence in the presence of 1 mM quinpirole (0.437 ± 0.052, n = 5), 400 nM sulpiride 
and 1 mM quinpirole (quin+sulp, 0.926 ± 0.070, n = 5), 1 mM U69,593 (0.838 ± 0.042, n 
= 4), and 1 mM naloxone (1.022 ± 0.053, n = 4), all bath-applied. (K) Single-trial 
fluorescence response to either a single pulse (black) or a train of five pulses at 40 Hz (red) 
in the absence (left) and presence (right) of the nicotinic acetylcholine receptor blocker 
hexamethonium (200 mM). (L) Quantification of fold change in peak fluorescence 
response in (K) (Hex/Control: 0.561 ± 0.038, n = 10; control 5stim/1stim: 1.13 ± 0.069, P 
= 0.06, n = 7; Hex 5stim/1stim: 1.76 ± 0.16, n = 6). *P < 0.05,  **P < 0.01, ***P < 0.001, 
****P < 0.0001 (paired t test).  
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Fig. 3. Deep brain imaging of DA release triggered by optogenetic stimulation and 
combined with calcium imaging in freely behaving mice. (A) Schematics showing fiber 
photometry recording of dLight1.1 or control sensor in NAc while stimulating VTA DA 
neurons by optogenetics. (B) Expression of dLight1.1 in NAc around fiber tip location and 
ChrimsonR-expressing axons from midbrain. (C) ChrimsonR-expressing TH+ DA neurons 
in VTA. (D) Averaged fluorescence increase in response to optogenetic stimuli (n = 5 
mice). (E) Quantification of peak fluorescence at 20 Hz. (F) Fluorescence fold changes 
relative to 5 Hz. (G and H) Optogenetically induced fluorescence increase of dLight1.1 
after systemic administration of saline, D1 antagonist (SCH-23390, 0.25 mg/kg), and DA 
reuptake inhibitor (GBR-12909, 10 mg/kg) (n = 5 mice). (I) Schematics showing fiber 
photometry recording of dLight1.1 in NAc and optogenetic stimulation of VTA GABA 
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neurons that inhibits VTA DA neurons. (J and K) Averaged fluorescence decrease in 
response to optogenetic stimulation at 40 Hz (n = 4 mice) and quantification of mean 
fluorescence. (L) Dual-color fiber photometry recording of DA release with dLight1.1 and 
local neuronal activity with jRGECO1a. (M and N) Increase of dLight1.1 (green) and 
jRGECO1a (magenta) fluorescence during 5% sucrose consumption with lick rate (black, 
n = 5 mice) and quantification of mean fluorescence. (O and P) Fluorescence decrease in 
dLight1.1 (green) and increase in jRGECO1a (magenta) during unpredictable footshock 
delivery (0.6 mA for 1 s, n = 5 mice) and quantification of mean fluorescence. Data shown 
are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 (paired or unpaired t tests for two-
group comparisons; one-way ANOVA by post hoc Tukey test for multiple-group 
comparisons).  
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Fig. 4. Dynamic changes of NAc DA signaling during appetitive Pavlovian 
conditioning and reward prediction error. (A) Pavlovian conditioning procedures 
involved learning to associate neutral cues (CS; house light and 5-kHz tone) with a sucrose 
reward (US; 50 ml of 5% sucrose) and subsequent extinction. (B) Change of CS-evoked 
licks across cue-reward learning (left) and extinction (right). (C and D) dLight1.1 
dynamics in response to CS and US in first and last sessions of cue-reward learning, shown 
in single (gray) and averaged (blue) trials (n = 20 trials) from a single animal (C) or 
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averaged across all trials and animals (n = 5 mice) (D). Lick rate is shown in black. (E) 
Same as (D) for cue-reward extinction (n = 5 mice). In (D) and (E), dotted lines indicate 
CS onset, US onset, and CS offset, respectively. (F to H) Evolution of CS-evoked (F) and 
US-evoked [(G), left] average fluorescence and US-triggered licks [(G), right] across 
learning and extinction sessions. (H) Quantification of peak fluorescence across learning 
and extinction. (I) Reward prediction error procedure. (J) Fluorescence response during 
expected (red) versus unexpected (black) reward consumption (n = 4 mice). (K) Peak 
fluorescence evoked by expected (red) and unexpected (black) reward consumption. (L) 
Fluorescence response during expected (red) versus unexpected (brown) reward omission 
(n = 4 mice). Second and third dotted lines indicate US onset and CS offset, respectively. 
(M) Mean fluorescence during baseline and after unexpected reward omission. Data are 
means ± SEM. **P < 0.01 (Pearson correlation coefficient and paired t test).  
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Fig. 5. Spatially resolved imaging of cortical dopamine release during a visuomotor 
association task. (A) Schematics of experimental setup. (B) A trial was initiated when 
mice were required to stand still for 10 s after a visual cue (blue square). If mice started to 
run during the stimulus phase (“hit trials”), a water reward was given. In 20% of randomly 
selected hit trials, the reward was withheld. If no run was triggered by stimulus 
presentation, the trials were counted as “miss trials.” Erroneous or spontaneous runs during 
the standstill phase ended the trial (no “Go” cue or reward). (C) Top: Dorsal view of mouse 
cortex with the chronic cranial window (circle) and imaging location indicated (square). 
Bottom: Heat map of dLight1.2 expression pattern in layer 2/3 of M1 cortex. The image is 
overlaid with computationally defined regions of interest (ROIs, ~17 mm × 17 mm). 
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Colored ROIs indicate the type of fluorescence responses observed during the task. (D) 
Population data (N = 4 mice, n = 19 recording sessions) showing average task-related 
dLight1.2 transients (bottom) and mouse running velocity (top) aligned to trial/standstill 
cue onset (0 s). The solid vertical line indicates “Go” cue onset. The dashed line marks the 
end of the reward expectation phase during unrewarded hit and miss trials. The period 
during which running velocity–dependent reward consumption occurred is indicated by the 
horizontal line. Left: ROIs showing significantly increased responses during reward 
expectation/locomotion. Right: ROIs showing significant fluorescence increases to reward 
(dark green) but not unexpected reward omission (light green). Shaded areas of DF/F traces 
indicate SD. (E) Population data realigned to running onset (vertical black line). ROIs with 
“Go” cue responses [(D), left] can be subdivided into ROIs responsive to locomotion in all 
trials (left) and responsive to reward expectation only (center), with no fluorescence 
increases during spontaneous runs (pink). P < 0.05 (Wilcoxon test, Bonferroni-corrected 
for multiple comparisons).  
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2.12 Supplementary figures 
 
Fig. S1. Screening dLight1 variants. (A) Membrane expression and response of original 
dopamine sensor built by inserting the original GCaMP6 cpGFP module (LSS-LE-cpGFP-
LP-DQL) into DRD1. Peak response (-19.4 ± 0.02 % ∆F/F, mean ± SEM, n=12 cells). Inset 
shows membrane intensity profile. Scale bar, 10 μm. (B) Resting fluorescence for all 
screened variants that showed expression. Proportion of response type in horizontal bar. 
Color-coding indicates significance value (n=3). (C-G) Optimizing insertion site of cpGFP 
in DRD1. (C) Sequence alignment of DRD1 and β2 adrenergic receptor encompassing 
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TM5-TM6 (replacement sites was indicated as 0 aa in each TM region) is shown. (D, E) 
Representative images showing membrane expression of dLight1 variants. Scale bar, 10 
μm. (F) Quantification of ∆F/F and surface expression from variants shown in D. ΔF/F: -
3 aa, 70.1 ± 10.8 %; -2 aa, -1.3 ± 6.7 %; -1 aa, 199.4 ± 13.1 %; 0 aa, 223.2 ± 8.2 %; +1 aa, 
652.3 ± 9.8 %. Surface expression values quantified in arbitrary units and normalized to 0 
aa control (-3 aa, 33.6 ± 4 %; -2 aa, 30 ± 1.8 %; -1 aa, 88.8 ± 6.4 %; +1 aa, 87 ± 2.7 %). 
(G) Quantification of fluorescent signal changes and surface expression from variants 
shown in e. ΔF/F values: -2 aa, -9.2 ± 2.3 %; 0 aa, 223.2 ± 8.2 %; +2 aa, 205 ± 21 %). 
Surface expression values quantified in arbitrary units and normalized to 0 aa control: -2 
aa, 36.4 ± 2.9 %; +2 aa, 25.9 ± 0.86 %. All values are shown as mean ± SEM. *p<0.05, 
**p<0.01, ****p<0.0001 versus 0 aa position control, One-way ANOVA with Dunnett’s 
post-hoc test.  
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Fig. S2. Characterization of dLight1.3a and dLight1.5. (A) Top, amino acid sequence 
of DRD2 insertion site for the cpGFP module. Bottom, representative images of dLight1.3a 
and dLight1.5 expressed on HEK293 cells before and after addition of DA (10 μM) and 
corresponding SNR heatmaps. Scale bars, 10 μm. (B) Quantification of fluorescence 
response of dLight1.3a (n=12) and dLight1.5 (n=4) to DA titrations on HEK293 cells. Data 
  
55 
were fit with Hill equation (EC50: dLight1.3a, 2300 ± 20 nM; dLight1.5, 110 ± 10 nM). 
(C) Representative images of dLight1.5 under basal conditions, after addition of quinpirole 
(10 μM) and haloperidol (50 μM), and trace showing quantification of fluorescence 
response during bath application of drugs (n=15). All data are shown as mean ± SEM.  
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Fig. S3. One photon emission spectrum and two-photon cross-section of dLight1 
expressed in HEK293T cells. Emission spectrum of both dLight1.1 and dLight1.2 peaks 
at 517 nm. Under 2P illumination, emission peaks are driven at 920 nm.  
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Fig. S4. Characterization of dLight1 in cultured hippocampal neurons and 
organotypic hippocampal slice. (A) Representative images showing membrane 
localization of dLight1.1 (GFP fluorescence in green, Alexa-564-conjugated anti-flag 
labeling in red) in cultured hippocampal neurons. Inset shows membrane intensity profile. 
(B) dLight1.1 and dLight1.2 responses to dopamine perfusion, which were abolished 
immediately with the addition of a DRD1 antagonist (mean ± SEM, n=4 sessions). (C) In 
situ titration on neurons (mean ± SEM, n=7 cells). Fitted with Hill equation (EC50: 
dLight1.1, 311 ± 26 nM; dLight1.2, 1,157 ± 44 nM). (D) Representative images showing 
uncaging spots (purple circle, 2 μm diameter, 40% laser power 405 nm light). Scale bar, 5 
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μm. (E) Representative traces of dLight1.2 fluorescence in response to increasing 
duration of uncaging light pulses (1ms per pulse). (F) Quantification of peak ΔF/F values 
which is correlated with the number of uncaging pulses (1 ms, 2.7 ± 0.01 %; 2 ms, 8.2 ± 
2.2 %; 5 ms, 18.9 ± 3.9; 10 ms, 32.8 ± 2.5; 20 ms, 58.4 ± 5.3; 50 ms, 83.4 ± 7.8; 100 ms, 
91.1 ± 6 %; n=3, mean ± s.d.). (G) Representative dLight1.2 responses to bath applied DA 
from sparsely-labeled CA1 pyramidal neurons in organotypic slice cultures. mCherry 
expression was used as a cell fill to visualize dendritic and synaptic structures (shown in 
rectangular and circular boxes, respectively) and to provide reference fluorescence. (H-I) 
Quantification of both green and red (control) fluorescence signal change at single spines 
and dendrites in response to a titration of DA concentrations. Maximal ΔF/F% fold change 
in the green channel were: synaptic spines, 227 ± 39; dendrites 201 ± 46 (mean ± s.d., n=5). 
EC50 values were: spines, 844 nM; dendrites, 883 nM.  
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Fig. S5. Specificity of dLight1. Specificity of dLight1 response was determined by 
titrations of a panel of 8 different neuromodulators on dLight1.1-expressing HEK293 cells. 
Acetylcholine, ACH; histamine, HIS; γ-aminobutyric acid, GABA; serotonin, SER; 
octopamine, OCT; epinephrine, EPI; norepinephrine, NE; dopamine, DA. Kd values for 
DA, NE and EPI were: 330 ± 28 nM, 19,850 ± 2,644 nM, 12,680 ± 1,559 nM, respectively. 
Results shown as mean ± SEM, (n=3).  
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Fig. S6. Functional analysis of dLight1 signaling properties. (A) cAMP response curve 
to a titration of DA in HEK293T cells expressing wild-type human DRD1 receptor or 
dLight1.1 or dLight1.2 or GFP. No significant cAMP response were observed in cells 
expression dLight1.1 (n=3, **p<0.01, ***p<0.001, one-way ANOVA, Dunnett’s post 
test). (B) cAMP response curves of a cell line endogenously expressing DRD1 (U2OS). 
Overexpression of dLight1.1 did not alter the cAMP response to DA (n=3, p=0.192, two-
way ANOVA with Tukey’s post-hoc test. (C) dLight1.1 internalization is significantly 
reduced compared to wild type DRD1 as assayed via flow cytometry (% internalized 
receptor: dLight1.1, 3.4 ± 0.5 %; DRD1, 14.3 ± 1.9 %; **p<0.01, unpaired t test). (D) TIRF 
microscopy visualization of dLight1.1 shows the fluorescent response to a DRD1 agonist 
(SKF81297) in green channel but not in red channel, which was immediately abolished by 
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applying antagonist (SCH23390). (E) In situ surface staining with an Alexa-647 
conjugated anti-flag antibody further confirmed the lack of internalized punctae. (F) 
Quantification of fluorescence responses in (D) and (E).  
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Fig. S7. Versatility of engineering approach to generate other GPCR-sensors. (A) Left, 
aligned sequences of TM 5 and TM6 from 7 GPCRs with insertion site for cpGFP module. 
To maximize ∆F/F in the B2AR and MT2 constructs the “QLQKID” sequence was inserted 
between TM5 (after the last R) and before LSS. Scale bars: 10 μm. Right, SNR heatmaps 
for a subset of GPCR sensors expressed in HEK cells. (B) Quantification of fluorescence 
response and membrane expression for each GPCR-sensor construct. Max ∆F/F of each 
sensor to bath applied agonist (B1AR: 70 ± 4%, n=8; B2AR: 149 ± 7%, n=9; A2AR: 77 ± 
8%, n=11; KOR: 60 ± 4%, n=8; MOR: 37 ± 2%, n=10; 5HT2A: 40 ± 3%, n=12; MT2: 38 
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± 3%, n=8). Agonists used were: norepinephrine for B1AR, B2AR, A2AR (100 μM); 
U50488 for KOR (10 μM); [D-Ala2, NMe-Phe4, Gly-ol5]-enkephalin (DAMGO) for 
MOR (10 μM); serotonin for 5HT2A (10 μM); melatonin for MT2 (10 μM). Membrane 
expression was calculated as membrane-to-cytosol ratio and normalized to dLight1.1 
(B1AR, 102 ± 4%; B2AR, 86 ± 6%; DRD2, 39 ± 4%; A2AR, 36 ± 4%, KOR, 45 ± 3%; 
MOR, 19 ± 1%; 5HT2A, 70 ± 3%; MT2, 24 ± 1%; n=6). Individual datapoints are shown. 
mean ± SEM shown in black.  
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Fig. S8. Characterization of dLight1 performance in striatal brain slice. (A-C) 
Spatially-distinct responses triggered by electrical stimuli in acute rat striatum slice. (A) 
Representative field of view for two-photon imaging of acute striatum slice infected with 
AAV9.hSynapsin1.dLight1.2. (B) ROIs hierarchically clustered based on correlations in 
the time course of their fluorescence values. (C) ROIs location relative to (A), with color-
coding corresponding to the dendrograms from the hierarchical clustering. (D) A steady-
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state concentration response curve with bath application of specified DA concentrations 
in the presence of cocaine (10 μM) and sulpiride (400 μM) to block D2-autoreceptors. The 
increase in fluorescence to each known concentration of DA (1-100 μM) was measured 
after reaching a steady level in 3-10 min. (E) Quantification of concentration-dependent 
fluorescence responses from (D). The fluorescence response reached half-maximal levels 
at about 5 μM DA and approached saturation at 30-100 μM. Curve was fitted with a Hill 
equation (EC50 = 5.3 ± 0.4 μM; mean ± s.d.; n=3). (F) Fluorescence response to a single-
pulse stimulation in the presence of amphetamine (10uM) or the DRD1 antagonist 
SKF83566 (1 μM). (G) Estimate of basal DA concentration in the presence of 
amphetamine at saturated concentration by interpolation on a dose-response curve, 
normalized to peak value (n numbers are shown for each concentration).  
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Fig. S9. Two photon imaging of locomotion related bi-directional dopamine transients 
in dorsal striatum. (A) Schematics of two-photon imaging of head-fixed mouse during 
treadmill locomotion. (B) Mean fluorescence projection from a representative imaging 
field showing green dLight1.1 expression (top) and red td-Tomato expression (bottom). 
(C) Average fluorescence changes in the field of whole in green (ΔF/F, green, top), red 
fluorescence (magenta, center), and treadmill velocity (black, bottom) for a representative 
imaging session. (D-E) Mean ΔF/F traces for 16 equal-sized ROIs tiling the imaging field 
pictured in (C) (red-dashed lines) in green and red. Note large positive-going transients 
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and the high synchrony across ROIs in dLight1.1 fluorescence, but not in td-Tomato 
fluorescence. (F) Mean ΔF/F for all significant positive-going transients in mice expressing 
either dLight1.1 (n = 2 mice, 131 transients) or dLight1.2 (n = 2 mice, 31 transients). (G-
H) Mean transient ΔF/F during rest and run for all fields in dLight1.1 (n = 2 mice, 5 fields) 
and dLight1.2 (n = 2 mice, 8 fields) (I) Cross correlation between acceleration and ΔF/F 
for dLight1.1 during run periods (peak mean cross correlation 240ms). (J-L) DA transients 
were rapidly and bi-directionally modulated by accelerations and decelerations. Mean ΔF/F 
from dLight1.1 aligned on the zero crossing of all large accelerations (J) or decelerations 
(K). Note the significant peak in ΔF/F following the acceleration peak (J) or the decrease 
below baseline following decelerations (K). (L) Same as (J, K) but for the td-Tomato 
traces. Note the lack of significant peaks or troughs to accelerations or decelerations. 
Shaded regions and error bars indicate SEM. Asterisks indicate p< 0.0001 with Wilcoxon 
rank-sum test.  
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Fig. S10. Fiber photometry setups and spontaneous DA transients in NAc. (A) 
Schematics of fiber photometry setup for dLight1 imaging. Two LEDs were used: 490 nm 
for dLight1.1 excitation and 405 nm for an isosbestic wavelength (63). These two LEDs 
were modulated at different frequencies and demodulated with lock-in functions 
implemented in the custom software. (B) Schematics of “dual color” fiber photometry 
setup. Compared to conventional fiber photometry, an additional 565 nm LED was added 
to excite red-shifted Ca2+ indicator jRGECO1a (31). Emitted fluorescence was divided into 
three channels based on their spectral profiles, detected by separate photoreceivers and then 
demodulated. (C) Representative traces of dLight1.1 (green) and control sensor (gray). 
Note that there are clear fluctuations of fluorescence in dLight1.1 with occasional bursts, 
while no apparent change of fluorescence is observed with control sensor.  
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Fig. S11. Histological verification of fiber tip locations during fiber photometry 
recordings. (A) Histologically verified anatomical positions of implanted fibers for 
photometry in the NAc. (B) Histologically verified anatomical positions of implanted 
fibers for optogenetic stimulation in the VTA. Histological brain images were reproduced 
from Paxinos and Franklin’s the Mouse Brain in Stereotaxic Coordinates (Academic Press, 
2012).  
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Fig. S12. Histological verification of virus expression in the NAc and VTA. (A) 
Histological image of dLight1.1 (green) expression in the NAc with fiber tip location in a 
VGAT-Cre mouse. Blue indicates nuclear staining DAPI. (B) Histological images showing 
  
71 
that ChrimsonR-expressing (magenta) neurons do not overlap with DA (green for 
tyrosine hydroxylase (TH)
+
) neurons in the VTA. (C) Histological images showing that 
ChrimsonR-expressing (magenta) neurons in the VTA co-localize with vgat mRNA (green, 
detected by hybrid chain reaction in situ hybridization, see supplementary information for 
details), but not with TH protein (blue, by IHC). Thick arrows indicate neurons co-
expressing ChrimsonR and vgat mRNA. (D) Representative low-magnification images of 
VTA regions in TH-Cre mice showing optical fiber tip locations (best visible in DAPI 
section) and virus expressions in the VTA. Blue is DAPI, green TH+ DA neurons, and 
magenta ChrimsonR+ neurons. (E) Same as (D) above, but for a VGAT-Cre mice. (F) 
Histological images of a NAc region with co-expression of dLight1.1 (green) and 
jRGECO1a (magenta).  
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Fig. S13. dLight1 fluorescence in response to optogenetic stimulation of VTA DA or 
GABA neurons and NAc DA dynamics underlying natural behaviors. (A) Magnified 
version of traces in Fig. 3D. Note that there are clear peaks of DA transients corresponding 
to each optogenetic stimulation pulses, even at 20 Hz. (B) Power spectral density analysis 
reveals peaks at matching stimulation frequencies (and harmonics) in dLight1.1, while the 
control sensor shows no clear peak in any frequency ranges. (C) Raw trace of a TH-Cre 
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mouse expressing dLight1.1 during VTA DA photostimulation. Optogenetic stimulation 
of VTA DA neurons caused evident and time-locked increase in fluorescence from 
spontaneously fluctuating transients. (D) Raw trace of a VGAT-Cre mouse expressing 
dLight1.1 during VTA GABA photostimulation. Fluorescence is decreased from baseline 
fluctuations upon optogenetic stimulation of VTA GABA neurons. (E) DA dynamics 
during natural behavior recorded from conventional fiber photometry with separate mouse 
cohort expressing dLight1.1 alone in the NAc. Mice consumed 5% sucrose water. 
Consistent with dual color fiber photometry results shown in Fig 3M and voluntary reward 
consumption was associated with increase of dLight1.1 fluorescence (mean fluorescence 
increase was quantified; paired t-test, t4 = 8.495, p = 0.0011). (F) DA dynamics while mice 
expressing dLight1.1 only in the NAc received unpredictable footshocks. Footshock 
caused transient depression of dLight1.1 fluorescence, which is consistent with dual color 
fiber photometry results shown in Fig 3O (mean fluorescence decrease were quantified; 
paired t-test, t4 = 3.765, p = 0.0197).  
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Fig. S14. Detection of US consumption onsets and details of DA dynamics after 
learning. (A) Individual trial heatmap data of lick rate (top) and fluorescence (bottom) 
from a mouse in learning session 1. Notice that lick onsets (indicated as magenta triangles 
or sudden color change from blue to yellow) are highly variable in this early session. When 
fluorescence is averaged from CS onset, fluorescence response from US is averaged or 
canceled out. However, when fluorescence is averaged from US consumption onset 
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(defined as lick onset after US is available), fluorescence peaks are aligned and results 
in higher US response. (B) Same as (A), but from learning session 12. After cue-reward 
association, mice show anticipatory lick behaviors in most of trials, therefore most lick 
onsets correspond to the time when US is available (t = 7 s after CS onset or second dotted 
line). Therefore, US response values are almost identical when fluorescence are averaged 
from CS onset or US consumption onset. (C) Averaged photometry traces from learning 
sessions 1, 2, 5, and 12. We observed total of four peaks in dLight1 fluorescence (best 
visible at the session 5): 1) CS-evoked (right after time = 0, which was dynamically 
modulated across learning and extinction), 2) pump sound induced (after time = 6), 3) US-
evoked (after time = 7) and 4) CS termination induced (after time = 10) peaks. (D) CS-US 
index (see supplementary information for definition) increases across learning sessions, 
suggesting that fluorescence response is transferred from US to CS. (E) Positive 
correlations between CS peak fluorescence and licks during CS presentation, both in 
learning (left) and extinction (right) sessions.  
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Fig. S15. Cortical dLight1 transients during animal behavior cannot be explained by 
image motion artifacts. (A) Top, average mouse running velocity for rewarded “Hit trials” 
from an example recording session. Data were aligned to running onset (vertical black line) 
prior to averaging. Three time intervals are indicated: “(I) Baseline interval” is part of the 
interval during which the animal was required to stand still; “(II) Reward expectation 
interval” defines the interval during which the mouse began to run and expected a reward; 
and “(III) Reward interval” defines the period during which the water reward was delivered 
in 80% of “Hit trials”. Bottom, 40x45 pixel detail from the corresponding time-lapse 
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fluorescence imaging data. Image data was motion corrected prior to averaging 
(Methods). Image comparison (dotted crosshair) indicates that residual image movement 
was below one pixel within and across the baseline, reward expectation, and reward 
intervals. (B) Top, average mouse running velocity from the same recording session but 
for all trial types. Bottom, corresponding dLight1.2 fluorescence transients across the entire 
field of view (FOV). Data was motion corrected prior to averaging. Full FOV transients 
retain the main characteristics of the single ROI transients (Fig. 5E), but details about the 
spatio-temporal heterogeneity of DA release are lost. (C) Lateral image displacements 
detected by the motion correction algorithm for the example average data shown in panel 
B. Image displacements were below one pixel for all trial types. (D) Maximum lateral 
image displacements for all averaged recording sessions and all mice. Error bars indicate 
SEM. (E) The motion correction algorithm reliably detected sub- and supra-pixel image 
displacements. Artificially introduced shifts (grey) to the data shown in panels A-C were 
tracked by the algorithm with sub-pixel precision (black). (F) Top, task-related dLight1.2 
fluorescence transients plotted as intensity average from an example ROI (from Fig. 
S16G). Bottom, transients extracted from the same ROI when applied to an artificially 
generated dataset in which the first frame of the top panel dataset was displaced using the 
lateral residual shifts shown in panel C. Intensity average transients produced by image 
shifts to the static first frame are negligibly small and distinct from task-related 
fluorescence transients.  
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Fig. S16. Behavioral performance and single-session dLight1 transients during 
cortical two-photon imaging. (A-D) Mouse performance on the visuomotor association 
task during imaging sessions. (A) Example performance data from one recording session. 
Out of all trials in which the “Go” stimulus was presented, the proportion of “Hit trials” 
(green) was >80%. The “Go” stimulus was not presented in “Spontaneous runs” (pink) 
during the stand-still phase. Animals typically performed the task successfully for several 
hundred trials before a steep increase in “Miss trials” (yellow) indicated that they had lost 
interest in the water reward. Trials beyond that point (black vertical line) were excluded 
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from analysis. (B) Reaction times (RT) from an example recording session. Most “Go” 
stimulus-triggered runs happened within the first second after stimulus onset indicating 
that the mouse had learned the task. The dashed line at 13s indicates the “Go” stimulus 
offset. (C) Population data showing mean proportion of “Hit trials” for all mice (N=4) and 
recording sessions (mouse #1: 4 sessions; mouse #2: 9 sessions; mouse #3: 2 sessions; 
mouse #4: 4 sessions). (D) Mean RTs for all mice and recording sessions. Error bars in 
panel C and D indicate SEM. (E) Dorsal view of the mouse cortex with the imaging 
locations (square) from all mice indicated. (F) Example fluorescence image details 
showing dLight1.2 expression pattern for different mice and recording locations: M1 
cortex, layer 1 and layer 2/3; FrA cortex, layer 2/3. The computationally defined regions 
of interest (ROIs), colored based on their response type, are overlaid. Single-session 
fluorescence transients of the highlighted ROIs (bold outlines) are shown in panel G. (G) 
Representative task-related dLight1.2 fluorescence transients from example recording 
sessions (population averages are shown in Fig. 5E). Top, mouse running speed on the 
spherical treadmill. Bottom, three common types of task-related fluorescence transients in 
M1. Left, example ROI showing significantly increased dLight1.2 fluorescence during 
locomotion but not reward; middle, ROI significantly active during reward expectation but 
not locomotion; right, ROI with significantly increased dLight1.2 fluorescence during the 
reward. Each colored trace is an average of the indicated number of trials aligned to running 
onset (vertical black line). p<0.05, Wilcoxon test, Bonferroni corrected for multiple 
comparisons. (H) Population data showing the number of ROIs with significant dLight 
transients in layer 1 (L1) and layer 2/3 (L2/3) of area M1 sorted by the three response types 
(see panel G and Fig. 5E). Significantly more reward related responses are seen in deeper 
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layers. * indicates significance, Binomial test, p<0.05, adjusted for total number of ROIs 
recorded in the respective layer.  
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2.13 Materials and methods 
Molecular Cloning 
All constructs were designed using circular polymerase extension cloning (CPEC) (Quan 
and Tian, 2011), restriction cloning, and gBlock gene fragments (Integrated DNA 
Technologies). Sequences coding for a hemagglutinin (HA) cleavable secretion motif and 
a FLAG epitope were placed at the 5’-end of the construct as in (Irannejad et al., 2013). 
HindIII and NotI cut sites were placed at the 5’- and 3’- end, respectively, for cloning into 
pEGFP-N1 (Addgene) to generate all pCMV constructs. BamHI and HindIII sites were 
introduced via PCR for final subcloning onto pAAV.hSynapsin1 and pAAV.CAG vectors.  
 
To maximize coupling between conformational changes and chromophore fluorescence, 
we chose to use a cpGFP module (LSS-LE-cpGFP-LP-DQL) from GCaMP6 (Chen et al., 
2013) for insertion into DRD1 via CPEC. For screening linker variants, we generated a 
linker library by first creating an insert DNA carrying a 2 aminoacid-long randomized 
linker on each side of cpGFP (LSS-xx-cpGFP-xx-DQL). Single colonies were manually 
picked and grown overnight as described in (Tian et al., 2009). All sensor sequences 
generated in this study are listed in the Supplementary Data S1 file.  
 
Structural modeling and sequence alignments  
Sequence alignments were performed using Jalview software (UK) (Waterhouse et al., 
2009) using a percentage identity color map. Inactive conformation of the sensor was 
predicted with rosetta_cm protocol of rosetta 3 (version 2015.31) (Song et al., 2013). 
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Primary sequence of sensor design was threaded with partial thread routine onto template 
PDB structures of inactive β2 adrenergic receptor (Cherezov et al., 2007) (ID: 2RH1) and 
unbound state of GCaMP3 (Chen et al., 2013) (ID: 4IK3). The threaded structures were 
then hybridized together with rosetta_cm protocol for membrane protein (Bender et al., 
2016). A total of 374 PDB structures were generated by rosetta_script routine. Structure 
with lowest total score was considered the final model.  
Cell culture, imaging and quantification 
HEK293T cells (ATCC #1573) and U2OS cells (ATCC #HTB-96) used in this study we  
cultured and transfected as in (Irannejad et al., 2013; Patriarchi et al., 2018). Primary 
hippocampal neurons were freshly isolated as previously described (Patriarchi et al., 2016). 
Neurons were infected using AAVs (1 x 109 GC/ml) at DIV5, two weeks prior to imaging. 
Prior to imaging, cells were washed with HBSS (Life Technologies). Cell imaging was 
performed using a 40X oil-based objective on an inverted Zeiss Observer LSN710 confocal 
microscope with 488/513 ex/em wavelengths. For testing sensor responses, 
neurotransmitters/drugs were directly applied to the bath during the imaging session. For 
neurotransmitter titrations, a dual buffer gravity-driven perfusion system was used to 
exchange buffers between different drug concentrations. Surface labeling was achieved as 
described previously (Irannejad et al., 2013; Patriarchi et al., 2018). One-photon emission 
spectrum for the sensors was determined using the lambda-scan function of the confocal 
microscope. Two-photon emission spectrum was obtained with a 40X water-based 
objective on a SliceScope (Scientifica) and was used to obtain the normalized two-photon 
cross-section using a custom-made script on MATLAB. For ROIs selection, masks were 
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generated either on the cell membrane or around the cytosol, depending on the 
experiment, using the threshold function in Fiji. We calculated spatial movies and images 
of Δ𝐹/𝐹 in response to an applied ligand as 
𝐹(𝑡) − ?̅?𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒
?̅?𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒
⁄  with 𝐹(𝑡) the pixel-
wise fluorescent value at each time, t, and mean fluorescence in time points prior to ligand 
application, ?̅?𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒. To avoid the possibility of infinite pixel values, we added a small 
offset to each pixel in ?̅?𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒. Based on the Δ𝐹/𝐹 maps we calculated a corresponding 
SNR map as Δ𝐹/𝐹 ×  √?̅?𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒. Δ𝐹/𝐹 heatmaps were generated using a custom MATLAB 
script. Surface expression of sensors was quantified as the ratio of membrane fluorescence 
over cytoplasm fluorescence. For titration curves, Kd values were obtained by fitting the 
data with a Hill function on Igor Pro (WaveMetrics).  
 
Dopamine-uncaging 
Uncaging experiments on neuronal dendrites were performed in the presence of 100 μM  
caged-dopamine (carboxynitroveratryl-DA, CNV-DA (Robinson et al., 2017)) in the 
HBSS. Optical recordings were performed at 153 ms/frame scan rate. Uncaging was 
achieved by shining 405 nm light (40% laser power) on a 2 μm wide circular region 
selected 10 μm away from the dendrite surface.  
 
Internalization assay with flow cytometry 
24 hours post transfection, cells were re-plated onto 6 well dishes. The following day, 
surface levels of receptors were assayed by addition of Alexa-647-conjugated M1 antibody 
(Sigma) for 45 minutes, as described previously (Irannejad et al., 2013). Fluorescence 
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intensity profiles of cells populations (>5000 cells) were measured using a FACS-
Calibur instrument (BD Biosciences). Each condition was performed in duplicate. 
Internalization was calculated by measuring the fraction of surface fluorescence remaining 
after 30 minutes of 1 μM SKF81297 (Tocris) and divided by the non-treated condition.  
 
Luminescence-based cAMP assay 
Experiments were conducted as previously described (Irannejad et al., 2013). Briefly, cells 
were transfected with the cyclic-permuted luciferase pGLOSensor-20F plasmid (Promega) 
and then treated with luciferin (GoldBio) in phenol and serum free media for 1 hour in a 
24 well dish. Luminescence values for SKF81297 (Tocris) treated conditions were 
measured at their peaks and normalized with reference to 10 μM forskolin (Sigma) at its 
peak.  
 
Total Internal Reflection Fluorescence Microscopy (TIRF-FM) Live Imaging 
Live cell TIRF-FM was conducted with a Nikon Ti-E inverted microscope at 37°C in a 
controlled humidity and CO2 controlled chamber as described previously (Irannejad et al., 
2013). D1 specific agonist SKF81297 (Tocris) was added at 1 μM while D1 antagonist 
SCH23390 (Tocris) was added at 10 μM.  
 
Preparation and transfection of cortical organotypic slice cultures  
Rat hippocampal slice cultures were prepared from P6 – P7 pups as previously described 
(Stoppini et al., 1991; Zhong et al., 2009). pCMV-dLight1.2 (12μg) and pCMV-mCherry 
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(3μg) were mixed with single cell electroporation solution (160 mM NaCl , 5.4 mM KCl, 
12mM MgCl2, 2 mM CaCl2 , 5 mM HEPES, pH 7.4 ) to total volume of 36 μl. One-week 
old hippocampal cultured slices were transfected with single cell electroporation 
(Otmakhov and Lisman, 2012). 5 – 7 days after transfection, single hippocampal cultured 
slice was transferred to the imaging chamber in a custom built two-photon imaging setup. 
Slices were perfused in 10ml gassed artificial cerebral spinal fluid (ACSF) containing 4mM 
Ca2+, 4mM Mg2+, 0.5 μM TTX and 10μM cocaine (DA transporter blocker) during 
imaging.  
 
AAV viral production  
All dLight1 AAV constructs were cloned in the laboratory, and viruses were produced by 
the UC Davis Vision Center Vector Design and Packaging Core facility. The viral titers of 
the viruses used in this study were: AAV1.CAG.flex.tdTomato, ~8 x 1012 genome copies 
(GC)/mL (University of Pennsylvania); AAV5.hSynapsin1.flex.ChrimsonR.tdTomato, ~4 
x 1012 GC/mL (University of North Carolina); AAV1. hSynapsin1.NES-jRGECO1a, ~3 x 
1013 GC/mL (University of Pennsylvania); AAV1. hSynapsin1.dLight1.1, ~1 x 1012 
GC/mL; AAV1. hSynapsin1.dLight1.2, ~2 x 1012 GC/mL; AAV9. hSynapsin1.dLight1.2, 
~4 × 1012 GC/mL; AAV9.CAG.dLight1.1, ~7 × 1011 GC/mL; AAV9.CAG.control_sensor, 
~1 x 1012 GC/mL.  
 
Animals 
Animal studies were conducted in compliance with the Guide for the Care and Use of  
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Laboratory Animals of the National Institutes of Health and approved by the Institutional 
Animal Care and Use Committee (IACUC) at the University of California, Davis or the 
relevant institutional regulatory body. Wild type rats were used in this study (0-2 months 
old) for neuronal and organotypic slice culture preparation and two-photon imaging in 
brain slice. Dopamine receptor-D1 (Drd1)-Cre mice (4-6 months old, Jackson Labs, Strain 
B6; 129- Tg(Drd1-cre)120Mxu/MMJax) were used for two-photon imaging in the dorsal 
striatum. Vesicular GABA transporter (VGAT)::IRES-Cre (Vong et al., 2011) (Jackson 
Labs, Slc32a1tm2(cre)Lowl/J) and Tyrosine hydroxylase (TH)::IRES-Cre (Lindeberg et 
al., 2004) (Jackson Labs, B6.129X1-Thtm1(cre)Te/Kieg) knock-in mice between 3 and 5 
months old were used for in vivo imaging using fiber photometry and for optogenetic 
manipulations. Wild type male mice (2 to 5 months old, C57BL6/J, Jackson Laboratories) 
were used for two-photon in vivo imaging in the cortex. Sample sizes (number of mice) for 
each experiment are stated in main text. All animals were group housed in standard plastic 
cages on a 12-hour light/dark cycle with food and water available ad libitum, except for 
mice trained on the visuomotor association task (see below). These mice were house 
individually on a reverse 12-hour light/dark cycle. Anesthesia was performed with 4.5% 
isoflurane for induction and 2% for maintenance.  
 
Viral injections  
Injection procedures were essentially identical to those described in (Howe and Dombeck, 
2016; Tufail et al., 2017; Matsui et al., 2014; Cardin et al., 2010) with a few exceptions.  
 
For dopamine imaging in brain slice, male and female Sprague-Dawley rats (p23-27) were 
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used for intracerebral microinjections. Briefly, anesthetized rats were immobilized in a 
Stereotaxic Alignment System (Kopf Instruments). AAV1.hSynapsin1.dLight1.2 (200 nl) 
was injected unilaterally into the dorsal striatum using the following coordinates from 
bregma (in mm): 0.48 anteroposterior (AP), ±2.19 mediolateral (ML), 4.69 dorsoventral 
(DV).  
 
For dopamine imaging in the dorsal striatum, mice were injected in the dorsal striatum at 
two caudal locations (+0.6 and +0.2 AP and 2.1mm ML to bregma) and 3 depths below the 
surface (-1.6mm, -1.9mm, and -2.2mm; 100 nL at each depth, total 0.6uL) with either 
AAV1. hSynapsin1.dLight1.1 or AAV1. hSynapsin1.dLight1.2 in combination with 
AAV1.CAG.flex.tdTomato (diluted 1:100 in PBS). The flex-tdTomato in our experiments 
is expressed in roughly half of the SPNs (Drd1-cre mice) to avoid potential issues, such as 
competition of expression when two AAVs are co-expressed in the same neurons.  
 
For dopamine imaging using fiber photometry, AAV9.CAG.dLight1.1 or 
AAV9.CAG.control_sensor was injected into the NAc (+1.3 mm AP, -1.25 mm ML, -4.25 
mm DV) and cre-dependent AAV encoding ChrimsonR-tdTomato was injected into the 
VTA (-3.3 mm AP, -0.5 mm ML, -4.3 mm DV). For dual color photometry experiments, 
AAV encoding jRGECO1a was 1:1 mixed with dLight1.1 virus and injected into the NAc 
region (+1.3 mm AP, -1.5 mm ML, -4.25 mm DV). A 10 μL NanoFil microsyringe (World 
Precision Instruments) with a blunt 35-gauge needle was used for viral injection and 
manipulated by a microsyringe pump (UMP3, World Precision Instruments) and a 
controller (Micro4, World Precision Instruments). 500 nL of AAV was slowly injected into 
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the target coordinates over 10 minutes, and additional 10 minutes were waited to allow 
diffusion. The needle was slowly withdrawn over 10-15 minutes.  
 
For dopamine imaging in the cortex, anesthetized animals (4% isoflurane for induction; 
~1.5% during surgery) were positioned in a computer-assisted stereotactic frame with 
digital coordinate readout and atlas targeting (Angle Two, Leica Biosystems Inc., Buffalo 
Grove, IL). Micropipettes were loaded with virus solution and slowly lowered into the 
brain under a ~32 injection angle until the target depth (~0.2 mm) was reached. Manual 
pressure was applied to a 30 mL syringe connected to the injection pipette. Virus solution 
was slowly injected over a period of 5–10 min. Once desired injection volume (200-400 
nl) was delivered, the syringe’s pressure valve was locked and position maintained for 
approximately 10 min to allow virus to spread and to avoid backflow upon needle 
retraction. Each mouse received two injections of AAV9. hSynapsin1.dLight1.2 (1:50 
dilution). Injection coordinates were (AP 3-3.2 mm, ML 1- 1.2 mm) and (AP 1.5 mm, ML 
1-1.5 mm).  
 
Slice preparation 
5% isoflurane was used to deeply anesthetize rats prior to decapitation. Brains were rapidly  
removed and placed in modified Krebs buffer containing (in mM) 126 NaCl, 2.5 KCl, 1.2 
MgCl2, 2.4 CaCl2, 1.4 NaH2PO4, 25 NaHCO3, 11 D-glucose, and with 10 μM MK-801. 
Horizontal slices (245 μm) were taken using a Leica vibratome and allowed to recover for 
at least 30 minutes prior to use in Krebs with MK-801 being continuously bubbled with 
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95/5% O2/CO2. Slicing and recovery was done at elevated temperatures (30-34° C). 
Following recovery, slices were secured in a recording chamber maintained at 34° C and 
perfused with modified Krebs at a rate of 3 ml/min.  
 
Surgical procedures for in vivo imaging  
Cannula implant for in vivo imaging in dorsal striatum 
Two-weeks post-injection, a chronic imaging window was implanted over the external 
capsule fibers above the striatal injection site as described previously (Howe and Dombeck, 
2016). Briefly, a 2.75mm craniotomy was performed on anaesthetized mice, and cortical 
tissue was slowly aspirated until the white matter of the external capsule was exposed. A 
thin layer of Kwik-Sil (WPI) was applied over the imaging region, and a metal cannula 
covered at one end by a glass coverslip was inserted into the aspiration site down to the 
fiber surface.  
 
Optical fiber implantation for fiber photometry and optogenetics 
Mice were anesthetized with isoflurane and carbogen mixture (4-5% for induction, 1.5-  
2% for maintenance) and carefully placed to a stereotaxic frame (Kopf Instruments) after 
shaving their hair. Head skin was sterilized with chlorohexidine and a midline incision was 
made using a sterile scalpel. The skull surface was exposed and cleaned with sterilized 
cotton swabs. Bregma and lambda points were identified and leveled to be at the same 
dorsal-ventral axis. Small craniotomy holes were made with drill bits (#73 size, Kyocera) 
over the nucleus accumbens (NAc) and ventral tegmental area (VTA). After viral delivery, 
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optical ferrule/fiber (for VTA/optogenetics, 300 μm diameter, 5-6 mm cut length, NA 
0.37, home-made; for NAc/photometry, 400 μm diameter, 5 mm cut length, NA 0.48, Doric 
lenses) was mounted to a stereotaxic cannula holder (Doric lenses). First, a 400 μm fiber 
was lowered to the NAc through a craniotomy hole and stopped at 200 μm above the virus 
injection target. A layer of adhesive cement (C&B Metabond, Parkell Inc.) was applied to 
the anterior portion of skull surface to strongly hold the implanted ferrule. Care was taken 
not to apply Metabond near the posterior craniotomy sites for VTA. Next, a 300 μm fiber 
was inserted to the VTA and stopped at 500 μm above the injection site. Another layer of 
adhesive cement was applied to hold the second fiber. After adhesive cement was fully 
dried, a thick layer of dental cement (Lang Dental) was applied to build a head cap.  
 
Head plate and cranial window implantation for in vivo imaging in the cortex  
A few weeks after viral injections, mice were implanted with a head plate and cranial 
window on a custom surgical bed (Thorlabs Inc., Newton, NJ). Body temperature was 
maintained at 36–37 °C with a DC temperature control system and ophthalmic ointment 
was used to prevent eyes from drying. Skin was cleaned and disinfected with 70% ethanol 
and Betadine. A small (~10 mm) incision was performed along the midline. The scalp was 
pulled open and periosteum cleaned. First, a portion of the scalp was surgically removed 
to expose frontal, parietal, and interparietal skull segments. Then, the metal plate was 
affixed to the bone with C&B Metabond Quick Adhesive Cement (Parkell Inc., Edgewood, 
NY). Next, to enable chronic two-photon imaging, a custom-made cranial window was 
implanted, similar to (55). The craniotomy (2.5 mm diameter) was centered around (AP 2 
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mm and ML 1.5 mm) and sealed with a custom three-layered cover glass assembly (each 
No.1 thickness) with the two layers closest to the cortex consisting of two pieces of circular 
2.5 mm-diameter cover glass and the outermost layer consisting of a circular 4 mm-
diameter cover glass that rested on the thinned skull. The dura mater was kept intact.  
 
Behavioral experiments  
Sucrose consumption 
Mice were handled daily for 5-10 minutes to reduce anxiety associated with experimenter’s 
handling. Following recovery from surgery (~7 days) mice were water-restricted to 1.5 mL 
per day and maintained at 85-90 % of ad libitum weight. All behavioral experiments were 
carried out in an operant chamber within a sound-attenuating box (Lafayette Instruments). 
Behavioral tasks were implemented and controlled by ABET II software (Lafayette 
Instruments). TTL pulses were used to synchronize with fiber photometry recordings. After 
at least 7 days of water deprivation, mice were introduced to an operant chamber and 
allowed to freely explore with a patch cord connected. 50 μL of 5 % sucrose water was 
delivered every 60 seconds (total 10 times) so that mice can learn the position of a lick 
port. Lick was detected as a break of infrared beam at the lick port. This habituation session 
was repeated two to three times for each mouse until they showed robust lick activity (>400 
licks per session). At the recording day, mice underwent the same sessions while recording 
dLight1 fluorescence with fiber photometry. For analysis, mean fluorescence values were 
obtained from baseline (-10~-5 s from lick onset) and during consumption (0~5 s).  
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Unpredictable footshock delivery  
Mice were placed into an operating chamber with a patch cord connected for photometric  
recordings. Five electric footshocks (0.6 mA for 1 second) were delivered with variable 
intervals (randomly chosen from uniform distribution between 45 and 75 seconds) without 
predictive cues. This was performed after all other experiments, since such aversive stimuli 
can induce sustained fear and anxiety to the context. For analysis, mean fluorescence values 
were obtained from baseline (-5~-1 s from lick onset) and during footshock (0~2 s).  
 
Cue-reward learning and extinction 
In cue-reward learning sessions, CS was turned on for 10 seconds and US was available 7 
seconds after CS onset, after variable inter-trial intervals (ITI). In cue-reward extinction 
sessions, same CS was turned on for 10 seconds without US delivery after variable ITI. In 
“expected reward delivery” trials, US was delivered after CS presentation, as in previous 
learning sessions.  
 
After sucrose consumption experiments, mice started appetitive Pavlovian conditioning, or 
cue-reward learning, in the same operant chamber. Conditioned stimuli (CS) consisted of 
house-light and 70 dB 5kHz tone, and were turned on for 10 seconds with variable intervals 
(randomly drawn from uniform distribution between 75 and 105 seconds). Unconditioned 
stimulus (US) was 50 μL of 5 % sucrose water, available at the 7th second after each CS 
onset. Pump sound from liquid dispenser was audible from 6th to 7th seconds. CS-US 
pairings were repeated 20 times per session (therefore ~30 minutes for each session). Mice 
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underwent a total of 12 sessions for cue-reward learning. Chambers and lick port were 
sanitized with Accel and 70% ethanol between animals to remove any odor. For all 
sessions, lick data and photometry recordings were simultaneously obtained. Two to three 
days after the last cue-reward learning sessions mice began cue-reward extinction. Identical 
CS were given 30 times per session with variable intervals (between 45 and 75 seconds), 
now without US delivery. Mice underwent total of 5 extinction sessions. To quantify CS-
triggered behavior, number of licks was counted during CS presentation. For photometry 
data, peak fluorescence was obtained for CS (0~3 s after CS onset) and US (-2~5 s around 
US consumption onset). US consumption onset for each trial was defined as the lick bout 
onset after US is available, where lick bout onset was detected with a threshold of 2 Hz. 
To examine fluorescence response shift from US to CS (or vice versa), we calculated CS-
US index, defined as (CS response – US response) / (CS response + US response).  
 
Unexpected reward delivery and omission  
After 12 cue-reward learning sessions, mice underwent reward prediction error 
experiments. In “unexpected reward delivery” session, animals were exposed to normal 
CS-US pairing trials; but in 25% of trials, US was delivered without CS, so that mice can 
explore to the lick port without predictive cues and consume reward in an unexpected 
manner. Peak fluorescence values after US consumption onset was obtained and compared 
between expected and unexpected conditions. In “unexpected reward omission” sessions, 
US delivery was omitted in 4 out of 20 trials (4th, 8th, 13th, and 16th trials) after predictive 
CS onset. For analysis, mean fluorescence values were obtained from baseline (-10~0 s 
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from CS onset) and after CS offset (10.5~11.5 s) and compared.  
 
Visuomotor learning task  
Prior to surgical preparation and behavioral training, mice were handled/tamed on two 
consecutive days to reduce stress during experiments. Following recovery from surgery 
(~7 days) mice were water-restricted to 25 ml kg-1 per day and maintained at 80-85% of ad 
libitum weight. Training was performed in a custom-built setup that included a color LCD 
monitor (12.1" LCD Display Kit/500cd/VGA, ICP Deutschland GmbH) on which visual 
stimuli were presented. To reduce noise in optical recordings, the monitor was covered 
with a color filter (R342 Rose Pink, Rosco Laboratories Inc.). During training, mice were 
head-fixed with a custom-build head holder and placed on a spherical treadmill (Habitrail 
Mini Exercise Ball, Animal World Network) facing the LCD display. An optical encoder 
(E7P OEM, US Digital) attached to the treadmill allowed measurement of both speed and 
direction of ball movement. Water reward was delivered with a programmable syringe 
pump (NE-500 OEM Syringe Pump, New Era Pump Systems, Inc.). Behavioral signals 
were acquired through a data acquisition board (PCI-6221, National Instruments) 
connected to a breakout box (BNC-2110, National Instruments) and interfaced to 
MATLAB using the Data Acquisition Toolbox (Version R2010bSP2, The MathWorks 
Inc.). Behavioral task sequence was controlled by the MATLAB-based software 
MonkeyLogic (www.monkeylogic.net) (Assad and Eskandar, 2008; Assad et al., 2013). 
Custom-written functions were added to MonkeyLogic to enable analysis and control of 
ball rotation parameters. Treadmill encoder signals, trial marker codes (generated by 
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MonkeyLogic), and imaging data were acquired in synchrony allowing running 
parameters, behavioral task events, and image frames to be linked.  
 
Once the mouse stopped moving on the ball, a sequence of task events was initiated. First, 
a blue square frame was displayed on the monitor and required the animal to continue to 
stand still for a period of 10 s (ball rotation/velocity ≤ 2 mm/s). If the mouse continued to 
stand still for the entire stand-still phase, a second stimulus, a filled blue square, was 
presented for 3 s, instructing the mouse to initiate a run. If the mouse initiated sustained 
movement (ball rotation/velocity >10 mm/s for >1s duration) during the 3s stimulus phase, 
a water reward was delivered. In 20% of pseudo-randomly selected trials the reward was 
withheld (“Unexpected reward omissions”; light green traces in Fig. 5, Fig. S15 and S16). 
If no running occurred, the trials counted as a miss trial. If the animal began to move during 
the 10 s stand-still phase (ball rotation/velocity > 2 mm/s), the trial was aborted and no 
water reward was delivered (“Spontaneous run trials”; pink traces). The mouse was able to 
initiate a new trial after an intertrial interval (ITI) of 5 s.  
 
During the first two days of training, mice spent ~15-30 min/day in the setup to become 
accustomed to head restraint. Mice were then trained daily for 60-90 min during which 
they performed ~300-700 trials. Task parameters were adjusted depending on individual 
animal’s performance. Initially, the duration of the stand-still phase was set to 3 s, the 
stimulus phase to 20 s, and the running threshold to 2 mm/s. This increased the chance for 
the mouse to receive the task-dependent reward. The stand-still phase was then 
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progressively extended and the stimulus phase shortened to establish the association 
between stimulus onset and running onset. Training continued until median reaction times 
(RT) had dropped below 1500 ms, which indicated that mice had learned to associate the 
visual cues with the desired behavior. Task proficiency was typically reached within 5-7 
days. During the initial training phase all successful “Go” trials were rewarded. 
Unexpected reward omission trials were introduced during imaging sessions only.  
 
In vivo optogenetic and pharmacological manipulations 
For optogenetic experiments, a patch cord (1 m length, 1.25 mm zirconia ferrule, 300 μm  
diameter fiber, Doric lenses) was used to connect to a ferrule on an animal’s head cap and 
a swivel commutator (fiber-optic rotary joints, Doric lenses) to allow free movement. 
Another patch cord was connected from the commutator and to a 635 nm diode-pumped 
solid-state laser (Changchun New Industries Optoelectronics Technology). The intensity 
of laser was measured with a power meter (PM100D, Thorlabs) and calibrated to be 10 
mW at the fiber tip. An external TTL pulse generator (OTPG4, Doric Lenses) was used to 
control the laser output. For activating VTA DA neurons, 5 Hz, 10 Hz, and 20 Hz of 10 ms 
pulses were applied for 2 seconds. For activating VTA GABA neurons, 40 Hz pulses were 
used (Eshel et al., 2015). These pulse trains were repeated 40 times per animal with 
intervals of 30 seconds. For pharmacological manipulations, the following drugs were 
used: DRD1 antagonist (SCH-23390, 0.25 mg/kg) and selective DA reuptake inhibitor 
(GBR-12909, 10 mg/kg) (Park et al., 2011). Animals were injected with these drugs or 
saline (0.9% sodium chloride) through intraperitoneal delivery 30 minutes before 
optogenetics/photometry experiments. Mean or peak fluorescence values were obtained 
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before (-5~-1 s from onset), during (0.5~2 s) or after (4~10 s) photoactivation.  
 
Data acquisition and analysis for ex vivo and in vivo imaging  
Ex vivo imaging in rat brain slice 
Imaging was carried out in a custom built 2-photon microscope. Data were acquired and  
collected using ScanImage software (Pologruto et al., 2003). Slices were scanned at 
different frequencies, depending on the experiment, using 920 nm light. Electrical 
stimulation through a glass mono-polar electrode placed within the slice near the area of 
imaging was used to evoke dopamine release. Experiments were carried out with a scan 
rate of 2 (128x128 pixels) or 15 (32x32 pixels) Hz. The fluorescence over the entire field 
(20x20 μm) was measured for each frame and plotted against time. Drugs were applied by 
superfusion. Line scans were taken at a 500 Hz frame rate. To measure the dopamine 
response curve, two-photon images were taken every minute. Image analysis was 
performed using custom software written in MATLAB.  
 
In vivo imaging in mouse dorsal striatum 
Treadmill velocity and acceleration were sampled at 1000Hz by a rotary encoder (E2-5000,  
US Digital) attached to the axle of the treadmill. Two-photon imaging was performed as 
described previously (Sheffield et al., 2017), using the same collection optics, but without 
the electric lens. 920 nm laser light was used for excitation and 1024x512 pixels time series 
datasets were acquired at 30 Hz. Imaging sessions began after mice were acclimated to 
head fixation and ran frequently on the treadmill (~1-3 days). Imaging data was collected 
over 1-2 days from dorsal striatum fields ranging from 250 to 450μm in diameter. All 
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analyses were carried out using custom software written in MATLAB. Time series 
movies were motion corrected on the static red channel using algorithms described 
previously (Dombeck et al., 2010) and x and y shifts from the red were used to correct the 
green channel. Mean whole field fluorescence was calculated from a large, hand-selected 
ROI containing all regions of the field with visible cellular structure in the red tdTomato 
channel. Fluorescence time series were converted to ΔF/F by normalizing signals to an 8th 
percentile baseline (Dombeck et al., 2010) within a sliding window (+/-15s around each 
point) to correct for slow drift and bleaching. Significant positive-going transients were 
calculated as previously described (Dombeck et al., 2010).  
 
In vivo imaging with fiber photometry  
Fiber photometry was performed as in (28, 63, 64). For dual color imaging a three LED 
system was used (FMC7, Doric Lenses): 490 nm for dLight1, 565 nm for jRGECO1a, and 
405 nm to be used as isosbestic wavelength for both indicators. The following dichroic 
filters and excitation/emission filters were used (all from Semrock): Di02-R405, Di02-
R442, FF495-Di03, FF552-Di02, FF593-Di03, FF01-405/10, FF01-433/24, FF01-475/28, 
FF02-520/28, FF01-565/24 and FF02-641/75 (Gunaydin et al., 2014; Lerner et al., 2015; 
Cho et al., 2017). Acquired photometry data were processed with custom-written codes in 
MATLAB. Raw data from each channel were low-pass filtered at 25 Hz (for single color 
imaging) or 12 Hz (for dual color imaging) using a 2nd order Butterworth filter with zero-
phase distortion. To calculate ΔF/F time series, a linear fit was applied to the 405 nm 
signals and aligned to the 490 and 565 nm signals. The fitted 405 nm signal was subtracted 
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from 490 and 565 nm channels, and then divided by the fitted 405 nm signal to yield 
ΔF/F values. Dual color imaging data were down-sampled to 100 Hz. In Pavlovian 
conditioning, ΔF/F time-series signal is further normalized using robust Z-score 
(subtraction of median and division by median absolute deviation, calculated from the 
entire session) to account for potential differences in signal variance across animals and 
sessions. Photometry signals were then extracted around relevant behavioral events (e.g., 
lick onset, footshock delivery, CS onset) and averaged. Power spectral density was 
estimated for averaged dLight1/control sensor fluorescence data upon optogenetic 
stimulation of different frequencies. We used Welch’s method with 2-second window size 
and 50% overlap to estimate power from 0.5 to 25 Hz in 0.1 Hz step.  
 
In vivo two-photon imaging in the cortex 
Once mice had reached proficiency on the task, they were imaged daily for up to 9 days.  
Imaging was performed using a resonant scanning two-photon microscope (Sutter 
Instrument) equipped with a pulsed femtosecond Ti:Sapphire laser (Chameleon Ultra II, 
Coherent). dLight1 fluorescence was excited with 910 nm light, and detected using a 
ET525/70M emission filter (Chroma Technology Corp.) and H7422-40 GaAsP 
photomultiplier tube (Hamamatsu Photonics). Average excitation power was 40-130 mW 
depending on imaging depth and dLight1 expression levels/duration. Typical recording 
depth was 80-150 μm below the pia. Data were acquired using a Nikon 16x 0.8-NA water 
immersion objective. A custom-made blackout curtain around the microscope’s detector 
was used to reduce light contamination by the LCD monitor. Images (512×512 pixels) were 
acquired at 30.8 frames/sec. Recording sessions consisted of five to twelve ~10 min 
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recordings, separated by short imaging breaks (3-5 min). Recordings within a given 
session were performed at the exact same location to maximize the number of trial 
repetitions for analysis. Recordings from different sessions were performed at the same 
injection sites but offset either laterally or axially to maximize tissue volume being 
sampled.  
 
Analysis of cortical in vivo imaging data 
All data were analyzed using custom code written in MATLAB (MathWorks). Data from  
four animals were included in the analysis. Mouse #1 underwent 4 recording sessions 
starting 8 weeks after virus injection. Mouse #2 underwent 9 recording sessions starting 3 
weeks after injection. Mouse #3 underwent 2 recording sessions starting 2 weeks after 
injection and Mouse #4 underwent 4 recording sessions starting 6 weeks after injection. 
Recording locations (M1/M2/FrA) are indicated in Fig. S16E.  
 
To confirm the animals’ responsiveness to the “Go” stimulus, we compared proportions of 
trials in which runs were triggered by “Go” stimulus presentation (“Hit trials”) and 
proportions of trials in which no such response occurred (“Miss trials”) (Fig. S16A and C). 
A steep increase in “Miss trials” at the end of the session indicated that mice had lost 
interest in the water reward. Trials beyond that point (black vertical line in Fig. S16A) were 
excluded from analysis. To confirm that mice had learned the task, we analyzed the 
animals’ RTs (defined as the time interval between “Go” stimulus onset and movement 
onset/ball velocity >10 mm/s) (Fig. S16B and D). RTs below 1500 ms indicated that mice 
had learned to associate the visual cues with the desired behavior.  
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To reduce random noise in our time-lapse recordings a sliding average filter was applied 
(8 frames or 260 ms). This filtering largely retained the temporal dynamics of dLight1 
fluorescence signals. Lateral image motion (e.g., due to mouse movement) was corrected 
using a cross-correlation registration algorithm, with an average image of 50 consecutive 
frames from the time-lapse recording serving as the reference image. The same reference 
image was used to correct image motion of other recordings from the same location. Noise 
in motion-corrected image data was further reduced using a Kalman filter.  
 
To quantify/classify dLight1 transients, we tiled the field of view (FOV) with equally sized 
(~17x17μm) regions of interest (ROIs). To exclude ROIs with little or no dLight1 
expression (e.g., on blood vessels) we first generated a mean fluorescence projection image 
from the corresponding time-lapse recording. We then calculated the projection image’s 
pixel intensity distribution. ROIs with mean pixel intensity values below the 55th percentile 
of this distribution were excluded from analysis. To extract fluorescence time traces F(t) 
from all remaining ROIs, pixel intensities of each ROI were averaged. ΔF(t)/F was 
calculated as (F(t) – mean F) / mean F. ROIs that showed transients with negative 
amplitudes (predominantly located near blood vessels) were excluded from further 
analysis.  
 
Each ROI’s time trace included multiple trials/task repetitions. Based on the animal’s 
performance on the trials, time traces were subdivided into “Expected reward”, 
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“Unexpected reward omission”, and “Spontaneous run” trial traces. This was done for 
all recordings from the same location using the same ROIs. Extracted trial traces were then 
sorted by trial type, aligned to running onset, and averaged (Fig. S16G, single ROIs). To 
ensure that cued and spontaneous running bouts were comparable, only traces from 
spontaneous runs starting > 5 s after stand-still cue onset and with > 5 mm/s ball 
rotation/velocity were included. To calculate population responses, “Expected reward”, 
“Unexpected reward omission”, and “Spontaneous run” trial traces from all animals, all 
sessions, and all significant ROIs were averaged (Fig. 5E, group average).  
 
To identify ROIs with significant increases in dLight1 fluorescence in response to the task, 
three analysis intervals were defined (Fig. S15A): (I) Baseline (from -7 to -2 s prior to run 
onset), (II) reward expectation (from run onset to 3.3 s after run onset), and (III) reward 
interval (from 4.3 s to 10.8 s after run onset). ΔF/F traces for each trial were averaged 
during the three trial intervals respectively. The distributions of the averaged ΔF/F traces 
for particular trial types were then statistically compared among each other and between 
intervals. ROIs that showed significant fluorescence increases during the reward 
expectation but not the reward interval, and for all trial types compared to the baseline 
interval, were defined as “ROI active during locomotion” (white squares in Fig. 5 and Fig. 
S16G). ROIs that showed significant fluorescence increases during the reward expectation 
but not reward interval for cued/triggered but not spontaneous run trials were classified as 
“ROI active during reward expectation” (black squares). Finally, ROIs that showed 
significant fluorescence increases during the reward interval for rewarded but not un-
rewarded or spontaneous run trials were defined as “ROI active during reward” (red 
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squares). Significance was determined using the Wilcoxon’s rank-sum test (p<0.05), 
Bonferroni corrected for multiple comparisons.  
 
All ROI analysis was performed on motion corrected image data (see above) averaged 
across trials of the same type and from the same session. To investigate whether this 
averaging introduces artifacts in the DA transients (e.g., due to stereotypic running-related 
image movements) we inspected our data more closely at cellular and population levels. 
Close observation of a 40x45 pixel detail of the motion corrected image data revealed 
stable and sharp images even during the most vigorous running periods (Fig. S15A). Next, 
we plotted the full field of view (FOV) intensity changes for the average data of each trial 
type aligned at run onset (Fig. S15B). This revealed that the main characteristics of the 
single ROI transients are retained in the full FOV average, arguing against a pronounced 
contamination by motion artifacts. Next, to investigate residual lateral shifts in the average 
image data for each trial type, we applied our motion correction algorithm. The detected 
residual image motion was <2 pixels for all sessions and mice (Fig. S15C and D). To verify 
that our motion correction algorithm reliably detects sub- and supra-pixel image 
displacements we artificially introduced random lateral shifts of up to 5 pixels to the same 
average image data (Fig. S15E). The error between the introduced shifts and the shifts 
detected by the algorithm across 100 repetitions was 0.089 ± 0.001 pixels (mean ± SEM). 
Together, this suggests that DA transients extracted from our 17x17μm ROIs are unlikely 
an artifact of image motion (Fig. S15F).  
 
Histology 
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Histological verification of proper sensor expression was as described previously (Cho 
et al., 2017). Primary antibodies used were: chicken anti-GFP (1:500; GFP-1020, Aves 
Labs), chicken anti-TH (1:500; TYH, Aves Labs) and rabbit anti-RFP (1:500; 600-401-
379, Rockland A&A).  
 
Hybrid chain reaction combined with immunohistochemistry 
To assess the expression pattern of ChrimsonR-tdTomato injected into the VTA of 
VGAT::IRES-Cre mice, we performed combined in situ hybridization for labeling vgat 
mRNA and immunohistochemistry (IHC) for detecting DAergic neurons (with TH). To 
achieve high-sensitivity in situ hybridization of vgat in tissue slices, we used hybridization 
chain reaction (HCR) (Choi et al., 2014; Choi et al., 2018). First, we designed 22 probes 
for targeting vgat using a custom written software (available at 
https://github.com/GradinaruLab/HCRprobe). Each probe consists of 20-nt target 
sequence, 2-nt spacer, and 18-nt initiator. We selected the target sequences that has (1) the 
GC content of 45-60%, (2) no nucleotide repeats more than 3, (3) no more than 20 hits 
when blasted, (4) higher than a ΔG of -9 kcal/mol to avoid self-dimers. Then we blasted 
full sequences (target sequences with spacer and initiator) and calculated Smith-Waterman 
alignment scores between all possible pairs to exclude probes forming cross-dimers. The 
designed probes were synthesized by Integrated DNA Technologies.  
 
HCR was performed on 50 μm-thick slices and kept in RNAlater solution (ThermoFisher 
Scientific). Slices were permeabilized in PBST (1xPBS with 0.1% Triton X-100) for 1 hour 
at room temperature (RT) and pre-hybridized in hybridization buffer (2x saline-sodium 
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citrate (SSC) , 10% ethylene carbonate, 10% dextran sulfate) for another hour at 37°C. 
Then the samples were incubated in pre-warmed hybridization buffer including probes (2 
nM for each) at 37°C overnight. After hybridization, we performed stringent washes with 
wash buffer (2xSSC, 10% ethylene carbonate) for 30 min at 37°C and washes with 2xSSC 
for 30 min at RT (twice for each). The amplification step was performed as described in 
(Shah et al., 2016) overnight. For IHC labeling of TH on HCR-labeled tissue slices, we 
used IHC buffer consisting of 2x SSC, 1% donkey serum, and 0.1% Triton X-100. We 
incubated the samples in IHC buffer for 1 hour at RT for blocking and added primary 
antibody (anti-TH, AB152, Millipore, 1:200). Primary antibody reaction was performed 
for overnight at RT. Following the wash steps with 2xSSC at RT for 30 min twice, the 
samples were incubated in IHC buffer including secondary antibodies (1:200) for overnight 
at RT. The samples were rinsed with 2xSSC a few times and mounted on a glass slide with 
mounting media (Prolong Diamond, ThermoFisher Scientific).  
Probe sequences (5’->3’)  
1 
CACTTCATATCACTCACTaaGACACGGAGGTGGCCACATT 
2 
CACTTCATATCACTCACTaaGCGATGCTCAAAGTCGAGAT 
3 
CACTTCATATCACTCACTaaCCTGAATGGCATTTGTCACG 
4 
CACTTCATATCACTCACTaaACCAGGACTTCTGCGACACG 
5 
CACTTCATATCACTCACTaaTTCTTCAGGAAGGCGCAGGG 
6 
CACTTCATATCACTCACTaaTTCTCCCAGGCCCAATCACG 
7 
CACTTCATATCACTCACTaaGTGTAGCTGAACACGATGAT 
8 
CACTTCATATCACTCACTaaGCGGCGATGTGTGTCCAGTT 
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9 
CACTTCATATCACTCACTaaACTTCCTTGGTCTCGTCGGC 
10 
CACTTCATATCACTCACTaaCGCGAAGAAGGGCAACGGAT 
11 
CACTTCATATCACTCACTaaAGGCGCAAGTGGAAGAGGCT 
12 
CCTTGGCCTGGGACTTGTTGaaCCCAATCTCTATCTACCC 
13 
ATGTCCATCTGCAGGCCCTGaaCCCAATCTCTATCTACCC 
14 
TAGGCCCAGCACGAACATGCaaCCCAATCTCTATCTACCC 
15 
CACCGCTGTGGCTATGATGGaaCCCAATCTCTATCTACCC 
16 
ACTTGGACACGGCCTTGAGAaaCCCAATCTCTATCTACCC 
17 
CGTCGATGTAGAACTTCACCaaCCCAATCTCTATCTACCC 
18 
AGGGCAGGAAGATCTGCGACaaCCCAATCTCTATCTACCC 
19 
AGAGACCCTTGAGCACGCAGaaCCCAATCTCTATCTACCC 
20 
CGGGCAGGTTATCCGTGATGaaCCCAATCTCTATCTACCC 
21 
TTCTCCAGCACTTCGACGGCaaCCCAATCTCTATCTACCC 
22 
ACAGCAGCTTGCGCCAGAGAaaCCCAATCTCTATCTACCC 
 
Statistical Analysis 
All statistical analyses were performed in MATLAB (MathWorks), Igor Pro 
(WaveMetrics) or Prism (GraphPad). We used both parametric (t-test, one-way ANOVA, 
two-way ANOVA) and non-parametric (Wilcoxon’s rank-sum) tests. Pearson’s correlation 
coefficients and their p-values were calculated to assess how behavior or dLight1 
fluorescence evolved across reward learning or extinction. All tests were two-tailed. Error 
bars are standard error of the mean or standard deviation as indicated in Figure legends and 
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main text. No statistical methods were used to predetermine sample size.  
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C h a p t e r  3  
DORSAL RAPHE DOPAMINE NEURONS MODULATE AROUSAL 
AND PROMOTE WAKEFULNESS BY SALIENT STIMULI 
[2] Cho, J. R. et al. (2017). “Dorsal raphe dopamine neurons modulate arousal and promote 
wakefulness by salient stimuli.” In: Neuron 94.6, pp. 1205-1219.e8. doi: 
10.1016/j.neuron.2017.05.020. 
 
3.1 Summary 
Ventral midbrain dopamine (DA) is unambiguously involved in motivation and behavioral 
arousal, yet the contributions of other DA populations to these processes are poorly 
understood. Here, we demonstrate that the dorsal raphe nucleus DA neurons are critical 
modulators of behavioral arousal and sleep-wake patterning. Using simultaneous fiber 
photometry and polysomnography, we observed time-delineated dorsal raphe nucleus 
dopaminergic (DRNDA) activity upon exposure to arousal-evoking salient cues, 
irrespective of their hedonic valence. We also observed broader fluctuations of DRNDA 
activity across sleep-wake cycles with highest activity during wakefulness. Both 
endogenous DRNDA activity and optogenetically driven DRNDA activity were associated 
with waking from sleep, with DA signal strength predictive of wake duration. Conversely, 
chemogenetic inhibition opposed wakefulness and promoted NREM sleep, even in the face 
of salient stimuli. Therefore, the DRNDA population is a critical contributor to wake-
promoting pathways and is capable of modulating sleep-wake states according to the 
outside environment, wherein the perception of salient stimuli prompts vigilance and 
arousal.  
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3.2 Introduction 
In mammals, behavioral arousal fluctuates as inputs are received from both the external 
environment (e.g., food availability, predator threat) and internal milieu (e.g., hunger, 
mating drive, homeostatic sleep demand) (Garey et al., 2003; Brown et al., 2012). While 
the neural circuits that encode these individual stimuli can be highly stimulus specific or 
tuned to a specific valence (positive or negative), their activation often promotes more 
general effects on arousal and electrocortical wakefulness through diverse wake-promoting 
neurons (Aston-Jones and Bloom, 1981; Szymusiak and McGinty, 2008). Akin to how the 
noradrenergic (NA) neurons of the locus coeruleus (LC) regulate circadian sleep-wake 
cycling (Takahashi et al., 2010) and promote vigilance during wake (Aston-Jones and 
Bloom, 1981), multiple neural circuits play roles in electrocortical wakefulness and 
behavioral arousal to motivationally relevant situations, including cholinergic neurons of 
the pons and basal forebrain (Jones, 1991; Xu et al., 2015; Pinto et al., 2013), the 
corticotrophin-releasing hormone (CRH) and hypocretin (orexin) neuropeptide systems 
(Sakurai et al., 1998; Winsky-Sommerer et al., 2005), and the mesolimbic dopamine (DA) 
system (Eban-Rothschild et al., 2016; Taylor et al., 2016).  
 
Several lines of basic research and clinical observations converge upon DA as a crucial 
modulator of wake drive, but the neuroanatomical underpinnings have resisted detailed 
characterization. For example, persistent elevation of DA tone via pharmacology (i.e., 
amphetamine [Daberkow et al., 2013], modafinil [Qu et al., 2008]) or genetic ablation of 
the dopamine transporter gene (Slc6a3) (Wisor et al., 2001) is associated with behavioral 
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arousal, but these manipulations are diffuse and brain-wide rather than localized to a 
certain region. Recent work has revealed a role for ventral tegmental area (VTA) DA 
neurons in electrocortical arousal and sleep-wake patterning (Eban-Rothschild et al., 2016; 
Taylor et al., 2016), which complements its long-standing role in behavioral arousal to 
motivationally relevant stimuli (Cohen et al., 2012; Lammel et al., 2014; Matsumoto and 
Hikosaka, 2009). In contrast, diminished DA signaling from the substantia nigra pars 
compacta (SNc) is associated with insomnia, a major symptom in Parkinson’s disease 
(Gjerstad et al., 2007). Considering the functional (Morales and Margolis, 2017), genetic 
(Poulin et al., 2014), and anatomical (Lammel et al., 2011, 2012; Margolis et al., 2008) 
heterogeneity of midbrain DA neurons, distinct DA subgroups may exert diverging effects 
on sleep-wake regulation.  
 
Previously, a small population of DA neurons (~1,000 cells in rats) in the dorsal raphe 
nucleus (DRN; or ‘‘A10 dc’’ or ‘‘ventral/ ventrolateral periaqueductal gray’’; herein 
referred to as the DRNDA) (Hokfelt et al., 1984; Descarries et al., 1986; Dougalis et al., 
2012) was observed to be wake promoting (Lu et al., 2006). Chemical lesion of these cells 
precipitated profound hypersomnia (~20% increase in sleep), while prolonged wakefulness 
elicited increased c-fos expression (Lu et al., 2006; but see Leger et al., 2010). Compared 
to other DA populations, little is known about the natural dynamics of DRNDA cells, such 
as whether their activity contributes to the valuation of external cues and whether this 
valuation is predictive of the corresponding behavioral response. Contrary to VTADA-
driven reward circuits, optogenetic activation of DRNDA neurons fails to reinforce operant 
responding (McDevitt et al., 2014) but instead conveys a negative affective state and 
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promotes social seeking via a negative reinforcement mechanism (Matthews et al., 
2016). Given these seemingly disparate roles of DRNDA cells, namely to promote 
wakefulness (Lu et al., 2006) and encode a ‘‘loneliness-like’’ state (Matthews et al., 2016), 
we hypothesized that DRNDA neurons may signal arousal on a more general level, including 
awakening from sleep, maintenance of wakefulness, and promoting arousal in response to 
behaviorally relevant cues.  
 
Here, we performed longitudinal monitoring of DRNDA activity by calcium imaging via 
fiber photometry (Gunaydin et al., 2014) and of sleep-wake states via 
electroencephalography (EEG) and electromyography (EMG) recordings, in conjunction 
with optogenetics and chemogenetics for reversible, spatially specific control of neural 
activity (Rajasethupathy et al., 2016; Urban and Roth, 2015). We found that DRNDA 
neurons are wake-active, showing higher population activity during wakefulness over sleep 
states, and that endogenous DRNDA activity correlates with state transitions and with 
external stimulus-driven behaviors. Furthermore, reversible and bi-directional 
manipulations of DRNDA firing support the sufficiency and necessity of these neurons in 
promoting vigilance and arousal. Taken together, our results provide evidence that DRNDA 
pathways provide a circuit for modulating behavioral states and salience-induced arousal 
in mammals.  
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3.3 Results 
DRNDA Neurons Are Activated by Arousal-Provoking Salient Cues  
To investigate the natural dynamics of DRNDA neurons during awake-behaving states, we 
monitored DRNDA population activity in subjects exposed to a diverse array of salient 
stimuli and environmental settings. In vivo activity of DRNDA neurons was recorded using 
fiber photometry (Gunaydin et al., 2014), which can measure bulk Ca2+-dependent 
fluorescence of GCaMP6, a genetically encoded calcium indicator (Chen et al., 2013), 
through a single optical fiber positioned in deep brain structures (Figures S1A, S1G, and 
S1H). Our photometry setup utilized a 490 nm beam to activate Ca2+-dependent GCaMP6 
fluorescence, as well as a 405 nm beam to image an isosbestic reference signal, which 
compensates for photo-bleaching and movement-related artifacts (Lerner et al., 2015). For 
specific targeting of DRNDA neurons, we stereotaxically injected an adeno-associated virus 
(AAV) encoding GCaMP6f in a Cre-dependent manner (AAV5-Syn-FLEX-GCaMP6f) 
into the DRN of tyrosine hydroxylase (TH)::IRES-Cre mice (Figures 1A and 1B). Control 
animals were injected with AAV encoding the fluorescent marker EGFP (AAV5-hSyn-
DIO-EGFP). An optical fiber was implanted over the DRN to acquire population 
fluorescence emitted from DRNDA neurons (Figures 1A and S1A). We confirmed that 
GCaMP6f-expressing neurons emitted dynamic fluorescence fluctuations, while EGFP-
expressing cells showed minimal fluorescence variation (Figures S1B and S1C).  
 
We quantified the efficiency and specificity of GCaMP6f+ neurons in the DRN of TH-Cre 
mice. Transfection was highly efficient (94.2%, n = 407/432 neurons). Similar to previous 
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reports that used the identical mouse line or others targeting TH or the Slc6a3 promoter 
(Matthews et al., 2016), 74.9% (n = 407/543) of GCaMP6f+ neurons were co-localized 
with TH in the DRN. These neurons are not noradrenergic, as they lack dopamine beta-
hydroxylase, which converts dopamine to norepinephrine (Nagatsu et al., 1979). 
Importantly, GCaMP6f+ or TH+ neurons never overlapped with serotonergic neurons 
(Figures 1B and S1D; Lu et al., 2006; Matthews et al., 2016), a major population in the 
DRN that is hypothesized to regulate arousal states (Jouvet, 1999). It is possible that 
GCaMP6f+/TH- neurons may express TH at a level below immunohistochemical detection 
limit but sufficient to drive Cre expression.  
 
We first tested DRNDA-GCaMP6f mice in a social interaction paradigm, in which physical 
contact with conspecifics after social isolation has been demonstrated to activate DRNDA 
neurons (Matthews et al., 2016). We observed the robust activation of DRNDA neurons in 
single-housed male DRNDA-GCaMP6f mice when they first interacted with female intruders 
(Figures 1C and 1D). Similar activation was observed with juvenile mice (Figure S2A; 
Movie S1; Matthews et al., 2016) and also when they displayed aggressive behavior toward 
adult male intruders (Figure S2B). Beyond social interaction, we also observed prominent 
DRNDA activity when mice consumed palatable food (Figures 1E and 1F; Movie S2). To 
further characterize the valence tuning of DRNDA cells, we also challenged DRNDA-GCaMP6f 
mice in assays with negative contexts. Surprisingly, DRNDA neurons showed phasic 
activation upon delivery of unexpected electric footshocks (Figures 1G and 1H), air puffs 
(Figure S2C), or motivated responding (mobility/struggling) in tail suspension tests (Figure 
S2D) and during investigation of predator odor TMT (component of fox urine; Figure 
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S2E). Furthermore, they showed sustained activation when subjects were physically 
restrained (Figure S2F).  
 
In contrast, DRNDA activity showed minimal change when mice interacted with novel or 
familiar objects (Figures 1I–1L, first encounters), which are less salient than social targets, 
food, or aversive cues. Indeed, DRNDA activation during female interaction, chocolate 
consumption, and footshock was significantly larger than that during object investigation 
(Figure 1M). Furthermore, the second and third bouts of female interaction and aggressive 
behavior continued to provoke a significant elevation in DRNDA activity, whereas it 
remained relatively unchanged from baseline with repeated novel object encounters, 
suggesting rapid habituation toward physically salient but motivationally neutral cues 
(Figures S2G–S2I).  
 
These findings did not vary with subject social history, as similar patterns of DRNDA 
activation were seen in group-housed mice (Figures S2J–S2L). Furthermore, DRNDA 
neuronal activation was not correlated with locomotion, which argues against the observed 
DRNDA activity resulting from the motor response alone (Figures S2M–S2O). Taken 
together, these findings suggest that DRNDA neurons are activated by a broad array of 
arousal-provoking stimuli, paralleling animals’ heightened environmental awareness that 
accompanies exposure to such motivationally salient stimuli.  
 
DRNDA Population Activity Correlates with Sleep-Wake States 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That DRNDA neurons were activated by exposure to a variety of salient cues expands 
their previous description as a socio-centric pathway (Matthews et al., 2016). It seems 
plausible that DRNDA neurons convey more generalized arousal signals across broad 
temporal scales, especially given that chemogenetic activation promotes analgesia (Li et 
al., 2016) and selective lesion causes hypersomnia (Lu et al., 2006).  
 
To test this hypothesis, we prepared TH-Cre mice for simultaneous and synchronized 
recording of DRNDA-GCaMP6s fluorescence (AAV5-Syn-FLEX-GCaMP6s, EGFP for control 
animals; DRN optical fiber insertion; Figures 2A and 2B) and polysomnography signals 
(implantation of EEG electrodes and EMG wires; Figure 2A). Sleep-wake states, which 
were manually classified in 5 s windows based on the visual and spectral characteristics of 
the EEG/EMG signals, were correlated to fluctuations in DRNDA population activity 
(Figures 2C and S3A). Variations in fluorescent signal were absent in control DRNDA-EGFP 
mice (Figures 2D and S3B), and viral delivery of transgenes (here and in all subsequent 
experiments) did not alter the basic sleep-wake architecture (Figures S1E and S1F).  
 
To record DRNDA activity over many episodes of distinct sleep-wake states, we collected 
fiber photometry and EEG/EMG across the entire light (inactive) phase (Figure 2E). 
DRNDA-GCaMP6s mice showed normal EEG spectral characteristics and sleep-wake patterns, 
even in the presence of GCaMP6s excitation light (Figures S3C and S3D). Over long 
recording sessions, GCaMP6s bleaching was observed, but it could be effectively removed 
by subtracting the linearly scaled control signal from 405 nm excitation (Figure S3E). To 
examine the correlation of DRNDA activity with sleep-wake states, we calculated the area 
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under the curve (AUC) for non-overlapping 5 s windows of photometry data during 
each state as an index of the estimated DRNDA population firing rate (Figure 2F). AUC 
values were significantly higher during wakefulness (Figure 2G). For further 
characterization, Ca2+ peak events were detected (Figure S3F), and their quantitative 
features were compared across states. The peak amplitude and summed AUC values of 
detected events were highest during wakefulness, but there was no significant difference 
in their frequency or duration across distinct states (Figures S3G–S3J). Altogether, these 
results suggest that DRNDA neurons are wake-active and that their activity profile correlates 
with arousal states.  
 
To examine the temporal dynamics of DRNDA activity during each state, we normalized 
the variable durations of sleep-wake states to a unit-less time from 0 (onset) to 1 (offset) 
and accordingly down-sampled the normalized photometry traces. During wakefulness, 
DRNDA population fluorescence peaked soon after wake onset and gradually decreased 
toward wake offset (Figure 2H). Indeed, the DRNDA activity at the early 20th percentile of 
a wake episode was significantly larger than at the late 20th percentile (Figure 2I). In 
contrast, DRNDA activity was continuously suppressed during NREM sleep and showed 
minimal variations during REM sleep (Figure 2H). We additionally verified that wake 
episodes whose durations were similar to sleep episodes demonstrated similar dynamics 
(Figure S3K), suggesting that the observed DRNDA wake dynamics did not originate from 
photobleaching over time. In sum, the activity level of DRNDA populations not only varies 
across sleep-wake states but also shows dynamic changes within wakefulness, showing the 
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highest activity after wake onset and gradual decrease toward sleep onset.  
 
Next, we examined DRNDA activity during state transitions. DRNDA fluorescence increased 
significantly at NREM to wake (Figure 3A; when wake duration >60 s). There was no 
significant fluorescence change at REM-to-wake transitions (Figure 3B; when wake 
duration >60 s). Conversely, DRNDA activity decreased when animals fell asleep (Figure 
3C). We also observed a gradual increase of DRNDA activity across NREM-to-REM 
transitions (Figure 3D). When a brief period of wake (<15 s) intervened in transition from 
REM to NREM, DRNDA activity exhibited a corresponding decrease across the brief wake 
and NREM onset (Figure S3L).  
 
Interestingly, we observed that the duration of wake episodes varied as a function of the 
change in DRNDA activity across the wake onset. The net fluctuation in DRNDA 
fluorescence across sleep-to-wake transitions (from both NREM and REM) was 
significantly larger when mice were awake for a longer period (‘‘long’’: >60 s) than when 
mice were briefly awake (‘‘short’’: <30 s; ‘‘intermediate’’: between 30 and 60 s; Figures 
3E and 3F). This suggests that DRNDA activity at wake onset is positively correlated with 
the duration of the following wake episode. In sum, these results provide correlative 
evidence that endogenous DRNDA firing is highest during wakefulness and that DRNDA 
activity is dynamic across state transitions.  
 
Optogenetic Activation of DRNDA Neurons Promotes Wakefulness 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To reveal a causal relationship between DRNDA activity and wakefulness, we tested for 
sufficiency using a Cre-dependent excitatory opsin to stimulate transduced DRNDA cells 
(AAV5-Ef1a-DIO-ChR2-eYFP, EGFP for controls; polysomnography for stage 
classification; Figures 4A and 4B). ChR2-eYFP expression was limited to the DRN and 
caudal linear nucleus, and never found in retrorubral field or VTA (Figures S4N and S4O). 
To avoid potential ceiling effects, we applied optogenetic stimulation to DRNDA neurons 
during the light phase (Figure 4C). As endogenous firing characteristics of DRNDA cells 
are unknown (one neuron reported by juxtacellular recording [Schweimer and Ungless, 
2010]), we used stimulus parameters commonly adopted for photoactivation of ventral 
midbrain DA neurons (Tsai et al., 2009), which operate in phasic and tonic firing modes. 
We applied both phasic (a train of ten 30 Hz pulses, 10 ms pulse width, every 5 s) and tonic 
(continuous 2 Hz pulses, 10 ms pulse width) stimulation patterns (Figures 4C and S4D). 
These specific parameters were designed to expose subjects to the same total number of 
light pulses with distinct temporal structures. We verified that DRNDA neurons were 
capable of faithfully following phasic pulse trains in whole-cell patch clamp recordings 
(Figure S4A).  
 
Two minutes of phasic stimulation caused immediate transitions to and maintenance of 
wakefulness from both NREM and REM sleep in DRNDA-ChR2 mice, but not in control 
DRNDA-EGFP mice (Figures 4D–4F, S4B, and S4C). By contrast, 2 min of tonic stimulation 
could only induce waking from REM sleep (Figures S4D–S4G). Because phasic 
stimulation more reliably evoked stage changes, we employed this paradigm in subsequent 
experiments. Phasic activation was effective in inducing immediate NREM-to-wake 
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transitions even after 4 hr of sleep deprivation, suggesting that DRNDA activation can 
promote instantaneous arousal in the face of high sleep pressure (Figure 4G). Phasic 
stimulation caused a significant change in cortical EEG in DRNDA-ChR2, but not in control 
DRNDA-EGFP mice, as revealed by spectral analysis (Figures 4H, 4I, S4H, and S4I); delta 
(0.5–4 Hz) and high-frequency (40–100 Hz) EEG powers were decreased and increased, 
respectively, upon DRNDA activation (Figures 4J and 4K).  
 
We next sought to examine the effect of longer, sustained activation of DRNDA neurons on 
behavioral states. A 1 hr epoch of phasic stimulation was applied 4 hr into the subject’s 
light phase when sleep pressure is high. Photostimulation resulted in a net increase in time 
awake relative to unstimulated epochs, due to the extension of wake episodes (Figures 4L 
and 4M). Spectral analysis revealed that delta (0.5–4 Hz) power was significantly 
diminished while high-frequency (40–100 Hz) activity was enhanced in ChR2-expressing 
mice (Figures 4N–4P). This spectral change from DRNDA activation could not be attributed 
to increased locomotion, which can also affect cortical activity and arousal (Vinck et al., 
2015), because optogenetic manipulations did not affect locomotion in either the light or 
dark phase (open field test; Figure S4L). Moreover, the sustained increase in wakefulness 
from DRNDA activation was directly mediated by DA, as systemic administration of D1 
and D2 receptor antagonists (SCH-23390 and eticlopride, respectively, 1 mg/kg) prior to 
stimulation abolished the wake-promoting effect of phasic stimulation in DRNDA-ChR2 mice 
but caused no overall effect in control mice (Figures S4J–S4K).  
 
In sum, phasic stimulation of DRNDA neurons can affect sleep-wake state patterning and 
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promote arousal by inducing immediate sleep-to-wake transitions and prolonging wake 
duration. DRNDA activity also causes electrocortical arousal, bi-directionally modulating 
low- and high-frequency rhythms across both minutes-short and hour-long temporal scales.  
 
Chemogenetic Inhibition of DRNDA Neurons Reduces Wakefulness  
To interrogate the necessity of DRNDA signaling for wake maintenance, we used a 
chemogenetic (Urban and Roth, 2015) approach to reversibly inhibit DRNDA activity 
during polysomnographic recordings (Figure 5A). Here, DRNDA cell recruitment via 
expression of the inhibitory DREADD (AAV2-hSyn-DIO-hM4Di-mCherry; Figures 5A 
and 5B) rather than the analogous opsin is not limited to light spread from optical fibers, 
and long-term suppression of DRNDA activity carries no potential for phototoxicity. We 
confirmed with ex vivo whole-cell patch-clamp recordings that bath application of 1 mM 
clozapine-N-oxide (CNO) reversibly reduced the firing of hM4Di-expressing DRNDA 
neurons via hyperpolarization but showed no effect on EGFP-positive cells in control mice 
(Figures S5B–S5E). We also verified that the hM4Di vector was not anterogradely or 
retrogradely transported from the DRN to other TH+ neurons (across a 4-week window; 
Figures S5F–S5I), some of which have been shown to have reciprocal connections (Lu et 
al., 2006).  
 
DRNDA-hM4Di and DRNDA-EGFP mice were habituated to experimenter handling for three 
days prior to intraperitoneal injection of saline or CNO (1 mg/kg) 3 hr into their dark 
(active) cycle, and EEG/EMG recordings took place for 2 hr afterward (Figure 5C). 
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Compared to saline, CNO injection led to a marked reduction in wakefulness (Figures 
5D and 5E). At the group level, DRNDA inhibition decreased the time spent in wakefulness 
and increased NREM sleep time (Figure 5F). Specifically, CNO injection into the DRNDA-
hM4Di mice increased NREM sleep duration (Figure 5G) but had no effect on the number of 
episodes of each state (Figure 5H). Importantly, saline or CNO injection into control mice 
did not affect sleep-wake proportions (Figures 5F–5H). A change was also evident in 
cortical EEG (Figure 5I); contrary to optogenetic activation, chemogenetic inhibition was 
associated with increased delta (0.5–4 Hz) power (Figure 5J) and decreased high-frequency 
(40–100 Hz) activity (Figure 5K) relative to vehicle injection. To test whether CNO-
induced sleep-wake states have normal EEG architecture, we verified that the EEG 
spectrum in each state after CNO injection was not distinguishable from those after saline 
injection (Figures S5J–S5L). Thus, our findings indicate that DRNDA neuronal activity is 
required for supporting wakefulness in normal physiological conditions.  
 
DRNDA Neuronal Activity Supports Wakefulness in the Presence of Salient Stimuli  
Since diverse salient stimuli activated DRNDA neurons (Figure 1) and their firing promoted 
wakefulness (Figures 4 and 5), we asked whether DRNDA neurons are necessary for 
maintaining arousal in the face of environmental salience by chemogenetically inhibiting 
their activity (Figure 6A). We introduced female mouse and predator odor TMT to the 
subject’s home cage during the dark cycle while monitoring behavioral states. These two 
stimuli, which were shown to induce robust DRNDA activity (Figures 1C, 1D, and S2E), 
hold ethological relevance, and are of opposite valence. CNO injection into the DRNDA-
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hM4Di mice reduced the time spent awake and promoted NREM sleep in both assays, 
contrary to other conditions where mice remained awake (Figures 6B and 6C). More 
broadly, DRNDA inhibition during these assays caused a shift in cortical EEG spectra; CNO 
treatment of DRNDA-hM4Di mice led to an increase in delta (0.5–4 Hz) power and decreases 
in high-theta (8–12 Hz) and high-frequency (40–100 Hz) power relative to saline condition, 
which was absent in control mice (Figures 6D–6G).  
 
We further asked if the unexpected presentation of arousing or alerting stimuli (e.g., loud 
noises) during sleep could induce immediate wake transitions with DRNDA firing. DRNDA-
GCaMP6s mice were exposed to randomized auditory stimuli (65 dB, 2–5 kHz, 2 Hz pulse 
frequency, 250 ms width, 10 s duration) throughout their light phase while recording 
GCaMP6s fluorescence and EEG/EMG signals (Figure S6A). We observed time-locked 
DRNDA activity upon tone onset, which was most prominent when subjects immediately 
(within 10 s) switched from sleep to wake (Figures S6B and S6C). There was no detectable 
difference in DRNDA activity increase between NREM- and REM-to-wake transitions 
(Figures S6D and S6E). To test for a causal contribution of DRNDA activity to cued arousal, 
we repeated the above experiment on mice expressing archaerhodopsin-3 (Arch; Mattis et 
al., 2011), which allows for time-locked reversible inhibition (Figures S6F and S6G). 
When DRNDA neurons were exposed to a continuous 20 s light pulse (532 nm, 10 mW) 
centered on tone delivery (70 dB), the probability of cued waking from NREM (Figures 
S6H–S6K), but not from REM sleep (Figures S6L–S6O), significantly decreased. DRNDA 
inhibition did not completely block NREM-to-wake transitions, which suggests that 
multiple pathways likely work together to sustain full arousal, including, but not limited 
  
132 
to, noradrenergic or cholinergic neurons (Aston-Jones and Bloom, 1981; Xu et al., 
2015). In sum, these data indicate that DRNDA activity is required for maintaining salience-
induced wakefulness and for triggering cued waking from sleep.  
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3.4 Discussion 
Using simultaneous calcium imaging and polysomnography in conjunction with 
optogenetic and chemogenetic manipulations, we demonstrated that DRNDA neurons 
respond to external salient events of positive and negative valence, show correlative 
fluctuations at the population level across distinct sleep-wake states, and promote 
wakefulness. Furthermore, DRNDA activity is necessary to maintain normal levels of 
wakefulness and support arousal in response to the perception of salient stimuli. These 
findings support a role for wake-promoting DRNDA neurons that parallels the arousal-
promoting function of isolated DA cells in invertebrates (Pimentel et al., 2016), as well as 
a more expansive role for DRNDA signaling beyond promoting social interaction via 
negative reinforcement (Matthews et al., 2016) or mediating anti-nociceptive effects (Li et 
al., 2016).  
 
Our photometry data demonstrate not only that social interaction robustly enhances DRNDA 
spiking (female interaction, male intruder; Figures 1 and S2), akin to previous findings 
(juvenile interaction; Matthews et al., 2016), but also that these neurons respond to the 
perception of highly salient, non-social stimuli (Figures 1 and S2). DRNDA activation by a 
wide variety of rewarding and aversive stimuli, both social and non-social, occurred 
irrespective of the subject’s social history, as the stimulus-evoked change in DRNDA 
fluorescence was not influenced by chronic separation from cage-mates (Figures S2J–
S2M). Given the subtleties in how various forms of social deprivation (e.g., maternal 
separation, acute or chronic social isolation) can differentially alter physiology and 
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behavior (George et al., 2010; Whitaker et al., 2013), the extent to which a subject’s 
social environment and rank causes plasticity in DRNDA neurons will require further 
investigation. Based on the documented heterogeneity of ventral midbrain DA groups 
(Bromberg-Martin et al., 2010; Morales and Margolis, 2017), it is plausible that DRNDA 
cells may also be heterogeneous and individually tuned to specific classes of stimuli. For 
example, some DRNDA neurons may play a general role in social engagement or may be 
more susceptible to changes in social history, while other subsets may fire selectively for 
arousing, non-social stimuli. Since we and Matthews et al. (2016) used different fiber-
placement methods (angled versus perpendicular, respectively), we may have sampled 
distinct, non-overlapping DRNDA subsets.  
 
Matthews et al. (2016) further demonstrated that DRNDA neurons signal aversion, a trend 
that was also corroborated, albeit weakly, by our data (Figure S4M). This is in stark contrast 
with wake-promoting VTADA neurons, whose activity supports robust place preference and 
operant responding (Tsai et al., 2009; Witten et al., 2011). That neural circuits may be 
involved in two seemingly unrelated roles, valence encoding and sleep-wake regulation, is 
not unique to midbrain DA groups; wake-promoting LC NA neurons and CRH inputs also 
convey negative valence (McCall et al., 2015). Considering the involvement of hypocretin 
and VTADA systems in reward behavior (Espana, 2012; Wise, 2004), there may be 
dichotomous wake-promoting pathways signaling positive or negative valence upon their 
activation. That DRNDA neurons can simultaneously send arousal and anti-nociceptive 
signals (Li et al., 2016) can be understood by considering DRNDA connectivity with the 
bed nucleus of stria terminalis (BNST; Figure S4Q), which is a critical regulator of pain 
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perception (Minami and Ide, 2015).  
 
Compared to ventral midbrain DA counterparts (Schultz, 1997; Ungless et al., 2004; 
Matsumoto and Hikosaka, 2009; Cohen et al., 2012; Lerner et al., 2015; Kim et al., 2016), 
the natural dynamics of DRNDA neurons are much less characterized. Due to their relative 
low number and shared projection targets, DRNDA neurons have been assumed to be 
functionally similar to VTADA neurons and hence termed the dorso-caudal extension of the 
VTA (A10) or A10 dc group (Hokfelt et al., 1984). Several pieces of evidence argue against 
their treatment as a mere extension of the VTA. Unlike the well-studied dorsal or lateral 
VTADA neurons, which fire bursts in response to rewarding or reward-predicting stimuli 
and are inhibited by punishment (Schultz, 1997; Ungless et al., 2004; Cohen et al., 2012; 
Kim et al., 2016), or the ventromedial VTADA neurons, which are selectively excited by 
aversive stimuli (Brischoux et al., 2009), DRNDA neurons appear to be activated by any 
alerting or salient stimulus, regardless of valence (Figures 1 and S2). Also, they appear to 
be minimally affected by physically salient but motivationally neutral cues, such as novel 
or familiar objects (Figure 1). Since both rewarding and aversive stimuli elicit arousal and 
motivated responding, the VTADA system may address this challenge of dual positive 
(Schultz, 1997) and negative (Brischoux et al., 2009; Matsumoto and Hikosaka, 2009; 
Zweifel et al., 2011) valence coding in part through segregating to functionally and 
electrophysiologically distinct subgroups split across anatomical gradients (Brischoux et 
al., 2009; Bromberg-Martin et al., 2010) or projection targets (Lammel et al., 2011). The 
DRNDA population, from our observations, showed bimodal activation at the population 
level, responding to both positive and negative stimuli. Whether individual DRNDA neurons 
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are uniformly excited by positive and negative valence (therefore encoding salience), 
or whether they are oppositely tuned and intermingled within the DRN, will require future 
single-cell recording techniques.  
 
DRNDA and VTADA populations diverge significantly in downstream targets, which may 
help to explain their functional heterogeneity. Optogenetic excitation of VTADA neurons, 
especially those projecting to the nucleus accumbens, supports both appetitive conditioning 
and positive reinforcement behavior (Wise, 2004; Witten et al., 2011; Steinberg et al., 
2014), whereas stimulation of DRNDA neurons produces neutral or mild aversion (Figure 
S4M; Matthews et al., 2016). These observations may be indicative of differences in 
downstream connectivity between these neuronal populations. Although DRNDA and 
VTADA neurons share overlap in some of their downstream targets (e.g., the prefrontal 
cortex and the basolateral amygdala), DA neurons projecting to cortical and striatal regions 
predominantly arise from the VTA (Bjorklund and Dunnett, 2007). DRNDA terminals, 
however, are biased toward the extended amygdala, such as the BNST and central nucleus 
of the amygdala (CeA) (Figures S4P–S4S; Hasue and Shammah-Lagnado, 2002). Thus, as 
a major source of excitatory DA drive to the BNST and CeA (Matthews et al., 2016), two 
regions known to bi-directionally affect motivated behavior and regulate complex 
emotional states (Jennings et al., 2013), DRNDA neurons are uniquely positioned to provide 
excitatory signals about environmental salience and internal arousal state to downstream 
nuclei, which can in turn initiate appropriate behavior, including triggering vigilance or 
patterning sleep-wake states.  
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Although DA has been implicated in sleep-wake regulation by pharmacological (Lin et 
al., 1992), genetic (Wisor et al., 2001), and clinical (Lima, 2013) studies, the precise 
circuits mediating such actions have been elusive. Single-unit recordings of VTADA and 
SNcDA neurons have indicated that they do not change their mean firing rate across distinct 
sleep-wake states (Miller et al., 1983; Dahan et al., 2007). Here, we show that DRNDA 
neurons are wake-active (Figures 2 and 3), whereas VTADA neurons exhibited increased 
burst firing or Ca2+ signals during REM sleep over wakefulness (Dahan et al., 2007; Eban-
Rothschild et al., 2016). While the role of VTADA firing during REM sleep remains elusive, 
optogenetic activation of VTADA neurons can promote behavioral and electrocortical 
arousal (Eban-Rothschild et al., 2016; Taylor et al., 2016). Unlike the DRNDA or VTADA 
populations, other DA groups appear to promote sleep rather than wakefulness. For 
example, chemical lesion of the SNcDA neurons projecting to the dorsal striatum (DS) 
promotes wakefulness, and optogenetic stimulation of SNcDA terminals in the DS increases 
NREM sleep (Qiu et al., 2016). Outside the midbrain, A13 zona incerta DA neurons 
express c-fos after REM sleep rebound (Leger et al., 2010). Taken together, these studies 
indicate that anatomically segregated DA populations may play functionally heterogeneous 
or even opposing roles in regulating sleep-wake states, and the DRNDA as well as VTADA 
systems represent key arousal-promoting DA populations.  
 
As shown here (Figures 6 and S6), external factors can influence sleep-wake patterns, and 
DRNDA neurons contribute to these processes. Our findings that DRNDA activity tracks the 
arousal states over broad temporal scales and that DRNDA neurons respond to salient 
external cues position the DRNDA system at the interface between internal (e.g., wake/sleep 
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drive) and external (e.g., salient stimuli) influences in regulating sleep-wake states. 
While this evolutionarily conserved trait is advantageous for organism survival, its 
dysfunction may have negative implications in humans, in which sleep disorders triggered 
by the malfunctioning of arousal-promoting circuits represent a highly morbid societal 
burden (Sanford et al., 2015). DRNDA neurons are not well studied in humans, but it has 
been shown that they degenerate in patients with multiple systems atrophy and Lewy body 
dementia, which commonly cause excessive daytime sleepiness (Benarroch et al., 2009). 
Going forward, therapeutic strategies targeting DRNDA activity may have utility in the 
treatment of primary sleep-wake disorders and sleep/arousal disturbances secondary to 
myriad neuropsychiatric diseases (Sateia et al., 2000), including major depressive disorder, 
bipolar affective disorder, and schizophrenia. 
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3.5 Main figures 
Figure 1. DRNDA Neurons Are Activated upon Exposure to Salient Stimuli or 
Behavioral Challenge. (A) TH-Cre mice were injected with AAV5-Syn-FLEX-GCaMP6f 
or AAV5-hSyn-DIO-EGFP and implanted with an optical fiber into the DRN for fiber 
photometry. (B) Confocal images of GCaMP6f+ (green) neurons show co-localization with 
TH+ neurons (red), but no overlap with 5-HT+ neurons (blue). Scale bar, 100 mm. (C) 
Social interaction between a male DRNDA-GCaMP6f resident mouse and a female intruder 
were associated with increased DRNDA activity; the trace is a representative recording with 
interaction bouts indicated. (D) Left: female interaction caused an increase in fluorescence 
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at the onset (first interactions only). Right: quantification of the area under the curve 
per second (AUC) during the interaction (0–5 s) shows that social interaction caused 
significant increase in DRNDA activity from baseline (-5 to 0 s) (n = 7 DRNDA-GCaMP6f mice; 
paired t test, t6 = 11.97, ***p < 0.001). (E) Chocolate consumption by a DRNDA-GCaMP6f 
mouse increased DRNDA activity; representative recording. (F) Left: DRNDA activity was 
increased upon chocolate consumption. Right: AUC quantification during consumption (0–
5 s) compared with baseline (-5 to 0 s) shows that food consumption is associated with 
significant fluorescence increase (n = 7 DRNDA-GCaMP6f mice; paired t test, t6 = 4.273, **p 
< 0.01). (G) Electric footshocks (0.25 mA, 1 s) were delivered; representative DRNDA 
trace during two consecutive footshocks. (H) Left: footshock induced phasic DRNDA 
activation. Right: DRNDA activity after footshock (0–5 s) was significantly increased 
relative to baseline (-5 to 0 s) (n = 7 DRNDA-GCaMP6f mice; paired t test, t6 = 5.763, **p < 
0.01). (I) DRNDA-GCaMP6f mouse was allowed to interact with a novel object; representative 
recording during interactions. (J) Left: first interaction of a novel object was associated 
with DRNDA activity increase. Right: DRNDA activity after first interaction (0-5 s) was 
significantly increased relative to baseline (-5 to 0 s) (n = 7 DRNDA-GCaMP6f mice; paired t 
test, t6 = 3.614, *p < 0.05). (K) A familiar object was introduced; representative DRNDA 
trace with interaction bouts. (L) Left: first interaction bout was not associated with any 
change in DRNDA fluorescence. Right: there was no change in DRNDA activity across 
familiar object interaction (n = 7 DRNDA-GCaMP6f mice; paired t test, t6 = 2.205, p > 
0.05). (M) Peak DRNDA fluorescence values during female interaction, chocolate 
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consumption, and electric footshocks were significantly higher than those during novel 
and familiar object interaction (n = 7 DRNDA-GCaMP6f mice; one-way ANOVA, F4,30 = 22.77, 
p < 0.0001, Bonferroni post hoc analysis, ***p < 0.001). Data represent mean ± SEM.  
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Figure 2. Simultaneous Fiber Photometry and EEG/EMG Recordings Reveal a 
Correlation between DRNDA Neuronal Activity and Sleep-Wake States. (A) In 
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addition to fiber photometry, EEG screw electrodes and EMG wires were implanted to 
classify sleep-wake states. (B) Representative confocal images of GCaMP6s+ neurons 
(green) co-localized with TH+ neurons (red). Scale bar, 100 mm. (C) Representative 
example of an NREM-to-wake transition from a DRNDA-GCaMP6s mouse with EEG 
spectrogram, EEG, EMG, and photometry traces. Note DRNDA fluorescence was increased 
at the wake onset, when EEG desynchronized from delta (0.5–4 Hz) and EMG amplitude 
increased. (D) Same as (C), but from a DRNDA-EGFP mouse. No change in photometry was 
observed. (E) Synchronized photometry and EEG/EMG recordings were performed 
during the entire light phase. (F) Representative photometry traces at distinct sleep-wake 
states (blue, wake; green, REM sleep; red, NREM sleep). (G) Quantification of AUC per 
5 s window revealed higher DRNDA activity during wakefulness over NREM and REM 
sleep (n = 6 DRNDA-GCaMP6s mice; one-way ANOVA, F2,15 = 10.58, p < 0.01; Bonferroni 
post hoc analysis, *p < 0.05, **p < 0.01). (H) Temporal dynamics of normalized DRNDA 
activity during wake (blue), NREM (red), and REM (green) episodes within normalized 
time. (I) Normalized DRNDA activity at early wake (first 20th percentile) was significantly 
increased from late wake period (last 20th percentile) (n = 6 DRNDA-GCaMP6s mice; paired t 
test, t5 = 5.672, **p < 0.01). Data represent mean ± SEM.  
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Figure 3. DRNDA Neuronal Dynamics across State Transitions. (A) Left: DRNDA 
activity increased across NREM-to-wake transitions. Right: DRNDA activity after 
transitions (wake) was significantly greater than before transitions (NREM) (n = 6 DRNDA-
GCaMP6s mice; paired t test, t5 = 3.052, *p < 0.05). (B) Left: DRNDA activity did not change 
across REM-to-wake transitions. Right: DRNDA fluorescence was not different across 
transitions (n = 6 DRNDA-GCaMP6s mice; paired t test, t5 = 1.556, p > 0.1). (C) Left: DRN
DA 
activity decreased at wake-to-NREM transitions. Right: the AUC values after transitions 
(NREM) were significantly lower than before transitions (wake) (n = 6 DRNDA-GCaMP6s 
mice; paired t test, t5 = 4.516, **p < 0.01). (D) Left: DRNDA fluorescence increased across 
NREM-to-REM transitions. Right: DRNDA activity significantly increased during NREM 
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to REM transitions (n = 6 DRNDA-GCaMP6s mice; paired t test, t5 = 3.192, *p < 0.05). (E) 
DRNDA activity increase across sleep-to-wake transitions was more prominent when mice 
spent longer time awake (> 60 s, blue) than when mice were awake for intermediate 
(between 30 and 60 s, purple) or short (< 30 s, pink) period. (F) Fluorescence increase 
across wake onsets was significantly larger for long-duration wake episodes than for 
intermediate- or short-duration wake episodes (n = 366 short, 158 intermediate, and 185 
long wake episodes; one-way ANOVA, F2,706 = 21.85, p < 0.0001; Bonferroni post hoc 
analysis, ***p < 0.001). Data represent mean ± SEM.  
  
146 
Figure 4. Optogenetic Stimulation of DRNDA Neurons Promotes Wakefulness. (A) TH-
Cre mice injected with AAV5-Ef1a-DIO-ChR2-eYFP or AAV5-hSyn-DIO-EGFP and 
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implanted with an optical fiber received optogenetic stimulation during sleep-wake 
state monitoring. (B) Confocal images of ChR2-eYFP+ neurons (green) co-localized with 
TH+ neurons (red). Scale bar, 100 mm. (C) Two-minute blocks (blue arrows) of phasic 
stimulations were delivered with intervals of 20 to 25 min throughout the light phase to 
photo-activate DRNDA neurons. (D) Probability of being awake was dramatically increased 
upon onset of the phasic stimulation, with concurrent reduction of both NREM and REM 
state probability in DRNDA-ChR2 mice. (E) Same as (D), but no change was observed in 
DRNDA-EGFP mice. (F) The increase in wake probability in DRNDA-ChR2 mice compared 
with DRNDA-EGFP mice was significant, as were the decreases in NREM and REM sleep 
probability (n = 8 per group; unpaired t test, ****p < 0.0001). (G) There was no difference 
in the latency to wake onset even after 4 hr of sleep deprivation in both groups (n = 4 per 
group; paired t test, p > 0.2). Regardless of sleep deprivation, latency to wake after 
stimulation was significantly shorter in DRNDA-ChR2 mice compared to controls (unpaired t 
test, *p < 0.05, **p < 0.01). (H) Power spectral density of frontal EEG shows reduced 
power in low-frequency range and increased power in high-frequency range during light 
ON (blue) compared to light OFF (gray) conditions in DRNDA-ChR2 mice. (I) Same as (H), 
but power spectral density showed no difference across light ON (orange) and OFF (gray) 
conditions in DRNDA-EGFP mice. (J) Left: time-varying spectral analysis showed that the 
amplitude of delta (0.5–4 Hz) rhythms was decreased upon phasic stimulation. Right: delta 
amplitude during the light ON epoch was significantly decreased compared to baseline 
OFF epochs (n = 8 per group; two-way ANOVA revealed group 3 epoch interaction, F2,26 
= 17.06, p < 0.0001; Bonferroni post hoc analysis, ****p < 0.0001). (K) Left: the 
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amplitude of high-frequency (40–100 Hz) rhythms was increased upon phasic 
stimulation. Right: high-frequency amplitude was significantly increased during the light 
ON epoch compared to the OFF epochs (n = 8 per group; two-way ANOVA revealed group 
3 epoch interaction, F2,26 = 5.096, p < 0.05; Bonferroni post hoc analysis, **p < 0.01). (L) 
1 hr of phasic DRNDA stimulation significantly increased the time spent in wakefulness 
during the light ON hour compared to the light OFF hours (n = 6 per group; two-way 
ANOVA revealed group 3 epoch interaction, F2,20 = 15.99, p < 0.0001; Bonferroni post 
hoc analysis, ***p < 0.001). (M) 1 hr of phasic stimulation significantly increased the 
duration of wake episodes (n = 6 per group; two-way ANOVA revealed group 3 epoch 
interaction, F2,20 = 12.16, p < 0.001; Bonferroni post hoc analysis, ***p < 0.001). (N) 
Power spectral density revealed decrease in low-frequency power and increase in high-
frequency power in DRNDA-ChR2 mice during light ON compared to the light OFF hours, 
but no changes were observed in DRNDA-EGFP mice. (O) Stimulation-induced delta (0.5–4 
Hz) power reduction was significantly larger in DRNDA-ChR2 mice (n = 6 per group; 
unpaired t test, *p < 0.05). (P) Stimulation-induced high-frequency (40–100 Hz) power 
increase was significantly larger in DRNDA-ChR2 mice (n = 6 per group; unpaired t test, **p 
< 0.01). Data represent mean ± SEM.  
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Figure 5. Chemogenetic Inhibition of DRNDA Neurons Reduces Wakefulness. (A) 
AAV2-hSyn-DIO-hM4Di-mCherry or EGFP vectors were injected to the DRN of TH-Cre 
mice, and EEG/EMG electrodes were implanted for sleep-wake state classification. (B) 
Confocal images of TH+ (green) neurons co-localized with hM4Di-mCherry (red) 
expression. Scale bar, 100 mm. (C) Saline or CNO (1 mg/kg) was intraperitoneally 
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injected to inhibit DRNDA neurons during the dark phase. EEG/EMG recordings were 
performed for 2 hr afterward. (D) Representative hypnogram (top), EMG amplitude 
(middle, in 5 s windows), and delta amplitude (bottom, in 5 s windows) from a DRNDA-
hM4Di mouse after saline injection. (E) Same as (D), but with CNO injection. CNO injection 
caused reduced wakefulness, accompanied by lower EMG and higher delta amplitudes. (F) 
CNO injections into the DRNDA-hM4Di mice decreased the time spent in wake and increased 
the time spent in NREM sleep (n = 5 per group; two-way ANOVA revealed a group 3 drug 
interaction in wake and NREM, F1,19 [wake] = 20.96, p < 0.01, F1,19 [NREM] = 28.34, p 
< 0.001, F1,19 [REM] = 2.07, p > 0.1; Bonferroni post hoc analysis, *p < 0.05, **p < 
0.01). (G) Duration of NREM sleep was significantly increased when DRNDA-hM4Di mice 
were administered with CNO (n = 5 per group; two-way ANOVA revealed a group 3 drug 
interaction in NREM, F1,19 [wake] = 3.84, p > 0.05, F1,19 [NREM] = 10.78, p < 0.05, F1,19 
[REM] = 0.26, p > 0.6; Bonferroni post hoc analysis, **p < 0.01, *p < 0.05). (H) There 
was no difference in the number of episodes in all states (n = 5 per group; two-way 
ANOVA revealed no group 3 drug interaction, F1,19 [wake] = 0.88, F1,19 [NREM] = 0.52, 
F1,19 [REM] = 0.55, all p > 0.3). (I) Power spectral density analysis revealed CNO-
induced increase in low-frequency power and decrease in high-frequency power in DRNDA-
hM4Di mice with respect to saline condition, but no change in controls. (J) CNO-induced 
delta (0.5–4 Hz) power increase was significantly larger in DRNDA-hM4Di mice compared to 
controls (n = 5 per group; unpaired t test, **p < 0.01). (K) CNO-induced high-frequency 
(40–100 Hz) power decrease was significantly larger in DRNDA-hM4Di mice compared to 
controls (n = 5 per group; unpaired t test, ****p < 0.0001). Data represent mean ± SEM.  
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Figure 6. DRNDA Firing Supports Wakefulness upon Exposure to Salient Stimuli. (A) 
DRNDA-hM4Di and DRNDA-EGFP mice were systemically administered with saline or CNO (1 
mg/kg) 45 min prior to the introduction of a female mouse or a filter paper with predator 
odor TMT. EEG/EMG recordings were carried out for 1 hr after salient stimuli 
presentation. (B) While the introduction of a female mouse induced robust wakefulness in 
other conditions, CNO-injected DRNDA-hM4Di mice spent significantly reduced time in 
wakefulness at the cost of NREM sleep (n = 4 per group; two-way ANOVA revealed a 
group 3 drug interaction, F1,15 [wake, NREM] = 20.83, p < 0.01, Bonferroni post hoc 
analysis, *p < 0.05, *p < 0.01). (C) Similar to (B), but a filter paper with predator odor 
TMT was introduced to home-cages. Compared to other conditions, CNO-injected DRNDA-
hM4Di mice spent significantly reduced time in wakefulness and increased time in NREM 
sleep (n = 4 per group; two-way ANOVA revealed a group 3 drug interaction, F1,15 [wake, 
NREM] = 26.88, p < 0.01, Bonferroni post hoc analysis, **p < 0.01). (D) Power spectral 
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density analysis during female mouse interaction revealed CNO-induced increase in 
low-frequency power and decrease in high-theta (8–12 Hz) and high-frequency power in 
DRNDA-hM4Di mice with respect to the saline condition but no change in control mice. (E) 
CNO-induced increase in delta (0.5–4 Hz) power and decrease in high-theta (8–12 Hz) and 
high-frequency (40–100 Hz) power were significantly larger in DRNDA-hM4Di mice than in 
controls (n = 4 per group; unpaired t test, **p < 0.01, ***p < 0.001). (F) Same as (D), but 
for the TMT condition. A similar trend was observed as (D). (G) CNO-induced increase 
in delta (0.5–4 Hz) power and decrease in high-theta (8–12 Hz) and high-frequency (40–
100 Hz) power were significantly larger in DRNDA-hM4Di mice than in controls (n = 4 per 
group; unpaired t test, *p < 0.05, **p < 0.01). Data represent mean ± SEM.  
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3.6 Supplementary figures 
Supplementary Figure 1: related to all main figures. (A) Schematic of a fiber photometry 
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setup. See Supplementary Experimental Procedures for details. (B) Representative trace 
from a DRNDA-GCaMP6f mouse that shows dynamic Ca2+-dependent fluorescence across time.  
(C) Representative trace from a DRNDA-eGFP mouse. Notice minimal fluctuations in 
fluorescence. (D) Confocal image of serotonin (5-HT, green) and dopamine (TH, red) 
neurons in the DRN. Notice that there is no overlap between the two populations and that the 
number of TH+ neurons is far less than that of 5-HT+ neurons. Scale bar is 100 μm. (E) Viral 
expression of diverse transgenes did not affect normal sleep-wake architecture both in light 
(left) and dark (right) phases (n = 4 per group; one-way ANOVA, all p > 0.2). (F) Time spent 
in each state per hour in 24-hour recordings: Wake (left), NREM (middle), and REM sleep 
(right). (G) Representative confocal image of GCaMP6f+ neurons in the DRN and the 
location of fiber-tip (in this case, for fiber photometry). Scale bar is 100 μm. (H) 
Histologically verified fiber-tip locations of DRNDA-GCaMP6f (dark blue), DRNDA-GCaMP6s 
(green), DRNDA-ChR2 (sky blue), DRNDA-eGFP (orange), and DRNDA-Arch (yellow) mice.  
Data are represented as mean ± s.e.m. 
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Supplementary Figure 2: related to Figure 1. (A) Left, social interaction between a male 
DRNDA-GCaMP6f resident mouse and a male juvenile intruder were associated with increased 
DRNDA activity. Right, quantification of the area under the curve per second (AUC) showed 
that DRNDA activity during first interaction (0 – 5 s) was significantly increased compared 
with baseline (-5 – 0 s) (n = 7 DRNDA-GCaMP6f mice, paired t-test, t6 = 4.679, **p < 0.01). (B) 
Left, attack/fight bouts (first bout only) between a male DRNDA-GCaMP6f resident and an adult 
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intruder were associated with increased DRNDA activity. Right, DRNDA activity during 
attack (0 – 5 s) was significantly increased relative to baseline (-5 – 0 s) (n = 4 DRNDA-GCaMP6f 
mice, paired t-test, t3 = 4.993, *p < 0.05). (C) Left, brief air puffs (<1 s) were intermittently 
delivered to the tail of a DRNDA-GCAMP6f mouse, which caused time-locked DRNDA 
fluorescence increase. Right, DRNDA activity after air puff delivery (0 – 5 s) was significantly 
increased relative to baseline (-5 – 0 s) (n = 7 DRNDA-GCaMP6f mice; paired t-test, t6 = 7.518, 
***p < 0.001). (D) Left, fiber photometry recording of DRNDA-GCaMP6f mice undergoing a 5-
minute tail suspension test. DRNDA neurons showed time-locked activation at the onset of 
mobility or struggling. Right, AUC values during mobility (0 – 5 s) were significantly 
increased compared with baseline (-5 – 0 s) (n = 7 DRNDA-GCaMP6f mice, paired t-test, t6 = 
3.044, *p < 0.05). (E) Left, investigation of predator odor TMT was associated with increase 
in DRNDA activity. Right, quantification of the AUC showed that there was significant 
difference in DRNDA activity between interaction (0 – 5 s) and baseline (-5 – 0 s) (n = 7 
DRNDA-GCaMP6f mice, paired t-test, t6 = 2.653, *p < 0.05). (F) Left, there was a prolonged 
increase in DRNDA neuronal activity while a DRNDA-GCaMP6f mouse was restrained or 
immobilized. Right, sustained activation of DRNDA neurons was observed throughout the 
restraint period (0 – 60 s), compared baseline (-60 – 0 s) (n = 6 DRNDA-GCaMP6f mice, paired 
t-test, t5 = 5.444, **p < 0.01). (G) Left, averaged DRN
DA activity was increased during 
second and third interaction bouts (red trace), when a resident male DRNDA-GCaMP6f mouse 
was investigating a female intruder. Photometry data from first interaction (black trace, Fig 
1D) was also illustrated for comparison. Right, AUC values during second and third 
interaction bouts (0 – 5 s) were significantly increased relative to baseline (-5 – 0 s) (n = 7 
DRNDA-GCaMP6f mice, paired t-test, t6 = 4.437, **p < 0.01). (H) Left, averaged DRN
DA activity 
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was increased during the second and third episodes of aggression (red trace) by a resident 
male DRNDA-GCaMP6f mouse against a male intruder. Photometry data from the first attack 
episode (black trace, Fig. S2B) was also illustrated for comparison. Right, quantification of 
AUC revealed that DRNDA activity during the second and third episodes of attack (0 – 5 s) 
was significantly increased relative to baseline (-5 – 0 s) (n = 4 DRNDA-GCaMP6f mice, paired 
t-test, t3 = 3.235, *p < 0.05). (I) Left, averaged DRN
DA activity during the second and third 
investigation bouts (red trace) in novel object interaction assays was not different from 
preceding baseline. Photometry data from first interaction bout (black trace, Fig. 1J) was also 
illustrated for comparison. Right, quantification of the area under the curve per second (AUC) 
showed that DRNDA activity during the second and third interactions with a novel object (0 
– 5 s) was not significantly increased compared with baseline (-5 – 0 s) (n = 7 DRNDA-GCaMP6f 
mice, paired t-test, t6 = 2.406, p > 0.05). (J) Left, a robust increase in DRN
DA activity during 
the first interaction bout with a female mouse was observed in both single-housed (black, 
Fig. 1D) and group-housed (purple) mice. Right, quantification of AUC values during 
interaction (0 – 5 s) from single-housed and group-housed mice showed that there was no 
significant difference in DRNDA activity based on housing conditions (n = 7 single-housed, 
n = 4 group-housed DRNDA-GCaMP6f mice; unpaired t-test, p > 0.1). (K) Left, time-locked 
DRNDA activation was present when single-housed (black, Fig. 1H) and group-housed 
(purple) mice received unexpected electric footshocks. Right, AUC values during footshock 
delivery did not differ between single- and group-housed mice (n = 7 single-housed, n = 4 
group-housed DRNDA-GCaMP6f mice; unpaired t-test, p > 0.7). (L) Left, small DRNDA 
activation was observed in the first interaction bout with a novel object in both single-housed 
(black, Fig. 1J) and group-housed (purple) mice. Right, AUC values during novel object 
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interaction were not distinct between single- and group-housed mice (n = 7 single-housed, 
n = 4 group-housed DRNDA-GCaMP6f mice; unpaired t-test, p > 0.5). (M) Representative fiber 
photometry recording (black: fluorescence trace) and real-time locomotion tracking (red: 
velocity) for a DRNDA-GCaMP6f mouse during the open field test. Notice the lack of temporal 
correlation between two signals. (N) Averaged velocities aligned by detected Ca2+ peak event 
onset showed that increased DRNDA activity is not associated with any change in velocity.  
(O) Averaged DRNDA activity aligned by detected locomotion onset revealed that 
locomotion onset (indexed by increase of velocity) was not associated with a change in 
DRNDA fluorescence. Data are represented as mean ± s.e.m. 
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Supplementary Figure 3: related to Figure 2 and 3. (A) Representative example of a 
REM-to-wake transition from a DRNDA-GCaMP6s mouse with EEG spectrogram, EEG, EMG, 
and fiber photometry traces. Note that DRNDA fluorescence was increased at the wake onset, 
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when EEG shifted from theta oscillations (5-10 Hz) to desynchronized rhythms and EMG 
amplitude abruptly increased. (B) Same as (A), but from a DRNDA-eGFP mouse. No change in 
fiber photometry signal is observed. (C) Power spectral density plots of DRNDA-GCaMP6s mice 
at each state: wake (blue), NREM (red), and REM (green). Notice that they show normal 
spectral EEG characteristics at each state: wake is characterized by smaller low-frequency 
activity and elevated high-frequency activity, NREM is characterized by high delta or slow 
wave (0.5-4 Hz) activity with suppressed high-frequency rhythms, and REM is associated 
with high theta (5-10 Hz) peak with elevated high-frequency activity. (D) Even with constant 
LED light exposure for exciting GCaMP6s, DRNDA-GCaMP6s mice showed normal sleep-wake 
architecture during light phase when synchronized photometry and EEG/EMG recordings 
were performed. For comparison, please see Fig. S1E. (E) After aligning the linearly scaled 
control 405 nm signal (red) with the 490 nm signal (blue), no noticeable decay was detected 
in the quality or signal-to-noise ratio of an extended photometry trace (black, 12-hour 
recording). (F) A representative photometry recording from a DRNDA-GCaMP6s mouse, with 
examples of automatically detected Ca2+ peak events (red). Detection onsets are denoted with 
black asterisks. (G) The frequency of detected peak events per 5-second window did not vary 
across sleep-wake states (n = 6 DRNDA-GCaMP6s mice; one-way ANOVA, F2,15 = 0.07802,  p 
> 0.9). (H) Duration of the detected peak events did not vary significantly across sleep-wake 
states (n = 6 DRNDA-GCaMP6s mice; one-way ANOVA, F2,15 = 0.2999,  p > 0.7).  (I) Amplitude 
(z-scored) of the detected peak events was significantly increased in wake compared to 
NREM sleep (n = 6 DRNDA-GCaMP6s mice; one-way ANOVA, F2,15 = 7.144,  p < 0.01; Post-
hoc Bonferroni Analysis, **p < 0.01) (J) Summed area under curve values within a 5-sec 
window was significantly increased at wake state over NREM and REM sleep (n = 6 DRNDA-
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GCaMP6s mice; one-way ANOVA, F2,15 = 15.59, p < 0.001; Post-hoc Bonferroni Analysis, 
**p < 0.01, ***p < 0.001). (K) Left, when mice made transitions from REM sleep to NREM 
sleep through a short period of arousal (wake shorter than 15 seconds), the DRNDA activity 
decreased. Right, Quantification of the area under the curve per second showed that DRNDA 
activity was significantly lower after transitions than before transitions (n = 6 DRNDA-GCaMP6s 
mice, paired t-test, t5 = 2.823, *p < 0.05). Data are represented as mean ± s.e.m. 
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Supplementary Figure 4, related to Figure 4. (A) Ex vivo patch clamp recording 
demonstrated that DRNDA neurons could faithfully follow our parameters of phasic 
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stimulation (30 Hz, 10 pulses, 10 ms pulse width). (B) Representative EEG (black) and 
EMG (gray) recordings when phasic DRNDA stimulation caused immediate (<5 second) 
NREM-to-wake transitions in a DRNDA-ChR2 mouse. Notice the termination of slow delta 
waves and abrupt increase of muscle activity after a phasic pulse. The same phasic 
stimulation paradigm did not cause any state changes in a DRNDA-eGFP mouse. (C) Same as 
(B), but when phasic stimulation occurred during REM sleep. (D) Two-minute tonic 
stimulations (continuous 2 Hz pulses for 2 minutes, 10 ms pulse width) were delivered every 
20-25 minutes to DRNDA-ChR2 and DRNDA-eGFP mice. (E) Tonic stimulation caused a small 
increase in the wake probability and a small decrease in the NREM and REM probability in 
DRNDA-ChR2 mice. (F) No changes were observed upon tonic stimulation in DRNDA-eGFP mice. 
(G) REM state probability was significantly decreased in DRNDA-ChR2 mice compared to 
DRNDA-eGFP mice (n = 8 DRNDA-ChR2 mice, n = 7 DRNDA-eGFP mice; unpaired t-test, *p < 
0.05). Although DRNDA-ChR2 mice appeared to spend more time in the wake state, this trend 
did not reach statistical significance (unpaired t-test, p = 0.057). There were no significant 
differences in NREM state probability change between two groups (unpaired t-test, p > 0.3). 
(H) Power spectral density of DRNDA-ChR2 mice (see Figure 4H), but divided into low (0.5-
30 Hz) and high (40-100 Hz) frequency ranges for better visualization. (I) Same as (H), but 
for power spectral density of DRNDA-eGFP mice (see Figure 4I). (J) Wake-promoting effect 
of DRNDA activation was abolished with systemic administration of D1 and D2 receptor 
antagonists. D1/D2 antagonists injection resulted in a significant decrease of the time spent 
awake (n = 4 DRNDA-ChR2 mice; paired t-test, t3 = 7.161, **p<0.01) and a significant increase 
in the time spent in NREM (paired t-test, t3 = 5.796, *p<0.05) and REM sleep (paired t-test, 
t3 = 6.673, **p<0.01), compared to saline injection. (K) DRN
DA-eGFP mice showed no 
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significant change in the time spent in any state (n = 4 DRNDA-eGFP mice, paired t-test, all 
p>0.4) after systemic administration of saline or D1/D2 antagonists. (L) DRNDA-ChR2 and 
DRNDA-eGFP mice underwent the open field test at the dark and light phases to examine the 
causal effect of DRNDA activation with locomotion. There was no difference in distance 
traveled in the open field between the two mouse groups across light OFF and ON epochs in 
both phases (n = 6 per group; two-way ANOVA revealed no light x epoch interaction in both 
phases, F2,20 (dark) = 0.089, p > 0.9, F2,20 (light) = 2.088, p > 0.1). (M) Real-time place 
preference/aversion assay with DRNDA-ChR2 and DRNDA-eGFP mice demonstrated that 
DRNDA-ChR2 mice spent less time in the chamber paired with phasic light stimulation, but this 
trend for place aversion was not statistically different from DRNDA-eGFP mice group place 
preference/aversion (n = 6 per group; unpaired t-test, p > 0.1). (N) Virus injection into the 
DRN results in the transgene expression in the caudal linear nucleus (CLi) but not in the 
retrotrubral field (RRF). Scale bar is 1 mm. (O) Virus injection into the DRN does not result 
in cell-body expression, but show fibers (originating from DRN) in the VTA or SNc. Scale 
bar is 1 mm. (P) ChR2-eYFP fibers were found in the basolateral amygdala (BLA) and the 
central nucleus of the amygdala (CeA). (Q) Bed nucleus of the stria terminalis (BNST). (R) 
Caudal part of nucleus accumbens (NAc). (S) Medial prefrontal cortex (mPFC). All scale 
bars from (P) to (S) are 500 μm. Data are represented as mean ± s.e.m. 
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Supplementary Figure 5, related to Figure 5. (A) Images of DIC (upper) and fluorescence 
(lower) from a patched DRNDA neuron expressing hM4Di-mCherry. (B) Representative 
example recording of membrane potentials from an hM4Di+ DRNDA neuron. Bath 
application of CNO (1 uM) resulted in hyperpolarization and a reduction of neuronal firing, 
which was recovered after washout. Holding potential was at -45 mV. (C) Same as (B), but 
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for an eGFP+ DRNDA neuron. Notice that there was no detectable change in membrane 
potential or firing rate. Holding potential was at -45 mV. (D) Application of CNO reduced 
the membrane potential of hM4Di+ neurons, but not in eGFP+ neurons. (n = 4 cells each; 
unpaired t-test, *p < 0.05). Baseline was defined as 1-minute epoch before CNO application, 
and CNO induced change was quantified from 2 to 4 minutes after CNO bath application. 
(E) Firing rate was significantly reduced with CNO application in hM4Di+ neurons, relative 
to eGFP+ neurons (n = 4 cells each; unpaired t-test, **p < 0.01). (F-I) Stereotaxic injection 
of AAV2-hSyn-DIO-hM4Di-mCherry (red) vectors into the DRN of TH-Cre mice did not 
result in anterograde or retrograde transport to other TH+ neurons (green) in (F) locus 
coeruleus (LC), (G) retrorubral field (RRF), (H) ventral tegmental area (VTA), and (I) 
substantia nigra pars compacta (SNc) after one month. Axonal fibers (presumably coming 
from the DRNDA neurons) were shown, but no cell body expression was present in these 
areas. Scale bars are 100 um. (J) Power spectral density during wakefulness from DRNDA-
hM4Di mice after saline (blue) and CNO (red) injection. Notice that EEG spectra after CNO 
delivery were not distinct from saline controls. (K) Same as (J), but for NREM sleep. (L) 
Same as (J), but for REM sleep. Data are represented as mean ± s.e.m. 
  
167 
 
Supplementary Figure 6, related to Figure 6. (A) Fiber photometry and EEG/EMG 
recordings were performed in DRNDA-GCaMP6s mice. Arousing auditory tones (65 dB, 2-5 kHz, 
2 Hz pulse frequency, 250 ms pulse, for 10 seconds) were randomly triggered during the 
light phase. (B) The presentation of auditory cues was associated with a time-locked increase 
in DRNDA activity, especially in sleep-to-wake transitions. (C) DRNDA activity change, as 
indexed by the difference in the area under the curve between before (-30-0 s) and after (0-
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30 s) tone presentation, was larger when the auditory tone induced sleep-to-wake 
transitions (within 10 seconds) than when it was turned on during the wake state or when it 
failed to cause sleep-to-wake transitions (n = 7 DRNDA-GCaMP6s mice; one-way ANOVA, F2,18 
= 10.79, p < 0.001, Bonferroni post-hoc analysis, *p < 0.05, ***p < 0.001). (D) Increased 
DRNDA population activity was observed when arousing tones woke up DRNDA-GCaMP6s mice 
from NREM (red) or REM (green) sleep states. (E) The time-locked increase in DRNDA 
activity upon auditory tone presentation did not vary according to the type of sleep-to-wake 
transitions (NREM-to-wake versus REM-to wake; n = 7 DRNDA-GCaMP6s mice, paired t-test, 
t6 = 1.4094, p > 0.2). (F) EEG/EMG monitoring was performed with DRN
DA-Arch or DRNDA-
hM4Di mice while auditory tones (70 dB) were turned on during the light phase. Green laser 
(532 nm) was applied for 20 seconds surrounding the tonal stimuli for time-locked DRNDA 
inhibition. (G) Confocal images of Arch+ (green) neurons co-localized with TH (red) 
expression. Scale bar is 100 μm. (H) There was a noticeable decrease in delta (0.5-4 Hz) 
amplitude in NREM-to-wake trials (blue), when auditory cues successfully caused wake 
transitions from NREM sleep, whereas there was minimal change of delta (0.5-4 Hz) 
amplitude in NREM-to-NREM trials (red), when auditory cues failed to cause wake 
transitions from NREM. Data are pooled together from both DRNDA-Arch and DRNDA-eGFP 
mice. (I) There was no difference in delta (0.5-4 Hz) amplitude before and after tones in 
NREM-to-NREM trials (n = 67 trials; paired t-test, t66 = 1.310, p > 0.1). However, there was 
significant decrease in delta (0.5-4 Hz) amplitude across tones in NREM-to-wake trials (n = 
123 trials; paired t-test, t122 = 10.58, ***p < 0.0001). (J) There was a noticeable decrease in 
theta (5-10 Hz) amplitude in REM-to-wake trials (blue), when auditory cues successfully 
caused wake transitions from REM sleep, while there was minimal change of theta (5-10 Hz) 
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amplitude in REM-to-REM trials (red), when auditory cues failed to cause wake 
transitions from REM trials. Data are pooled together from both DRNDA-Arch and DRNDA-
eGFP mice. (K) There was no difference in theta (5-10 Hz) amplitude before and after tones 
in REM-to-REM trials (n = 5 trials; paired t-test, t4 = 0.2832, p > 0.7). However, there was 
significant decrease in theta amplitude across tones in REM-to-wake trials (n = 30 trials; 
paired t-test, t29 = 5.786, ***p < 0.0001). (L) The probability of NREM-to-wake transitions 
upon auditory tones was significantly lower in DRNDA-Arch mice compared to DRNDA-eGFP 
mice (n = 6 DRNDA-Arch mice, n = 4 DRNDA-eGFP mice; unpaired t-test, p < 0.001). (M) Left, 
delta (0.5-4 Hz) amplitude decrease was less prominent in DRNDA-Arch mice compared to 
control mice. Right, delta (0.5-4 Hz) amplitude during the tone was significantly higher in 
DRNDA-Arch mice than DRNDA-eGFP controls (n = 6 DRNDA-Arch mice, n = 4 DRNDA-eGFP mice; 
unpaired t-test, *p < 0.05). (N) The probability of REM-to-wake transitions upon auditory 
tones presentation was not different between DRNDA-Arch and DRNDA-eGFP mice (n = 6 
DRNDA-Arch mice, n = 4 DRNDA-eGFP mice; unpaired t-test, p > 0.1). (O) Left, the decrease in 
theta (5-10 Hz) amplitude was similar between DRNDA-Arch and DRNDA-eGFP mice. Right, 
there was no statistically detectable difference in the theta (5-10 Hz) amplitude between 
groups during the tone presentation (n = 6 DRNDA-Arch mice, n = 4 DRNDA-eGFP mice; 
unpaired t-test, p > 0.6). 
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3.7 Supplementary movie captions 
Supplementary Movie 1. DRNDA neuronal activity increases upon social contact with 
a juvenile mouse, related to Figure 1. DRNDA neuronal activity was recorded with fiber 
photometry while a TH-Cre mouse expressing GCaMP6f was in his home cage and a novel 
juvenile mouse was introduced. The corresponding DRNDA fluorescence (upper right) 
shows increased activity upon contact with or investigation of the juvenile mouse. 
 
Supplementary Movie 2. DRNDA activity increases during the consumption of 
palatable food, related to Figure 1. DRNDA neuronal activity was recorded with fiber 
photometry while a TH-Cre mouse expressing GCaMP6f was exploring in a novel empty 
cage and palatable food (peanut butter chocolate) was introduced to a corner. The 
corresponding DRNDA fluorescence (upper right) shows increased activity upon 
investigation and consumption of the food.  
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3.8 Materials and methods 
 Key Resources Table 
REAGENTS or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Chicken polyclonal anti-TH Aves Labs Cat#: TYH 
Rabbit polyclonal anti-TH Santa Cruz Cat#: sc-14007 
Chicken polyclonal anti-GFP Aves Labs Cat#: GFP-1020 
Goat polyclonal anti-5HT Immunostar Cat#: 20079 
Rabbit polyclonal anti-mCherry Abcam Cat#: ab167453 
Anti-chicken Alexa Fluor 488 Jackson ImmunoResearch Cat#: 703-545-155 
Anti-rabbit Alexa Fluor 488 Jackson ImmunoResearch Cat#: 711-545-152 
Anti-goat Rhodamine Red-X Jackson ImmunoResearch Cat#: 705-297-003 
Anti-rabbit Rhodamine Red-X Jackson ImmunoResearch Cat#: 711-297-003 
Anti-rabbit Alexa Fluor 647 Jackson ImmunoResearch Cat#: 711-607-003 
Anti-chicken Alexa Fluor 647 Jackson ImmunoResearch Cat#: 703-606-155 
Chemicals 
Clozapine-N-oxide Enzo Life Science Cat#: BML-NS105 
Experimental Models: Organisms/Strains 
Mouse: TH::IRES-Cre European Mouse Mutant 
Archive 
EM::00254 
Recombinant DNA 
AAV5-Syn-FLEX-GCaMP6f Penn Vector Core AV-5-PV2819 
AAV5-Syn-FLEX-GCaMP6s Penn Vector Core AV-5-PV2821 
AAV5-Ef1a-DIO-ChR2(H134R)-
eYFP 
UNC Vector Core N/A 
AAV5-Ef1a-DIO-eArch3.0-eYFP UNC Vector Core N/A 
AAV5-hSyn-DIO-eGFP UNC Vector Core N/A 
AAV2-hSyn-DIO-hM4Di-mCherry UNC Vector Core/Addgene N/A 
Software and Algorithms 
MATLAB R2014a Mathworks N/A 
pClamp 10.4 Molecular Devices N/A 
SleepSign 3.0 Kissei Comtec N/A 
EthoVision XT10 Noldus Information 
Technology 
N/A 
ABETII Lafayette Instrument N/A 
Prism 5.0 GraphPad Software N/A 
Illustrator CS6 Adobe N/A 
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Experimental Model and Subject Details 
Tyrosine hydroxylase (TH)::IRES-Cre knock-in mice (Lindeberg et al., 2004) were obtained 
from the European Mouse Mutant Archive (EM::00254) and crossed with wild-type 
C57BL/6N mice. We exclusively used male heterozygote mice for fiber photometry during 
behaviors and used both male and female heterozygote mice for other experiments with 
EEG/EMG. After weaning, animals were group-housed until they were 3-4 months old. 
Upon the completion of any surgical procedures, mice were allowed to recover from 
anesthesia on a heating-pad, and then they were transferred, singly-housed (or group-housed 
for the group-housed cohort) to a new residence room for full recovery (2-4 weeks) prior to 
the start of any behavioral experiments or habituation to EEG/EMG tethers. In this 
residence/procedure room, subjects were housed on a 12 h: 12 h light/dark cycle (light off at 
6AM, light on at 6PM) with ad libitum access to food and water. Animal husbandry and all 
experimental procedures involving animal subjects were approved by the Institutional 
Animal Care and Use Committee (IACUC) and by the Office of Laboratory Animal 
Resources at the California Institute of Technology under IACUC protocol 1672. 
 
Surgeries for viral delivery, optical fiber and EEG/EMG implantation 
General surgical procedures and viral delivery 
Mice were anesthetized with isoflurane gas/carbogen mixture (5% for induction and 1.5-2% 
for maintenance during surgery) and placed to a stereotaxic frame (David Kopf Instruments, 
CA, USA). After shaving their hair and sterilizing the skin with chlorohexidine, a midline 
incision was made with a sterile scalpel. The skull surface was wiped and cleaned with 
autoclaved cotton swabs. Bregma and lambda were identified and leveled to be on the same 
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z-axis. Small craniotomy holes were made for 20 degree angled injection of viruses and 
optical fiber implantation over the dorsal raphe nucleus (DRN, antero-posterior (AP) axis: -
4.65 mm, medio-lateral (ML) axis: ±1.2 mm, relative to Bregma). Adeno-associated viral 
vectors (AAV, see below for details) were injected to the DRN (AP -4.6 mm, ML ±1.2 mm, 
dorso-ventral (DV) -2.95 mm, at a 20 degree angle relative to vertical axis from the left and 
right sides). Viral injection was performed using a blunt 35-gauge microinjection needle 
within a 10 uL microsyringe (NanoFil, World Precision Instruments, FL, USA), which was 
controlled by a microsyringe pump (UMP3, World Precision Instruments) connected to a 
controller (Micro4, World Precision Instruments). 0.3-0.5 uL of AAV was infused per site at 
a rate of 50 nL per min. Following injection, the needle/syringe was held in the same location 
for an additional 10 minutes to allow further diffusion. To prevent potential backflow, the 
needle/syringe was slowly withdrawn over approximately 10 minutes.  
 
EEG and EMG implantation 
To implant the EEG/EMG apparatus, three additional craniotomy holes were made in frontal 
(for first EEG channel; AP +2.0 mm, ML +0.7 mm), central (for second EEG channel; AP -
1.3 mm, ML +1.3 mm) and lateral parietal (for reference and ground; AP -3.5 mm, ML -2.5 
mm) regions with a drill bit (#73, 105-0240.340, Kyocera, Kyoto, Japan). 0.10’’ electrodes 
with wire leads (8403, Pinnacle Technology Inc., KS, USA) were screwed to the craniotomy 
holes. With the leads from the screw electrodes held away from the surface of the skull to 
prevent accidental glue application, a thin layer of adhesive cement (C&B Metabond, Parkell 
Inc., NY, USA) was applied on the skull surface to secure the screw electrodes. Another thin 
layer of dental cement (51458, Stoelting Co., IL, USA) was additionally applied until it 
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covered screw heads. The EEG/EMG headmount (8201, Pinnacle Technology Inc.) was 
then affixed on the dental cement layer and lead wires from screw electrodes were connected 
to the headmount. Silver epoxy (MG Chemicals, BC, Canada) was applied to ensure 
electrical conduction between lead wires and the headmount. Additional layer of dental 
cement was applied to secure the headmount to the animal’s head. Finally, EMG leads from 
the headmount were inserted into the trapezius muscles and then the incision was closed. 
 
Optical fiber implantation (for fiber photometry and optogenetic experiments) 
Following virus infusion, an optical ferrule/fiber with cut length of 4 mm and diameter of 
300 um (for optogenetics, NA 0.37, home-made) or 400 um (for fiber photometry, NA 0.48, 
Doric lenses, Quebec, QC, Canada) was firmly mounted to a stereotaxic holder (1766AP, 
David Kopf Instruments, CA, USA). An optical ferrule/fiber was then inserted to the DRN 
(AP -4.6 mm, ML ±1.2 mm, DV -2.5~2.7 mm, at a 20 degree angle relative to vertical axis 
from either left or right side) through a craniotomy hole, and stopped 200 (for fiber 
photometry) or 500 um (for optogenetics) above the viral injection site. A thin layer of 
adhesive cement was applied on the skull surface to strongly hold the ferrule/fiber. After 
adhesive cement was completely dried, a thick layer of pink dental cement was applied to 
build a robust head cap.  
 
Viral constructs 
For fiber photometry experiments, 0.5 uL of AAV serotype 5 encoding GCaMP6f or 
GCaMP6s (Chen et al., 2013) under synapsin promoter and Cre-dependent FLEX switch 
(AAV5-Syn-FLEX-GCaMP6f or GCaMP6s, 1.0-1.5 X 1013 genome copies/mL) was 
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unilaterally injected. GCaMP6 viruses were packaged and purchased from the University 
of Pennsylvania Vector Core (Philadelphia, PA, USA). For optogenetic activation 
experiments, 0.3 uL of AAV serotype 5 encoding ChR2-eYFP under Ef1a promoter and 
double-floxed inverse open reading frame (DIO) (AAV5-Ef1a-DIO-ChR2(h134R)-eYFP, 
4.5 X 1012 genome copies/mL) was bilaterally injected. For chemogenetic experiments, 0.3 
uL of AAV serotype 2 encoding hM4Di-mCherry under human synapsin promoter and DIO 
switch (AAV2-hSyn-DIO-hM4Di-mCherry, 4.0 - 5.0 X 1012 genome copies/mL) was 
bilaterally injected. For optogenetic inhibition experiments, 0.5 uL of AAV serotype 5 
encoding eArch3.0-eYFP under Ef1a promoter and DIO frame (AAV5-Ef1a-DIO-eArch3.0-
eYFP, 3.4 X 1012 genome copies/mL) was bilaterally injected. For control animals, 0.5 uL 
of AAV5-hSyn-DIO-eGFP (4.7 X 1012 genome copies/mL) was bilaterally injected. ChR2-
eYFP, hM4Di-mCherry, eArch3.0-eYFP and eGFP viruses were packaged and purchased 
from the University of North Carolina Vector Core (Chapel Hill, NC, USA). hM4Di-
mCherry vector was also purchased from Addgene (Cambridge, MA, USA). 
 
Fiber photometry 
Fiber photometry is a method of measuring population Ca2+ sensitive fluorescence from 
genetically defined cell types in deep brain structures, such as TH-expressing neurons in the 
DRN, using a single optical fiber for both excitation and emission in freely moving mice 
(Gunaydin et al., 2014). We based our photometry design from previous literature (Lerner et 
al., 2015; Calipari et al., 2016) with a few modifications. Two wavelength LEDs (490 nm 
for GCaMP6 excitation and 405 nm for isosbestic wavelength excitation, M490F1 and 
M405F1, Thorlabs Inc.,NJ, USA) were modulated at two different frequencies (211 Hz for 
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490 nm, 531 Hz for 405 nm), which were controlled by a real-time processor (RX8-2, 
Tucker David Technologies, FL, USA) and a custom-written software (provided by Drs. Karl 
Deisseroth and Tom Davidson at Stanford University). The emission signal from 405 nm 
illumination was shown to be Ca2+-independent with GCaMP6 and to mostly reflected 
bleaching and motion artifacts (Lerner et al., 2015; Kim et al., 2016): thus, this signal serves 
as a control reference signal. 490 nm and 405 nm excitation lights were passed through GFP 
and violet cleanup excitation filters (FF02-472/30-25 and FF01-400/40-25, Semrock, NY, 
USA) respectively, and reflected off dichroic mirrors (DMLP425 and MD498, Thorlabs). 
Excitation light was coupled into a low auto-fluorescence 400 um patch cord (0.48 NA, 2 m 
cable length, Doric lenses) with a high NA coupler/collimator (F240FC-A, Thorlabs). 
Another end of the patch cord was connected to a ceramic optical ferrule/fiber (1.25 mm 
diameter ferrule, 400 um fiber core diameter) implanted on animals. The LED powers for 
either excitation wavelength was measured with a power meter (PM100D, Thorlabs) and set 
to be 50-80 uW at the end of patch cord. GCaMP6 emission signals were collected through 
the patch cord and collimator and passed through a dichroic mirror (MD498, Thorlabs) and 
a GFP emission filter (MF525-39, Thorlabs) to reach a femtowatt photoreceiver (Model 2151, 
Newport Co., Irvine, CA, USA) using a focusing lens (62-561, Edmunds Optics, Barrington, 
NJ, USA). Photoreceiver signals were relayed into a RX8-2 processor through a BNC cable 
and were demodulated into two signals, corresponding to each LED excitation wavelength 
based on its modulation frequency. These outputs were digitized at a sampling rate of 382 
Hz and low-pass filtered at 15 Hz. One digital input channel was additionally acquired to 
record any TTL pulses from an external source in order to synchronize transients with 
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EEG/EMG, video recording, or behavioral events. Custom-written software was used to 
control data acquisition and signal visualization. 
 
Behavioral experiments 
All behavioral experiments involving fiber photometry were performed at least 2 weeks after 
viral injection. Behavioral tests with optogenetics were performed at least 4 weeks after 
surgery to allow maximal transgene expression. Mice underwent the following assays during 
their dark phase (10AM-5PM) in their residence room, unless otherwise stated.   
 
Resident-intruder assay 
Mice with an implanted optical fiber were connected to a patch cord for recording of fiber 
photometry. After connection, mice were placed back into their home cages and habituated 
to the open cage setup for 10 minutes. After habituation, a juvenile male (3-4 weeks old), 
adult female (2-3 months old), or adult male (2-3 months old) mouse was introduced as an 
intruder into each home cage. Video recording was performed and synchronized with fiber 
photometry signals. After 5 minutes, the intruder mouse was removed from the home cage. 
The behavior of resident mice, such as investigation and attack (observed only towards adult 
males), was manually scored by an experimenter. 
 
Novel object interaction assay 
The novel object interaction test setup is almost identical to the resident-intruder assay, but 
a distinct novel object was placed into the center of the empty cages instead of an intruder 
mouse. To run the test, mice were connected to the photometry patch cord, and habituated to 
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being tethered in the open empty cage environment. Then, a novel object was introduced, 
and the subject was allowed to freely explore the object for a 5-minute test session. Behavior 
scoring was manually performed to identify interaction bouts, which consist of the subject 
approaching, sniffing, and/or touching of the object with forelimbs. 
 
Familiar object interaction assay 
This assay is similar to the novel object interaction assay described above, except that the 
designated familiar object (similar size and characteristics as used for the novel objects) was 
placed into the subject’s home cage 5 days prior to photometry recording sessions.  
 
Feeding assay 
Two days before the experiment, the palatable food treat (approximately 1 g of peanut butter 
chocolate pieces (Reese’s peanut butter cups)) was presented to each mouse for consumption. 
After connecting the mouse to the patch cord, they were placed to a clean, empty cage. After 
5 minutes of habituation, approximately 2 g of treats in a small weighing boat were 
introduced into one of the cage corners. All tested subjects approached and consumed the 
treat after variable delays. Leftover treats were removed after 10 minutes. Video recordings 
were manually scored to identify food consumption bouts.   
 
Air puff 
Mice were connected to a patch cord and placed to a clean empty cage without any bedding. 
Mice were allowed to explore and habituate for 5 minutes. Six brief (<1 s) air puffs were 
applied to the tail using a compressed air duster with an inter-puff interval of 30-60 seconds. 
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TTL pulses were sent to the fiber photometry digital input channel for time stamping 
when air puffs were applied.  
 
Unpredictable delivery of electric footshocks 
Mice were connected to a patch cord and placed inside an operant chamber (Lafayette 
Instruments, IN, USA). Mice were allowed to explore and habituate to the operant box for 
10 minutes. Two mild footshocks (0.3 mA, 1 second) were delivered with intervals about 30 
seconds. TTL pulses were sent to the fiber photometry digital input channel for accurate time 
stamping. 
 
Exposure to predator odor 
Mice were connected to a patch cord and put to a clean empty cage. They were allowed to 
explore for 5 minutes to habituate to the environment. After photometry recording started, a 
filter paper applied with 10 uL of 2,3,5-trimethyl-3-thiazoline (TMT, a component of fox 
urine, SRQ Bio, Inc, FL, USA) was introduced at the corner. Simultaneous photometry video 
recordings were performed to identify the time point of odor investigation. 
 
Restraint/Immobilization 
A test subject was connected to a patch cord and placed to a clean empty cage. A 5-minute 
habituation session was conducted in which the subject was allowed to freely explore the 
cage. At the start of fiber photometry recording, 3 minutes of baseline was obtained. Then, 
taking care not to cause significant pain to the subject, a trained experimenter restrained the 
subject for one minute by placing gentle pressure on the mouse body with the left hand and 
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immobilizing the tail with the right hand. All subjects engaged in active struggling and 
escape behaviors. Recordings were terminated after 3 minutes of recovery.  
 
Tail suspension test 
Mice were connected to a patch cord, and the tail was placed between strips of common lab 
tape that were affixed to a horizontal bar that was suspended about 50 cm from the ground. 
We additionally put a lightweight (~1 g) plastic cylinder around the tail to prevent the mouse 
from climbing onto the tail. Synchronized fiber photometry and video recordings were 
performed for 5 minutes, and video was manually and blindly scored to pinpoint “mobility” 
bouts during which the animals struggled by moving their bodies.  
 
Open field test 
Mice were connected to a patch cord and transferred to the open field box (50 cm x 50 cm x 
25 cm) that contained a video camera positioned above the behavioral arena to track the 
position and velocity of subject mice. Mice were habituated for 10-15 minutes prior to the 
start of testing. Locomotor activity tracking by a video camera was controlled by Ethovision 
XT 9 software (Noldus Information Technology, Wageningen, Netherlands). Fiber 
photometry and video recordings were synchronized via TTL pulses generated by the Noldus 
USB-IO box. Recording sessions lasted for 15 minutes. Fiber photometry experiments took 
place during the subjects’ dark phase (10AM-5PM). For optogenetic experiments, open field 
tests were performed during both the dark phase (9AM-1PM) and light phase (6PM-10PM) 
to examine whether locomotion varied across the circadian cycle. The order of open field 
test sessions during dark and light phases was counter-balanced. 
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Real time place preference/aversion assay 
A subject was connected to a patch cord and transferred to the open field box (50 cm x 25 
cm x 25 cm), which was divided into left and right compartments. The subject was given 
free access to explore the two compartments for 30 minutes. However, upon entering the 
“paired chamber”, the subject received phasic bursts of optogenetic stimulation (30 Hz, 10 
pulses, 10 ms pulse width, every 5 seconds). The side paired with optogenetic stimulation 
was counter-balanced. Ethovision XT 9 software (Noldus) was used to track the movement 
and location of mice. As a dependent variable, time spent in the paired compartment was 
quantified.  
 
EEG/EMG data acquisition, processing, and sleep-wake state classification 
After EEG/EMG implantation surgery, animals were single-housed for four weeks in a 
regular mouse cage for recovery and transgene expression. Mice were then transferred to a 
transparent cylindrical cage (12’’ diameter and 12” height) and connected to a customized 
pre-amplifier (10x gain, 0.5 Hz high-pass filter, 10 Hz high-pass filter for EMG; Pinnacle 
Technology Inc., Lawrence, KS, USA) and a commutator (8204, Pinnacle Technology Inc.) 
for freely moving recordings. They were habituated for at least seven days to the recording 
setup before beginning any experiments. At the 7th day, four animals were randomly selected 
per group (depending on the viral transgene they expressed) and 24-hr baseline recordings 
were performed to test whether viral transgene expression or other experimental artifacts 
altered mice’s sleep-wake architecture. Food and water were available ad libitum. EEG/EMG 
signals were digitized through the OmniPlex System (Plexon, TX, USA) with a sampling 
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rate of 1,000 Hz in most experiments, or through Pinnacle Sirenia Acquisition (Pinnacle 
Technology Inc, KS, USA) with a sampling rate of 400 Hz (for 24-hr baseline recordings 
and chemogenetic experiments in presence of salient stimuli). Mice with lost EEG and EMG 
signals were excluded from the experiment; very occasionally, some mice showed a low 
signal-to-noise ratio or unintelligible EEG/EMG traces.  
 
Data acquired in Plexon’s or Pinnacle proprietary file format (.pl2 or .pvfs) were converted 
to the European data format (.edf) with MATLAB (MathWorks, MA, USA) using the 
EEGLAB plug-in (Schwartz Center for Computational Neuroscience, La Jolla, CA, USA). 
Polysomnographic EEG/EMG recordings were loaded and scored to corresponding 
behavioral states using sleep analysis software (SleepSign for Animal, Kissei Comtec Co., 
Nagano, Japan).  
 
Sleep-wake state classification is manually performed based on visual and spectral signatures 
of EEG and EMG signals. We assigned each state during consecutive non-overlapping 5-
second windows. We defined wakefulness as desynchronized, low-amplitude, and high 
frequency EEG rhythms with elevated EMG activity. We defined NREM sleep as 
synchronized, high-amplitude, and low frequency (<4 Hz) EEG activity with lower tonic 
EMG tone. We defined REM sleep as containing prominent theta (6-10 Hz) oscillations on 
EEG and minimal EMG activity. All sleep-wake state scorings were performed by an 
experimenter (J.R.C.), who was blind to the type of expressed transgenes and experimental 
conditions.  
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Optogenetic and chemogenetic modulation of behavioral states and locomotion 
For optogenetic experiments, one side of a patch cord (1.25 mm ceramic ferrule, 300 um 
diameter, Doric lenses) was connected to the implanted optical ferrule/fiber with another side 
(FC/PC connector) connected to a swivel commutator (fiber-optic rotary joints, 
FRJ_1x1_FC-FC, Doric lenses) to allow free movement. Another patch cord was connected 
from the commutator to a 473 nm laser (MLL-FN-473nm/150mW, Changchun New 
Industries Optoelectronics Technology, Changchun, China). The intensity of laser beam was 
measured with an optical power meter (PM100D, Thorlabs) and set to be 10 mW at the tip. 
Laser output was controlled by a TTL pulse generator (OTPG4, Doric lenses) via a BNC 
cable. For phasic stimulation, ten 30-Hz, 10-ms pulses were applied every 5 seconds. For 
tonic stimulation, continuous 2-Hz, 10-ms pulses were used. These phasic and tonic 
parameters were chosen to have the same number of pulses for a given duration but with 
distinct temporal pattern. Both phasic and tonic patterns of stimulation were applied for 2 
minutes with intervals of 20-25 minutes. Animals used for optogenetic experiments were 
always connected to the preamplifier and Plexon system to continuously acquire EEG and 
EMG signals for sleep-wake state classification. TTL signals for controlling laser output 
were split and input into the Plexon acquisition system through an analog input for accurate 
time stamping of triggered stimulation. All optogenetic experiments with EEG/EMG 
monitoring were carried out during the light phase (6 PM-6 AM). 
 
To test whether the wake-promoting effect of DRNDA activation was mediated by direct 
action of DA, DRNDA-ChR2 or DRNDA-eGFP mice habituated to the recording setup were 
systemically administered with the dopamine receptor antagonists SCH-23390 (a selective 
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D1 antagonist, 1 mg/kg) and eticlopride (a selective D2 antagonist, 1 mg/kg) 45 minutes 
before the onset of light phase. The concentration of these dopamine antagonists was selected 
based on previous literatures (Burgess et al., 2010; Eban-Rothschild et al., 2016). For 
controls, we injected sterile saline at the same circadian time. EEG/EMG recording and 
phasic optogenetic stimulation started at the light phase onset and lasted for 2 hours.  
 
To study whether the wake-promoting effect of optogenetic DRNDA stimulation is influenced 
by homeostatic sleep pressure, DRNDA-ChR2 or DRNDA-eGFP mice were sleep deprived for 0 
or 4 hours by gentle handling (Palchykova et al., 2006; Eban-Rothchild et al., 2016). The 
order of experiments (0 or 4-hour deprivation) was counter-balanced across animals. For 
sleep deprivation, mice were continuously monitored by an experimenter (with EEG and 
EMG recordings turned on). Mice were softly touched by a brush whenever they become 
motionless and/or exhibited reduced EMG tone or absent EMG bursts. After the sleep 
deprivation procedure, two phasic bursts (30 Hz, 15 pulses, 10 ms width, 5-second interval) 
were applied about 5~10 minutes after they entered into NREM sleep, and the latency to 
wake transitions was measured.  
 
To study the causal effect of increased DRNDA activity on locomotion, we performed the 
open field test with DRNDA-ChR2 and DRNDA-eGFP mice. Procedures and experimental 
equipment were similar those described above for open field testing during fiber photometry. 
Mice were first habituated in the open field for 20 minutes, and the video recording was 
obtained while tracking the position of the test subject mice. After acquiring 20 minutes of 
baseline activity (not including habituation), laser stimulation (phasic or tonic patterns) was 
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was delivered for 5 minutes. After stimulation, five additional minutes were recorded. 
Throughout testing, distance travelled during 5-minute epochs of before, during, and after 
stimulation were analyzed.  
 
For chemogenetic experiments, animals with hM4Di-mCherry or eGFP injection were 
connected to the data acquisition system for EEG and EMG signals. Animals were habituated 
to experimenter handling for 3-4 days before any experiments commenced. Saline or 
clozapine-N-oxide (CNO, selective ligand for hM4Di, 1 mg/kg dissolved in saline; Enzo Life 
Sciences Inc., Exeter, UK) was intraperitoneally injected immediately prior to the start of 
testing at 9 AM (3 hours after dark phase onset). Recordings were carried out for 2 hours 
following injection.  
 
To test whether DRNDA neuronal activity is required for wake maintenance after exposure to 
salient environmental stimuli, DRNDA-hM4Di or DRNDA-eGFP mice (which were already 
habituated to experimenter’s handling) were first injected with saline or CNO (1 mg/kg) 45 
minutes before testing. Then, a female mouse (contained in an inverted wire cup, and thus 
not directly accessible for mounting) or a filter paper with predator odor TMT was introduced 
into the recording cage. We chose these two stimuli because they are of opposite valence 
(positive versus negative) and were shown effective in inducing robust DRNDA neuronal 
activity (See Fig. 1 and S2). EEG/EMG recording began right after introduction of the salient 
stimulus and lasted for 1 hour.  
 
Auditory cue arousal test 
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To examine whether DRNDA firing mediates cue-induced arousal from sleep, we 
performed simultaneous recording of fiber photometry and EEG/EMG signals on DRNDA-
GCaMP6s mice. On each experimental day, recordings began at the light phase onset (6PM). 
Auditory tonal stimuli (65 dB; 2, 3, or 5 kHz frequency; 2-Hz pulse; 250-ms pulse width, 10-
second duration) were randomly applied during the first half of the light phase (for 6 hours) 
with a minimum inter-trial interval of 15 minutes from a speaker located adjacent to the 
testing cages. In order to limit habituation to specific tonal frequencies, three different tones 
were administered in random order with a 33.3% probability for each frequency. The speaker 
was placed 30 cm away from the cage, and the auditory tone intensity inside the cylindrical 
cage was calibrated with a sound meter (Digital Sound Level Meter, Foneso, Shenzhen, 
China) before the beginning of each session with mice temporarily removed from the room. 
TTL pulses were generated when auditory cues were turned on and inputted onto the Plexon 
data acquisition system for accurate time stamping. 
 
Sleep-wake states were classified as described above by an experimenter (J.R.C.) who was 
blind to the experimental conditions. Depending on the behavioral consequence of auditory 
cues, each trial was classified as 1) sleep-to-wake transitions (further divided from NREM 
or from REM sleep), 2) sleep-to-sleep (when auditory cue failed to induce wakefulness), and 
3) wake-to-wake (auditory stimuli that were administered during wakefulness) cases. In 
order for the data to be scored as sleep-to-wake transitions, animals had to show at least 3 
seconds of wake EEG and EMG signs (EEG: desynchronized from delta or theta rhythm, 
EMG: sudden phasic elevation of muscle activity) within 10 seconds of the auditory cue 
onset. If these criteria were not met, they were categorized as sleep-to-sleep cases.  
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To test for the necessity of DRNDA firing in auditory cue-induced arousal from sleep, we 
inhibited DRNDA neurons in a time-locked manner with the inhibitory proton pump eArch3.0 
(Arch). The experimental setup was identical to the procedure described above, except that 
we used slightly higher intensity tone (70 dB) to avoid possible floor effects and that 20 
seconds of 532 nm green laser (10 mW at the tip) was continuously applied surrounding the 
tone presentation (starting 5 seconds before the tone, terminating 5 seconds after the end of 
the tone) to the DRNDA-Arch or DRNDA-eGFP mice. Only data epochs when auditory cues were 
turned on during NREM or REM sleep were considered and we manually reviewed whether 
auditory tones caused wake transitions (see above for specific criteria). If cues successfully 
woke up the animal, they were categorized as ‘NREM-to-Wake’ or ‘REM-to-Wake’ trials. 
If tones did not lead to immediate wake transitions, they were categorized as ‘NREM-to-
NREM’ or ‘REM-to-REM’ trials. To confirm that sleep-related oscillations (delta for NREM 
and theta for REM) were not perturbed in  ‘NREM-to-NREM’ and ‘REM-to-REM’ trials, 
we calculated the delta and theta amplitude for NREM and REM, respectively, and determine 
whether there were any changes across the tone onset (see Figure S6H-S6K).   
 
Data analysis 
Fiber photometry data processing and analysis 
Acquired data files were loaded and processed with custom-written codes in MATLAB. Pre-
processing was performed as previously described (Lerner et al., 2015). Fiber photometry 
traces from 490 and 405 nm excitation wavelengths were first low-pass filtered at 2 Hz using 
a 4th order Butterworth filter with zero-phase distortion. To calculate ΔF/F, a least-squares 
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linear fit was applied to 405-nm signal and aligned to the 490-nm signal. The fitted 405-
nm signal was subtracted from the 490-nm signal and then divided by the fitted 405-nm 
signal again to yield the ΔF/F time-series.  
 
To visualize peri-event photometry traces, ΔF/F data epochs were extracted around 
immediately before and after relevant behavioral events (e.g. event onsets identified by either 
video scoring or TTL pulses) and averaged. For statistical comparison between baseline and 
behavior, areas under the curve (AUC) per second values were calculated for given 
conditions. Similarly, to visualize Ca2+ fluorescence change across state transitions, the 
temporal locations of state transitions were identified, and 120 seconds of photometry traces 
around the transition time points were extracted and averaged. AUC was also calculated to 
compare DRNDA population activity before and after transitions. We performed analyses for 
NREM-to-wake, REM-to-wake, wake-to-NREM, and NREM-to-REM transitions. We 
excluded other possible combinations as rodents rarely transit directly from REM to NREM, 
and none of the tested mice showed wake-to-REM transitions, which is a common feature of 
narcolepsy. We termed periods of less than 15 seconds of wakefulness after REM state as 
“short arousal” and we separately plotted these transitions as “REM-to-short arousal-to-
NREM”.  
 
To detect Ca2+ peak events from photometry traces and quantify them across sleep-wake 
states, we first normalized the trace using z-score and then high-pass filtered at 0.01 Hz using 
2nd order butterworth filter with zero-phase distortion to eliminate possible low frequency 
fluctuations across states. Then we detected prominent Ca2+ peak events with an amplitude 
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threshold, which was defined as the 75th percentile of the entire photometry data 
amplitude distribution. This percentile threshold was heuristically chosen because the 
photometry amplitude distribution is positively skewed and does not follow Gaussian 
distribution, which makes it more sensitive to the presence of outliers (such as during Ca2+ 
peak events). For quantification of these detected events, we calculated 1) peak amplitude, 
2) duration (from detection onset to offset), 3) frequency or number of events in a 5-second 
window, and 4) summed AUC values of detected events in a 5-second window. 
 
In order to account for inter-subject variability in amplitude during investigations into the 
temporal dynamics of DRNDA activity during each behavioral state from onset to offset, we 
first converted the fluorescence traces into z-scores (calculated from the entire traces). Next, 
photometry traces from each state including 10% of the trace before and after were cropped 
and down-sampled to 120 points in order to normalize the timescale. This allowed us to 
project variable length photometry traces containing z-score normalized fluorescence 
changes onto the normalized time of -0.1 to 1.1, where 0 notes the onset and 1 notes the offset 
of a wake or sleep episode.  
 
To examine any correlation between DRNDA activity and locomotion, we obtained the 
synchronized recordings of fiber photometry and video tracking. To test if increased DRNDA 
activity is associated with any change in locomotion, we detected prominent Ca2+ peak events 
as previously described above, extracted 10 seconds of velocity traces around peak event 
onsets, and then averaged. Conversely, to test if initiation of locomotion is associated 
increased DRNDA activity, we detected locomotion onset similarly as the Ca2+ peak events 
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(but with 65th percentile as an amplitude threshold), extracted 10 seconds of photometry 
traces around locomotion onsets, and then averaged.  
 
EEG spectrogram 
To visualize spectral and temporal profiles of EEG activity across distinct behavioral states, 
we decomposed EEG into time-frequency plan using Morlet wavelet. EEG data epoch of 
interest was convolved with a complex Morlet wavelet, 𝑤(𝑡, 𝑓0), having a Gaussian shape 
both in the time (𝜎𝑡) and frequency (𝜎𝑓) domain around its central frequency, 𝑓0: 
𝑤(𝑡, 𝑓0) = (
𝜎𝑡
𝜋
)−1/2 𝑒𝑥𝑝 (−
𝑡2
2𝜎𝑡2
) 𝑒𝑥𝑝(2𝑖𝜋𝑓0𝑡), where 𝜎𝑓 = 1/2𝜋𝜎𝑡. 
A wavelet family was characterized by a constant (𝑓0/𝜎𝑓) ratio of 6 from 1 to 20 Hz in 1 Hz 
steps. The time-varying energy of the signal, 𝐸(𝑡, 𝑓0), is defined as the squared norm of the 
convolution product of a complex wavelet 𝑤(𝑡, 𝑓0) , with the signal s(t): 𝐸(𝑡, 𝑓0) =
|𝑤(𝑡, 𝑓0) × 𝑠(𝑡)|
2. Time-varying energy is then smoothed by a moving average filter with 
span of 2 seconds for each frequency step to enhance visualization.  
 
Calculation of EEG frequency band 
To extract time-varying amplitude of a certain EEG frequency band (e.g. 0.5-4 Hz for delta, 
5-10 Hz for theta, and 40-100 Hz for high-frequency - notch filter was applied from 58 to 62 
Hz before calculating high-frequency activity amplitude to avoid any contribution from 60 
Hz line noise), the signal of interest was first band-pass filtered using a 2nd order Butterworth 
filter. A zero-phase shift filter was used to prevent any phase distortion. Instantaneous 
amplitude was obtained by taking the absolute value of the Hilbert transform of the band-
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passed signal. EEG frequency band amplitude signals were smoothed by a moving 
average filter (with 10-second window for Figure 4 and S4 and with 2-second window for 
Figure 6 and S6) and then normalized using z-score with respect to the baseline. EEG data 
epochs containing high-amplitude artifacts were excluded from analysis. 
 
Power spectral density 
Power spectral density was estimated for EEG data using a Welch’s method. We used a 5-
second window size and 50% overlap to estimate power from 0.5 to 100 Hz (except from 58 
to 62 Hz). For 1-hour chronic optogenetic stimulation, spectral power changes during 
optogenetic stimulation with respect to the baseline (1 hour before the stimulation) were 
obtained for both DRNDA-ChR2 and DRNDA-eGFP mice. For chemogenetic experiments, 
spectral power changes of CNO conditions from saline conditions were calculated at each 
frequency step. EEG data epochs with high-amplitude artifacts were excluded from analysis. 
 
Efficiency and specificity of GCaMP6f+ expression 
Efficiency was defined as “the number of GCaMP6f+ and TH+ neurons out of the total 
number of TH+ neurons”. Specificity was defined as “the number of GCaMP6f+ and TH+ 
neurons out of the total number of GCaMP6f+ neurons”. 
 
Ex vivo electrophysiology  
Electrophysiological recordings were performed as previously described (Xiao et al., 2016) 
to check the functionality of optogenetic and chemogenetic constructs. In brief, TH-cre mice 
expressing ChR2-eYFP or hM4Di-mCherry were euthanized with carbon dioxide and 
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transcardially perfused with ice-cold sucrose-based cutting solution saturated with 95% 
O2 / 5% CO2 (carbogen) that contained (mM) 85 NaCl, 75 sucrose, 2.5 KCl, 1.25 NaH2PO4, 
4.0 MgCl2, 0.5 CaCl2, 24 NaHCO3 and 25 glucose. The brain was removed and 250-μm 
coronal slices that contained the DRN were prepared in oxygenated cutting solution using a 
vibratome (VT-1200, Leica Biosystems, IL, USA). Slices were recovered at 32 °C for one 
hour prior to recording in carbogenated ACSF containing (mM): 125 NaCl, 2.5 KCl, 1.2 
NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 26 NaHCO3, and 11 glucose. Slices were transferred to the 
recording chamber and perfused (1.5 - 2.0 ml/min) with carbogen-saturated ACSF at 32 ± 
0.5 °C. Whole-cell patch clamp recordings of fluorescently tagged (TH+) DRN neurons were 
obtained using a MultiClamp 700B amplifier (Molecular Devices, CA, USA) and a Digidata 
1440 analog-to-digital converter (Molecular Devices). Data were sampled at 10 kHz and 
filtered at 2 kHz with Clampex 10.4 (Molecular Devices). Patch electrodes had resistance of 
4 - 6 MΩ and were filled with a potassium gluconate intrapipette solution (mM): 135 K 
gluconate, 5 KCl, 5 EGTA, 0.5 CaCl2, 10 HEPES, 2 Mg-ATP, and 0.1 GTP. 
Electrophysiological data were analyzed with Clampfit 10.4 (Molecular Devices). For Figure 
S4A, light-evoked currents (voltage clamp) and action potentials (current clamp) were 
evoked by ten of 30 Hz (10 ms pulse width) blue (420-455 nm) light delivered by an LED 
light source (Lumencor, OR, USA) in neurons held at -70mV. Once we patched hM4Di-
mCherry+ or eGFP+ DRNDA cells (Figure S5A-S5E), neuronal firing was evoked by 
depolarizing the membrane potential to -45 mV in current clamp mode. After collecting 
baseline for ~2 minutes, 1 μM of CNO was applied to the bath for neuronal silencing. After 
3-4 minutes, CNO was washed out. 
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Histology  
Perfusion 
Mice were euthanized with CO2 and transcardially perfused with 20 mL of ice-cold 1x PBS 
with heparin (10 U/mL) and then with 30 mL of ice-cold 4% PFA in 1x PBS. Mouse brains 
were carefully removed from the skull and post-fixed in 4% PFA at 4 °C overnight. The 4% 
PFA solution was switched to 1x PBS in the morning. Brains were sectioned into 50 μm 
coronal slices with a vibratome (VT1200, Leica Biosystems, IL, USA). Slices were stored in 
1x PBS at 4 °C until immunohistochemical processing. 
 
Immunohistochemistry 
Brain sections were incubated in a 1x PBS solution containing 0.1% Triton X and 10% 
normal donkey serum (NDS; Jackson ImmunoResearch, PA, USA) with primary antibodies 
(see below for details) at 4 °C overnight. Afterwards, sections were thoroughly washed four 
times (15 minutes each) in 1x PBS and temporarily stored at 4 °C. Sections were then 
transferred into a secondary cocktail, which included 1xPBS with 0.1% Triton-X, 10% NDS 
with secondary antibodies (see below for details), and stored at 4 °C overnight. The next 
morning, sections were again washed by 1x PBS solution four times (15 minutes each), 
mounted on glass microscope slides (Adhesion Superfrost Plus Glass Slides, #5075-Plus, 
Brain Research Laboratories, MA, USA), dried, and cover-slipped with a DAPI-containing 
mounting media (Fluoromount G with DAPI, 00-4959-52, eBioscience, CA, USA). 
 
Antibodies 
  
194 
For primary antibodies, anti-chicken TH (1:500; TYH, Aves Labs, OR, USA), anti-rabbit 
TH (1:500; sc-14007, Santa Cruz Biotechnology, CA, USA), anti-chicken GFP (1:500; GFP-
1020, Aves Labs), anti-goat 5HT (1:1000; 20079, ImmunoStar, WI, USA), and anti-rabbit 
mCherry (1:500; ab167453, Abcam, Cambridge, UK) were used. For secondary antibodies, 
anti-chicken/rabbit Alexa Fluor 488 (1:500; 703-545-155, 711-545-152, Jackson 
ImmunoResearch), anti-goat/rabbit Rhodamine Red-X (1:500; 705-297-003, 711-297-003, 
Jackson ImmunoResearch), and anti-rabbit/chicken Alexa Fluor 647 (1:500, 711-607-003, 
703-606-155, Jackson ImmunoResearch) were used.  
 
Confocal microscopy imaging 
Fluorescent images from brain tissue were acquired by a LSM 780 confocal microscope (Carl 
Zeiss, Jena, Germany). We used a 10x Plan Apochromat air objective (NA 0.45), 25x Plan 
Apochromat water immersion objective (NA 1.2) and 4 laser wavelengths (405 nm, 488 nm, 
561 nm, and 633 nm). Image acquisition was controlled by Zen 2011 software (Zeiss), which 
also allowed automated z-stacking, tiling, and maximum intensity projection. Images were 
not further processed. 
 
Quantification and Statistical Analysis 
All data are represented as mean ± s.e.m. Sample sizes were determined to be comparable to 
previous studies that used optogenetics or chemogenetics to study neural circuits of sleep and 
wake state regulation (Carter et al., 2010; Xu et al., 2015). All statistical analyses were 
performed with in-built functions of the Statistics and Machine Learning toolbox in 
MATLAB (Mathworks) or Prism (GraphPad). Paired and unpaired t-tests were used for 
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single value comparisons. One-way ANOVA was used to compare more than two groups. 
Two-way repeated measures ANOVA was used to perform group comparisons with multiple 
measurements. Data is considered to be statistically significant if p < 0.05. We used 
Bonferroni correction to control for multiple comparisons where appropriate. 
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C h a p t e r  4  
DORSAL RAPHE DOPAMINE NEURONS SIGNAL  
MOTIVATIONAL SALIENCE 
4.1 Summary 
The previous chapter demonstrated that DRNDA neurons are critical mediators of sleep-
wake regulation and promote behavioral arousal. Then what do these neurons encode or 
signal while animals are awake? That DRNDA neurons were robustly activated for any 
environmental stimuli with positive or negative valence, but not with neutral value, 
suggests these neurons may encode motivational salience. To further address this idea, 
mice were trained for appetitive and aversive classical conditioning tasks during fiber 
photometry recordings, where they learned associations between originally neutral cues 
and positive or negative outcomes. Across associative learning, initially unresponsive 
DRNDA neurons developed positive response to cues paired with both positive and negative 
outcomes. After extinction learning, DRNDA neurons no longer responded to the previously 
paired cues. Further experiments demonstrated that DRNDA neurons signal unsigned 
prediction error, showing enhanced neural activity for unexpected outcomes over fully 
expected ones. These salience responses were also sensitive to animal’s internal 
motivational state, as response to reward-predicting cues were diminished after satiety. 
Altogether, these data suggest that DRNDA neurons encode or signal motivational salience 
of environmental cues at the population level. 
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4.2 DRNDA dynamics during classical conditioning 
In the previous chapter, I have shown with fiber photometry recordings that DRNDA 
neuronal activity fluctuates across distinct sleep and wake states and that its activity is 
highest during wakefulness and suppressed in sleep stages. However, the level of arousal 
fluctuates even within wakefulness: for example, animals can be highly aroused and hence 
motivated to perform goal-directed behavior when they face with rewarding (such as food 
or social targets) or aversive (such as predator odor, threat, or pain) stimuli. Therefore, 
whether DRNDA neurons also respond to arousal-provoking stimuli or situation during 
wakefulness is a naturally extended question to be addressed. Indeed, Figure 1 and S2 in 
the Chapter III demonstrated that DRNDA neurons were activated by diverse arrays of 
motivationally salient stimuli or during motivated responding to such situation, regardless 
of their value (i.e., whether they are rewarding or aversive). This leads to a hypothesis that 
DRNDA neurons encode motivational salience (i.e., absolute of motivational value), distinct 
from lateral VTADA or medial SNcDA neurons that signal motivational valence (Bromberg-
Martin et al., 2010). 
 
To further address this idea, I trained TH-Cre mice expressing a novel genetically encoded 
calcium indicator jGCaMP7f (Dana et al., 2018) in the DRNDA neurons for classical 
conditioning tasks. While freely moving inside an operant chamber, mice were presented 
with two auditory tones as conditioned stimuli (CS; 5 kHz beeping at 4 Hz or continuous 
white noise) and salience or valence of these CS was manipulated by pairing with positive, 
negative, or neutral outcome at different stages. In the first stage, mice underwent 
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“appetitive learning” phase where tone A was paired with 5% sucrose water delivery 
(50 uL per trial) and tone B had no outcome (Figure 1A). Across repeated sessions, mice 
fully learned the association between tone A and reward, as demonstrated by increased 
anticipatory licks (licking after CS onset and even before reward is available) in response 
to reward-predicting tone A over neutral tone B (Figure 1B). After appetitive learning 
phase, mice underwent “aversive learning”, where tone A no longer predicted sucrose 
water delivery and tone B signaled the delivery of aversive footshocks (0.4 mA for 1 sec; 
Figure 1C). Mice were able to learn the shifts in valence of CS and appropriately responded 
to it, showing increased freezing behavior to tone B over now-neutral tone A (Figure 1D). 
Finally, mice underwent “extinction learning” phase, where salience or valence of both 
tone A and tone B was removed by pairing with no outcome.  
 
Across the three separate stages of classical conditioning tasks, motivational valence and 
salience of CS were modulated, which have no intrinsic values before associative learning 
(i.e., auditory tones do not trigger any type of response or motivated behavior). For 
example, originally neutral tone A became salient and positive in valence after appetitive 
learning and later became neutral after aversive learning and extinction (Figure 1). Tone B 
was neutral until appetitive learning phase but became salient and negative in valence after 
aversive learning and later became neutral again across extinction (Figure 1). It has been 
shown that valence-encoding lateral VTADA or medial SNcDA neurons develop positive, 
phasic responses to reward-predicting cues and reward itself, while showing inhibition or 
suppression of firing upon punishment or predicting cues (Schultz et al., 1997; Bromberg-
Martin et al., 2010; Cohen et al., 2012). I hypothesized that, if DRNDA neurons neurons are 
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functionally distinct from valence-encoding DA neurons and indeed signal 
motivational salience, it would develop positive responses to both reward- and punishment-
predictive cues across learning. 
 
Before learning occurs (1st session of appetitive conditioning), DRNDA neuronal responses 
to both CS types were present but small, and their amplitude increase was not differentiable 
until mice consumed delivered sucrose water after predictive cues and showed robust 
fluorescence increase (Figure 2A), consistent with the previous finding that DRNDA 
activity increased during reward consumption (Cho et al., 2017). Across appetitive learning, 
reward-predicting cues (tone A) developed phasic, positive response, while no-outcome 
cues (tone B) elicited negligible fluorescence change (Figure 2B). Reward consumption-
related DRNDA fluorescence increase was also present, but its amplitude was smaller than 
predictive cue response (Figure 2B). After aversive learning, however, the fluorescence 
amplitude of tone A, which predicted no outcome at this stage, was greatly diminished, 
while punishment-predicting tone B developed sustained, positive response, as well as 
phasic fluorescence increase upon footshock delivery (Figure 2C; Cho et al., 2017). After 
extinction where both of CS types predicted no outcome and their valence became neutral, 
DRNDA response to those cues were almost completely abolished (Figure 2D). 
Quantification of CS-evoked DRNDA dynamics at each stage indicated that DRNDA 
neurons developed cue responses only when they are paired to both positive and negative 
outcomes (Figure 2E). This suggests that DRNDA neurons track the dynamic nature of 
motivational salience attributed to environmental cues, rather than specific valence. 
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4.3 DRNDA neurons encode unsigned prediction error 
One of the key features in DA signaling is that ventral midbrain DA neurons encode reward 
prediction error (RPE), calculating the difference between the reward and its prediction 
(Schultz et al., 1997). In other words, unexpected reward elicits enhanced DA neuronal 
firing (positive prediction error), a fully predicted reward induces small or no response, 
and the omission of an expected reward produces a depression or inhibition of firing 
(negative prediction error). RPE serves as a key mechanism for reinforcement learning by 
monitoring error between prediction and outcome and providing feedback update (Schultz, 
2016). RPE encoding in VTADA neurons was also shown to play causal roles in cue-reward 
learning in rodents (Steinberg et al., 2013).  
 
Whether RPE encoding property is generalizable to or different in other DA populations in 
the brain remains largely unknown. To address this question, I performed prediction error 
experiments during fiber photometry recordings of DRNDA neurons in DRNDA-jGCaMP7f 
mice, after they fully learned the association between cues and positive or negative 
outcome. After appetitive learning phase, mice underwent reward prediction error 
experiments where reward was provided after predictive cue (“expected”, 10 trials per 
session), but in some cases, reward became available without any predictive cues in a 
randomized order (“unexpected”, 5 trials per session; Figure 3A). Similarly, after aversive 
learning phase, mice underwent punishment prediction error experiments, where 
unpredicted footshocks were given without cues (3 trials per session; first, second and last) 
as well as normal CS-shock paired trials (10 trials; Figure 3A). It is hypothesized that 
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unexpected reward and punishment would carry stronger salience than expected ones, 
even though the amount of reward or the current amplitude of footshock was kept identical 
(Figure 3B).  
 
Similar to RPE-encoding ventral midbrain DA neurons (Schultz et al., 1997), DRNDA 
neurons also demonstrated positive prediction error dynamics for reward: unexpected 
reward consumption elicited higher DRNDA fluorescence than expected consumption after 
predictive cues (Figure 3C). Interestingly, DRNDA neurons showed similar encoding 
strategy for punishment: unexpected footshock induced higher DRNDA fluorescence than 
expected ones delivered after predictive cues. These results indicate that DRNDA neurons 
signal unsigned prediction error, showing higher neural activity towards unexpected salient 
events.  
 
As RPE-encoding DA neurons also show negative prediction error where they show 
depression of neural activity below the baseline for unexpectedly omitted reward (Schultz 
et al., 1997), I have also performed unexpected omission experiments for both reward and 
punishment during photometry recording of DRNDA neurons. In “unexpected reward 
omission” experiment, reward-predictive cues were turned on to signal sucrose water, but 
its delivery was omitted in a few, random-ordered trials (5 out of 15 total trials; Figure 4A). 
Photometry recordings demonstrated that, in expected trials, there were robust DRNDA 
fluorescence increase for both CS and sucrose consumption, similar to “after appetitive 
learning” (Figure 2B). However, when reward was omitted, CS-evoked DRNDA neural 
activity slowly decayed back to the baseline level, showing no evidence of reduced firing 
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or inhibition below the baseline (Figure 4B). Similarly, in “unexpected footshock 
omission” experiment (Figure 4C), CS-induced DRNDA fluorescence slowly decreased 
down to the baseline level when shocks were unpredictably omitted (Figure 4D). As it was 
demonstrated that slow Ca2+ kinetics from GCaMP6 can also report inhibition-related 
depression upon unexpected reward omission in VTADA neurons (Saunders et al., 2018), 
these results suggest that DRNDA neurons may not encode negative prediction error for 
salient stimuli with suppression of neural activity like classically described RPE-encoding 
neurons. 
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4.4 DRNDA neurons are modulated by internal motivational state 
Motivational salience attributed to environmental cues can be dynamic in nature. In other 
words, the same objects can be perceived less (or more) salient depending on animal’s need 
or motivational state. For example, salience of water or food is contingent on the animal’s 
internal state: if thirsty or hungry, they perceive it as highly salient, which may drive 
approach behavior for consumption. But when fully sated, they may not perceive it as 
motivationally salient and simply ignore it. Related to this question, I asked whether 
DRNDA neuronal response to motivational salience can be modulated by internal 
motivational state or physiological need. 
 
After appetitive learning phase in classical conditioning experiments (Figure 1A), mice 
underwent the half of appetitive conditioning sessions (tone A predicted reward delivery 
and tone B predicted no outcome) when thirsty and later completed the other half after fully 
sated (Figure 5A). To induce satiety in animals, mice were given free access to regular and 
sucrose water for three hours in-between. It is hypothesized that same reward cues (tone 
A) may be perceived less motivationally salient to animals when sated (Figure 5B), 
manifested as less reward consumption in behavior and less activated DRNDA fluorescence 
to reward-predicting cues. 
 
Indeed, mice were highly motivated to obtain reward only when they were thirsty (Figure 
5C and 5D): they even showed baseline licks (0.5~1 Hz) before any cues were available. 
They could discriminate reward-predicting tone A to neutral tone B, showing increased 
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anticipatory licks only to reward-predictive CS. After satiety, baseline licking was 
absent and mice no longer showed anticipatory licks in response to reward-predictive cues. 
Mice consumed reward only in a subset of trials in satiety condition, showing slightly 
increased lick rate well after sucrose water was available. Overall, motivated behavior 
(anticipatory licks in response to reward-predicting cues) was greatly reduced from thirsty 
to sated state (Figure 5D).  
 
At the neuronal level, DRNDA responses to reward-predicting cues and reward 
consumption were present in both conditions, but the CS-evoked DRNDA fluorescence was 
significantly diminished when mice were sated (Figure 5E and 5F). On contrary, DRNDA 
response to nothing-predicting tone B was absent and not different across two conditions. 
These behavioral and neuronal data suggest that motivational salience of same 
environmental cues can be modulated by animal’s internal state or physiological need, and 
DRNDA neuronal response can faithfully follow the changed perception of motivational 
salience. 
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4.5 Future directions 
Fiber photometry recordings during classical conditioning and prediction error 
experiments suggest that DRNDA neurons encode or signal motivational salience, rather 
than valence or value. While this finding is novel and complements on the recently 
described functional heterogeneity of DA system, one natural weakness of this data is that 
fiber photometry records the bulk fluorescence from all GCaMP-expressing neurons under 
the optical fiber, providing the neuronal dynamics only at the population level. Therefore, 
potential heterogeneity within DRNDA populations, if any, cannot be addressed with this 
method. There can be multiple scenarios on what may occur at the single-cell level (Figure 
6A): for example, most of individual, responsive DRNDA neurons may fire in synchronized 
manner and behave like its population sum. It is equally plausible that DRNDA neurons are 
divided into two functional clusters, one signaling positive valence and another promoting 
negative valence. Alternatively, salience- and valence-encoding DA neurons can be 
intermingled within DRN populations. All of these scenarios can lead to same qualitative 
results in population recordings as I have observed. To address these possibilities, it is 
required to optically record DRNDA neurons at the single-cell level with surgically 
implanted gradient index (GRIN) lens and multi-photon microscope (Otis et al., 2017; 
McHenry et al., 2017).  
 
To achieve this goal, my lab and Dr. Daniel Wagenaar at the Caltech Neurotechnology 
Center worked together to build a customized two-photon microscope (Figure 6B). To 
image single DRNDA neurons, Cre-dependent adeno-associated virus encoding GCaMP6m 
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(Chen et al., 2013) was injected into the DRN of TH-Cre mice and GRIN lens was 
implanted (0.5 mm diameter, 8.4 mm length, Inscopix; with 25-degree angle from lateral 
side; Figure 6C). Mice were habituated to the head-fixation setup while waiting for optimal 
GCaMP6m expression. Individual DRNDA neurons could be visualized with this method 
and fluorescence traces for each cell could be extracted from manually hand-drawn region 
of interest (Figure 6D). Preliminary data showed that majority of recorded DRNDA neurons 
respond positively to un-cued delivery and consumption of sucrose water (Figure 6E). 
Immediate future plan with this single-cell resolution imaging technique is to perform same 
classical conditioning procedures (Figure 1) while maintaining the same field of view, in 
order to investigate the encoding properties (whether they signal salience or certain 
valence) of DRNDA neurons at the single-cell level. It is also of interest to examine how 
DRNDA neurons can modulate downstream neuronal processing in the extended amygdala 
regions. It would be viable to record individual neurons in the central amygdala or the bed 
nucleus of stria terminalis where DRNDA neurons heavily project to (Matthews et al., 2016; 
Cho et al., 2017) and investigate how they respond to salient stimuli, while modulating 
DRNDA neurons with optogenetics or chemogenetics. Those experiments are forthcoming 
and will help disclose original and novel insights on how salience-signaling DRNDA 
neurons affect circuit dynamics in the downstream forebrain regions and effectively 
promote the appropriate behavioral response to salient stimuli.  
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4.6 Figures 
 
Figure 1. Classical conditioning procedures. (A) At the first stage, mice underwent 
appetitive learning where auditory tone A predicted the delivery of 5% sucrose water 5 
seconds after onset and tone B was paired with no outcome. Therefore, tone A became 
motivationally salient (x-axis) and positive in valence (y-axis), while tone B remained 
neutral. (B) After learning, mice were able to discriminate reward-predicting cues from 
nothing-predicting cues by showing increased anticipatory licks to tone A over tone B (n 
= 5 DRNDA-jGCaMP7f mice; two-way repeated measures ANOVA revealed trend in 
interaction, F = 4.583 and p = 0.0647, and significance in time effect, F = 11.54 and p = 
0.0094. Post-hoc Bonferroni tests, *p < 0.05). (C) After appetitive learning, mice 
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underwent aversive learning phase where tone A (previously paired with sucrose water) 
no longer had outcome and tone B predicted the delivery of a footshock (0.4 mA, 1 sec) 
after 10 seconds of cue presentation. Therefore, tone A was reduced in both salience and 
valence dimensions and became neutral, while tone B became salient and negative in 
valence. (D) After aversive learning, mice were able to discriminate aversive shock-
predicting cues over neutral cues by showing increased freezing to tone B, which was 
paired with footshocks (n = 5 DRNDA-jGCaMP7f mice; two-way repeated measures ANOVA 
revealed significance in interaction, F = 10.41 and p = 0.0121, and in time effect, F = 32.15 
and p = 0.0005. Post-hoc Bonferroni tests, ***p < 0.001). (E) Finally, mice underwent 
extinction learning where both of tone A and B predicted no outcome. By extinction, both 
salience and valences of tone A and B became close to zero or neutral.  
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Figure 2. DRNDA dynamics during classical conditioning. (A) Before learning, both tone 
A (blue) and tone B (red) showed only small, non-differentiable increase of DRNDA activity 
from the baseline after conditioned stimuli (CS) onset (first dashed line). DRNDA 
fluorescence was increased upon reward consumption (second dashed line) only after tone 
A. (B) After appetitive learning, DRNDA neurons showed positive, phasic response to 
reward-predicting tone A, but showed negligible response to tone B paired with no 
outcome. Reward consumption-related response was also observed. (C) After aversive 
learning, DRNDA neurons showed higher and more positive response to shock-predicting 
tone A than now nothing-predicting tone A. Strong phasic response was recorded upon the 
delivery of footshocks after tone B. (D) After extinction, DRNDA neurons did not show 
significant responses for both tones, although there was small negative activity to tone B 
which was previously paired to punishment. (E) Quantification of cue (tone) responses 
with calculating the area under curve (AUC, per second) showed that DRNDA neurons 
developed significantly enhanced responses to reward-predicting cues after appetitive 
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learning and to punishment-predicting cues after aversive learning, both significantly 
higher than pre-learning or after extinction (n = 5 DRNDA-jGCaMP7f mice; two-way repeated 
measures ANOVA revealed significance in interaction, F = 15.78 and p < 0.0001, and in 
time effect, F = 11.63 and p < 0.0001. Post-hoc Bonferroni tests, ***p < 0.001, **p < 0.01). 
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Figure 3. DRNDA neurons encode unsigned prediction error. (A) Procedures for 
prediction error experiment. Left; After appetitive learning, reward prediction experiment 
was performed: while reward-predicting tone A was turned on to signal reward delivery, 
same amount of sucrose water was delivered without any predictive cues in a few random 
trials. Right; After aversive learning, punishment prediction experiment was performed: 
while punishment-predicting tone B was turned on to trigger footshock delivery, same 
footshock was delievered without any predictive cues in a few random trials. (B) Prediction 
error experiments enables comparison of DRNDA neuronal response to expected and 
unexpected outcomes. It is hypothesized that unexpected reward or punishment (without 
predictive cues) is more salient and also stronger (more positive or more negative) in a 
valence dimension. (C) Left; DRNDA response to unexpected rewards (darker blue) was 
larger than that to fully expected rewards (lighter blue), when aligned to consumption or 
lick onset. The last five trials were analyzed for expected condition. Right; the 
quantification of AUC confirmed that DRNDA response to unexpected rewards was 
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significantly larger than that to expected rewards (n = 5 DRNDA-jGCaMP7f mice; paired t-
test, t4 = 3.091, p = 0.0365. *p < 0.05). (D) Left; DRN
DA response to unexpected 
punishment (orange) was larger than that to fully expected punishment (yellow). Last five 
trials were analyzed for expected condition. Right; the quantification of AUC confirmed 
that DRNDA response to unexpected footshock was significantly higher than that expected  
(n = 5 DRNDA-jGCaMP7f mice; paired t-test, t4 = 3.586, p = 0.0230. *p < 0.05). 
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Figure 4. DRNDA response to unexpected omission. (A) In unexpected reward omission 
experiments after appetitive learning, tone A was turned on to predict the delivery of 
sucrose water as expected. In some trials, however, tone A was turn on without outcome 
and reward delivery was omitted. (B) DRNDA response to unexpected reward omission. 
Tone A elicited non-differentiable, positive cue responses to both cases. When reward was 
delivered as expected, mice consumed it and DRNDA activity was increased. When it was 
unexpectedly omitted, DRNDA fluorescence slowly converged to baseline. Last five trials 
were analyzed for expected condition. (C) In unexpected punishment omission 
experiments after aversive learning, tone B was turned on to predict the delivery of a 
footshock. In some trials, however, tone B was turn on but footshock delivery was omitted. 
(D) DRNDA response to unexpected footshock omission. Tone B elicited non-
differentiable, positive cue responses to both cases. When footshock was delivered as 
expected, DRNDA activity was sharply increased. When it was unexpectedly omitted, 
DRNDA fluorescence slowly went back down to baseline. Last five trials were analyzed for 
expected condition. 
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Figure 5. DRNDA response to reward-predicting cues can be modulated by internal 
motivational state. (A) To examine if DRNDA response can be affected by internal state 
or physiological needs, appetitive conditioning sessions were separately performed first 
during thirsty state and later during sated state. (B) It is hypothesized that reward cues can 
be perceived more saliently when mice are thirsty compared to sated as they are more 
motivated to consume reward after predictive cues. (C) Behavioral (lick) data with respect 
to cue (tone) onsets. When thirsty (blue on left for tone A, red on right for tone B), mice 
demonstrated increased baseline licks before CS onset and showed anticipatory licks only 
after reward-predicting tone A. After satiety, baseline licks (green on left for tone A, brown 
on right for tone B) or anticipatory licks were no longer observed. (D) Quantification of 
lick behavior. Left; Anticipatory licks were present when thirsty and were increased for 
reward-predicting tone A over nothing-predicting tone B (n = 5 DRNDA-jGCaMP7f mice; two-
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way repeated measures ANOVA revealed significance in interaction, F = 11.33 and p 
< 0.0098, and in time effect, F = 32.93 and p = 0.0004. Post-hoc Bonferroni tests, ***p < 
0.001). Middle; Anticipatory licks to tone A was significantly increased when thirsty than 
sated (n = 5 DRNDA-jGCaMP7f mice; paired t-test, t4 = 5.206, p = 0.0065, **p < 0.01). Right; 
Anticipatory licks to tone B was not different from two conditions (n = 5 DRNDA-jGCaMP7f 
mice; paired t-test, t4 = 2.444, p = 0.0709). (E) DRN
DA dynamics to cues during thirst and 
satiety. DRNDA response to reward-predicting tone A became smaller after satiety. There 
was no difference in DRNDA response to tone B with no outcome. (F) Quantification of 
photometry data. Left; DRNDA fluorescence to tone A was significantly increased during 
thirst compared to satiety (n = 5 DRNDA-jGCaMP7f mice; two-way repeated measures 
ANOVA revealed significance in interaction, F = 6.875 and p < 0.0306, and in time effect, 
F = 9.384 and p = 0.0155. Post-hoc Bonferroni tests, ***p < 0.001). Middle; DRNDA 
response to tone A was significantly higher while thirsty compared to sated (n = 5 DRNDA-
jGCaMP7f mice; paired t-test, t4 = 2.865, p = 0.0457, *p < 0.05). Right; DRN
DA response to 
tone B was not different between two conditions (n = 5 DRNDA-jGCaMP7f mice; paired t-test, 
t4 = 1.790, p = 0.1479). 
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Figure 6. Deep brain two-photon imaging of DRNDA neurons at the single cell level. 
(A) While DRNDA neurons track motivational salience at the population level, single cell 
correlates could be diverse. In case 1, most of responsive DRNDA neurons encode salience 
similar to its population sum. In case 2, DRNDA neurons are divided into two functional 
groups tune to opposite valence. In case 3, salience- and valence-encoding cells are 
intermingled. (B) Schematic of two-photon microscope and imaging when a mouse is head-
fixed under the objective. (C) Schematic of GRIN lens surgery for two-photon imaging. 
Cre-dependent AAV carrying GCaMP6m was stereotaxically injected into the DRN and 
GRIN lens is implanted. (D) Representative fields of view (standard deviation projection 
map) from 2 DRNDA-GCaMP6m mice. Fluorescence traces from three arrowed neurons were 
extracted. Vertical lines indicate sucrose water delivery. (E) Majority of DRNDA neurons 
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(74.2%, 72 out of 97 cells from 7 DRNDA-GCaMP6m mice) were significantly activated 
from baseline (paired t-test, FDR correction, significance at q < 0.05).  
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